<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>66c92c4fd6c5899239528c7d73898d26-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft10{font-size:11px;font-family:Times;color:#c02f3b;}
	.ft11{font-size:11px;font-family:Times;color:#231f20;}
	.ft12{font-size:19px;font-family:Times;color:#ac2b30;}
	.ft13{font-size:14px;font-family:Times;color:#231f20;}
	.ft14{font-size:7px;font-family:Times;color:#c13c49;}
	.ft15{font-size:8px;font-family:Times;color:#c13c49;}
	.ft16{font-size:10px;font-family:Times;color:#231f20;}
	.ft17{font-size:10px;font-family:Times;color:#231f20;}
	.ft18{font-size:10px;font-family:Times;color:#231f20;}
	.ft19{font-size:10px;font-family:Times;color:#231f20;}
	.ft110{font-size:16px;font-family:Times;color:#ac2b30;}
	.ft111{font-size:11px;font-family:Times;color:#231f20;}
	.ft112{font-size:5px;font-family:Times;color:#231f20;}
	.ft113{font-size:11px;font-family:Times;color:#231f20;}
	.ft114{font-size:13px;font-family:Times;color:#231f20;}
	.ft115{font-size:10px;font-family:Times;color:#ffffff;}
	.ft116{font-size:13px;font-family:Times;color:#ffffff;}
	.ft117{font-size:13px;font-family:Times;color:#231f20;}
	.ft118{font-size:19px;line-height:42px;font-family:Times;color:#ac2b30;}
	.ft119{font-size:7px;line-height:24px;font-family:Times;color:#c13c49;}
	.ft120{font-size:10px;line-height:21px;font-family:Times;color:#231f20;}
	.ft121{font-size:10px;line-height:19px;font-family:Times;color:#231f20;}
	.ft122{font-size:10px;line-height:19px;font-family:Times;color:#231f20;}
	.ft123{font-size:11px;line-height:18px;font-family:Times;color:#231f20;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page1-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft10">Oncotarget</p>
<p style="position:absolute;top:1111px;left:438px;white-space:nowrap" class="ft11">42382</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft10">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:122px;left:87px;white-space:nowrap" class="ft12"><b>IK channel activation increases tumor growth and induces&#160;</b></p>
<p style="position:absolute;top:148px;left:87px;white-space:nowrap" class="ft12"><b>differential&#160;behavioral responses in two breast epithelial&#160;cell&#160;</b></p>
<p style="position:absolute;top:173px;left:87px;white-space:nowrap" class="ft118"><b>lines<br/>Amy&#160;E.&#160;Thurber1,2,&#160;Michaela&#160;Nelson3,&#160;Crystal&#160;L.&#160;Frost3,&#160;Michael&#160;Levin4,&#160;William&#160;J.&#160;</b></p>
<p style="position:absolute;top:235px;left:87px;white-space:nowrap" class="ft119"><b>Brackenbury3&#160;and David L. Kaplan2<br/>1</b>Program&#160;in Cell, Molecular, and&#160;Developmental&#160;Biology, Sackler School&#160;of&#160;Graduate&#160;Biomedical Sciences,&#160;Tufts&#160;University,&#160;</p>
<p style="position:absolute;top:279px;left:93px;white-space:nowrap" class="ft16">Boston, Massachusetts, USA</p>
<p style="position:absolute;top:296px;left:87px;white-space:nowrap" class="ft120"><b>2</b>Department of Biomedical Engineering, Tufts University, Medford, Massachusetts, USA<br/><b>3</b>Department of Biology, University of York, Heslington, York, UK<br/><b>4</b>Biology&#160;Department,&#160;and&#160;Tufts&#160;Center&#160;for&#160;Regenerative&#160;and&#160;Developmental&#160;Biology,&#160;Tufts&#160;University,&#160;Medford,&#160;Massachusetts,&#160;</p>
<p style="position:absolute;top:358px;left:93px;white-space:nowrap" class="ft16">USA</p>
<p style="position:absolute;top:380px;left:87px;white-space:nowrap" class="ft17"><i><b>Correspondence to:</b>&#160;William J. Brackenbury,&#160;<b>email:</b>&#160;william.brackenbury@york.ac.uk</i></p>
<p style="position:absolute;top:395px;left:207px;white-space:nowrap" class="ft18"><i>David L. Kaplan,&#160;<b>email:</b>&#160;david.kaplan@tufts.edu</i></p>
<p style="position:absolute;top:414px;left:87px;white-space:nowrap" class="ft122"><i><b>Keywords:</b>&#160;oncochannel, bioelectricity, potassium channel, cancer<br/><b>Received:</b>&#160;April 19, 2016&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b>Accepted:</b>&#160;March 08, 2017&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<b>Published:</b>&#160;March 21, 2017<br/></i><b>Copyright:&#160;</b>Thurber&#160;et&#160;al.&#160;This&#160;is&#160;an&#160;open-access&#160;article&#160;distributed&#160;under&#160;the&#160;terms&#160;of&#160;the&#160;Creative&#160;Commons&#160;Attribution&#160;License&#160;3.0&#160;<br/>(CC&#160;BY&#160;3.0),&#160;which&#160;permits unrestricted&#160;use,&#160;distribution,&#160;and&#160;reproduction&#160;in&#160;any medium,&#160;provided the&#160;original author&#160;and source&#160;<br/>are&#160;credited.</p>
<p style="position:absolute;top:526px;left:87px;white-space:nowrap" class="ft110"><b>ABSTRACT</b></p>
<p style="position:absolute;top:567px;left:177px;white-space:nowrap" class="ft111"><b>Many potassium channel families are over-expressed in cancer, but&#160;their mechanistic&#160;</b></p>
<p style="position:absolute;top:586px;left:141px;white-space:nowrap" class="ft123"><b>role in disease progression is poorly understood. Potassium channels modulate membrane&#160;<br/>potential&#160;(V</b></p>
<p style="position:absolute;top:615px;left:227px;white-space:nowrap" class="ft112"><b>mem)&#160;and&#160;thereby&#160;influence&#160;calcium&#160;ion&#160;dynamics&#160;and&#160;other&#160;voltage-sensitive&#160;</b></p>
<p style="position:absolute;top:624px;left:141px;white-space:nowrap" class="ft123"><b>signaling&#160;mechanisms,&#160;potentially&#160;acting&#160;as&#160;transcriptional&#160;regulators.&#160;This&#160;study&#160;<br/>investigated&#160;the&#160;differential&#160;response&#160;to&#160;over-expression&#160;and&#160;activation&#160;of&#160;a&#160;cancer-<br/>associated&#160;potassium&#160;channel,&#160;the&#160;intermediate&#160;conductance&#160;calcium-activated&#160;potassium&#160;<br/>channel&#160;(IK),&#160;on aggressive&#160;behaviors&#160;in mammary&#160;epithelial&#160;and breast&#160;cancer&#160;cell&#160;lines.&#160;<br/>IK&#160;was&#160;over-expressed&#160;in&#160;the&#160;highly&#160;metastatic&#160;breast&#160;cancer&#160;cell&#160;line&#160;MDA-MB-231&#160;<br/>and the spontaneously immortalized breast&#160;epithelial cell line MCF-10A, and the effect&#160;<br/>on cancer-associated behaviors was assessed. IK over-expression increased primary&#160;<br/>tumor growth and metastasis of MDA-MB-231 in orthotopic xenografts, demonstrating&#160;<br/>for&#160;the&#160;first&#160;time&#160;in&#160;any&#160;cancer&#160;type&#160;that&#160;increased&#160;IK&#160;is&#160;sufficient&#160;to&#160;promote&#160;cancer&#160;<br/>aggression. The primary tumors had similar vascularization as determined by CD31&#160;<br/>staining and similar histological characteristics. Interestingly, despite the increased&#160;<br/><i>in vivo</i></b><b>&#160;growth and metastasis, neither IK over-expression nor activation with agonist&#160;<br/>had&#160;a&#160;significant&#160;effect&#160;on&#160;MDA-MB-231&#160;proliferation,&#160;invasion,&#160;or&#160;migration&#160;<i>in&#160;vitro</i></b><b>.&#160;In&#160;<br/>contrast, IK decreased MCF-10A proliferation and invasion through Matrigel but had no&#160;<br/>effect&#160;on&#160;migration&#160;in&#160;a&#160;scratch-wound&#160;assay.&#160;We&#160;conclude&#160;that&#160;IK&#160;activity&#160;is&#160;sufficient&#160;<br/>to&#160;promote cell aggression&#160;<i>in vivo</i></b><b>. Our data provide novel evidence supporting IK and&#160;<br/>downstream signaling networks as potential targets for cancer therapies.</b></p>
<p style="position:absolute;top:962px;left:87px;white-space:nowrap" class="ft110"><b>INTRODUCTION</b></p>
<p style="position:absolute;top:1001px;left:123px;white-space:nowrap" class="ft114">Breast cancer is one of the most common forms of&#160;</p>
<p style="position:absolute;top:1020px;left:87px;white-space:nowrap" class="ft114">cancer with roughly 230,000 new cases per year and is&#160;</p>
<p style="position:absolute;top:1038px;left:87px;white-space:nowrap" class="ft114">responsible for 40,000 deaths in the United States alone.&#160;</p>
<p style="position:absolute;top:1056px;left:87px;white-space:nowrap" class="ft114">About 1 in every 8 women will be diagnosed with breast&#160;</p>
<p style="position:absolute;top:1074px;left:87px;white-space:nowrap" class="ft114">cancer at some point in her lifetime.&#160;Women diagnosed&#160;</p>
<p style="position:absolute;top:962px;left:487px;white-space:nowrap" class="ft114">with localized breast cancer have an excellent prognosis&#160;</p>
<p style="position:absolute;top:981px;left:487px;white-space:nowrap" class="ft114">with over 98% 5 year survival. Unfortunately, patients&#160;</p>
<p style="position:absolute;top:999px;left:487px;white-space:nowrap" class="ft114">with metastases have only a 25.9% 5 year survival&#160;</p>
<p style="position:absolute;top:1018px;left:487px;white-space:nowrap" class="ft114">highlighting the need for treatments aimed at metastasis&#160;</p>
<p style="position:absolute;top:1037px;left:487px;white-space:nowrap" class="ft114">[1].&#160;A&#160;major&#160;hindrance&#160;to&#160;the&#160;development&#160;of&#160;better&#160;breast&#160;</p>
<p style="position:absolute;top:1055px;left:487px;white-space:nowrap" class="ft114">cancer treatments is a lack of understanding of what drives&#160;</p>
<p style="position:absolute;top:1074px;left:487px;white-space:nowrap" class="ft114">disease&#160;progression&#160;to&#160;metastasis.&#160;For decades&#160;it&#160;has&#160;been&#160;</p>
<p style="position:absolute;top:68px;left:77px;white-space:nowrap" class="ft115"><b>www.impactjournals.com/oncotarget/&#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160;</b></p>
<p style="position:absolute;top:65px;left:397px;white-space:nowrap" class="ft116"><b>Oncotarget, 2017, Vol. 8, (No. 26), pp: 42382-42397</b></p>
<p style="position:absolute;top:98px;left:714px;white-space:nowrap" class="ft117"><b>Research Paper</b></p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>66c92c4fd6c5899239528c7d73898d26-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft20{font-size:11px;font-family:Times;color:#c02f3b;}
	.ft21{font-size:11px;font-family:Times;color:#231f20;}
	.ft22{font-size:13px;font-family:Times;color:#231f20;}
	.ft23{font-size:13px;font-family:Times;color:#231f20;}
	.ft24{font-size:16px;font-family:Times;color:#ac2b30;}
	.ft25{font-size:14px;font-family:Times;color:#231f20;}
	.ft26{font-size:7px;font-family:Times;color:#231f20;}
	.ft27{font-size:6px;font-family:Times;color:#231f20;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page2-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft20">Oncotarget</p>
<p style="position:absolute;top:1111px;left:438px;white-space:nowrap" class="ft21">42383</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft20">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:70px;left:87px;white-space:nowrap" class="ft22">known that some cancers remain in a benign state for long&#160;</p>
<p style="position:absolute;top:88px;left:87px;white-space:nowrap" class="ft22">time&#160;periods&#160;while&#160;others&#160;quickly&#160;progress&#160;to&#160;malignancy,&#160;</p>
<p style="position:absolute;top:106px;left:87px;white-space:nowrap" class="ft22">and that generally only a subset of tumor cells are&#160;</p>
<p style="position:absolute;top:124px;left:87px;white-space:nowrap" class="ft22">capable&#160;of&#160;metastasis.&#160;Although&#160;many&#160;metastasis-specific&#160;</p>
<p style="position:absolute;top:142px;left:87px;white-space:nowrap" class="ft22">pathways have been described, our understanding of the&#160;</p>
<p style="position:absolute;top:160px;left:87px;white-space:nowrap" class="ft22">upstream signals that activate these pathways, and the&#160;</p>
<p style="position:absolute;top:178px;left:87px;white-space:nowrap" class="ft22">factors that cause certain cells to metastasize while nearby&#160;</p>
<p style="position:absolute;top:196px;left:87px;white-space:nowrap" class="ft22">syngeneic cells do not, remain largely unknown [2].</p>
<p style="position:absolute;top:214px;left:123px;white-space:nowrap" class="ft22">Over the past decade ion channels have been receiving&#160;</p>
<p style="position:absolute;top:232px;left:87px;white-space:nowrap" class="ft22">increased attention for their roles in cancer progression.&#160;</p>
<p style="position:absolute;top:250px;left:87px;white-space:nowrap" class="ft22">Numerous cancer types have altered ion channel expression,&#160;</p>
<p style="position:absolute;top:268px;left:87px;white-space:nowrap" class="ft22">with expression of certain channels correlating with cancer&#160;</p>
<p style="position:absolute;top:286px;left:87px;white-space:nowrap" class="ft22">stage&#160;[3].&#160;In&#160;various&#160;cases,&#160;inhibiting&#160;these&#160;channels&#160;leads&#160;to&#160;</p>
<p style="position:absolute;top:304px;left:87px;white-space:nowrap" class="ft22">a decrease in cancer-associated behaviors including primary&#160;</p>
<p style="position:absolute;top:322px;left:87px;white-space:nowrap" class="ft22">tumor growth and metastasis&#160;<i>in vivo</i>&#160;[4–6]. Most studies have&#160;</p>
<p style="position:absolute;top:340px;left:87px;white-space:nowrap" class="ft22">focused on ion channels as downstream targets of signaling&#160;</p>
<p style="position:absolute;top:358px;left:87px;white-space:nowrap" class="ft22">pathways that execute critical mechanical functions required for&#160;</p>
<p style="position:absolute;top:376px;left:87px;white-space:nowrap" class="ft22">aggressive behaviors. For instance, inhibiting certain chloride&#160;</p>
<p style="position:absolute;top:394px;left:87px;white-space:nowrap" class="ft22">and potassium channels responsible for generating changes&#160;</p>
<p style="position:absolute;top:412px;left:87px;white-space:nowrap" class="ft22">in cell volume decreases cell migration and proliferation [7].&#160;</p>
<p style="position:absolute;top:430px;left:87px;white-space:nowrap" class="ft22">However,&#160;evidence&#160;suggests&#160;ion&#160;channels&#160;may&#160;have&#160;upstream&#160;</p>
<p style="position:absolute;top:448px;left:87px;white-space:nowrap" class="ft22">regulatory roles as well, and little is known about the ability of&#160;</p>
<p style="position:absolute;top:466px;left:87px;white-space:nowrap" class="ft22">ion channel activity to initiate signaling cascades to promote&#160;</p>
<p style="position:absolute;top:484px;left:87px;white-space:nowrap" class="ft22">aggressive cancer behaviors [8, 9].</p>
<p style="position:absolute;top:502px;left:123px;white-space:nowrap" class="ft22">The intermediate conductance calcium-activated&#160;</p>
<p style="position:absolute;top:520px;left:87px;white-space:nowrap" class="ft22">potassium channel (IK) is over-expressed in numerous&#160;</p>
<p style="position:absolute;top:538px;left:87px;white-space:nowrap" class="ft22">cancer types including breast, prostate, uterus, stomach,&#160;</p>
<p style="position:absolute;top:556px;left:87px;white-space:nowrap" class="ft22">colorectal, pancreas, pituitary gland, and brain cancers&#160;</p>
<p style="position:absolute;top:574px;left:87px;white-space:nowrap" class="ft22">[10] and inhibiting IK decreases cancer cell proliferation,&#160;</p>
<p style="position:absolute;top:592px;left:87px;white-space:nowrap" class="ft22">migration, and&#160;<i>in vivo</i>&#160;tumor growth and metastasis&#160;</p>
<p style="position:absolute;top:592px;left:433px;white-space:nowrap" class="ft22">&#160;</p>
<p style="position:absolute;top:610px;left:87px;white-space:nowrap" class="ft22">[11–16].&#160;Based&#160;on&#160;these&#160;results,&#160;the&#160;widely&#160;held&#160;theory&#160;in&#160;the&#160;</p>
<p style="position:absolute;top:628px;left:87px;white-space:nowrap" class="ft22">field&#160;is&#160;that&#160;IK&#160;is&#160;a&#160;downstream&#160;effector&#160;of&#160;signaling&#160;pathways&#160;</p>
<p style="position:absolute;top:646px;left:87px;white-space:nowrap" class="ft22">and&#160;is&#160;required&#160;in&#160;the&#160;late&#160;steps&#160;of&#160;enacting&#160;aggressive&#160;cancer&#160;</p>
<p style="position:absolute;top:664px;left:87px;white-space:nowrap" class="ft22">behaviors. However, IK may have additional upstream&#160;</p>
<p style="position:absolute;top:682px;left:87px;white-space:nowrap" class="ft22">instructive&#160;roles&#160;and&#160;its&#160;activity&#160;may&#160;be&#160;sufficient&#160;to&#160;initiate&#160;</p>
<p style="position:absolute;top:700px;left:87px;white-space:nowrap" class="ft22">aggressive behaviors through its effect on calcium dynamics.&#160;</p>
<p style="position:absolute;top:718px;left:87px;white-space:nowrap" class="ft22">In prostate cancer cells, activation of IK with its agonist&#160;</p>
<p style="position:absolute;top:736px;left:87px;white-space:nowrap" class="ft22">was&#160;sufficient&#160;to&#160;significantly&#160;increase&#160;intracellular&#160;calcium&#160;</p>
<p style="position:absolute;top:754px;left:87px;white-space:nowrap" class="ft22">concentrations suggesting IK could regulate downstream&#160;</p>
<p style="position:absolute;top:772px;left:87px;white-space:nowrap" class="ft22">calcium-dependent signaling pathways [17]. Furthermore,&#160;</p>
<p style="position:absolute;top:790px;left:87px;white-space:nowrap" class="ft22">IK&#160;&#160;activation&#160;&#160;was&#160;&#160;sufficient&#160;&#160;to&#160;&#160;increase&#160;&#160;prostate&#160;&#160;cancer&#160;</p>
<p style="position:absolute;top:808px;left:87px;white-space:nowrap" class="ft22">proliferation, providing additional evidence of the ability of&#160;</p>
<p style="position:absolute;top:826px;left:87px;white-space:nowrap" class="ft22">IK to activate signaling pathways [12]. However, the possible&#160;</p>
<p style="position:absolute;top:844px;left:87px;white-space:nowrap" class="ft22">sufficiency&#160;of&#160;IK&#160;to&#160;promote&#160;aggressiveness&#160;has&#160;not&#160;been&#160;</p>
<p style="position:absolute;top:862px;left:87px;white-space:nowrap" class="ft22">previously studied in breast cancer cells.</p>
<p style="position:absolute;top:880px;left:123px;white-space:nowrap" class="ft22">In the present study, our aims were (1) to investigate&#160;</p>
<p style="position:absolute;top:898px;left:87px;white-space:nowrap" class="ft22">whether&#160;&#160;increased&#160;&#160;IK&#160;&#160;activity&#160;&#160;was&#160;&#160;sufficient&#160;&#160;to&#160;&#160;promote&#160;</p>
<p style="position:absolute;top:916px;left:87px;white-space:nowrap" class="ft22">proliferation&#160;in&#160;breast&#160;epithelial&#160;cells&#160;and&#160;cancer&#160;cells&#160;and&#160;(2)&#160;</p>
<p style="position:absolute;top:934px;left:87px;white-space:nowrap" class="ft22">to&#160;investigate&#160;whether&#160;an&#160;increase&#160;in&#160;IK&#160;was&#160;also&#160;sufficient&#160;</p>
<p style="position:absolute;top:952px;left:87px;white-space:nowrap" class="ft22">to increase other aggressive cancer behaviors, including&#160;</p>
<p style="position:absolute;top:970px;left:87px;white-space:nowrap" class="ft22">tumor growth and metastasis&#160;<i>in vivo</i>.&#160;We chose to use the&#160;</p>
<p style="position:absolute;top:988px;left:87px;white-space:nowrap" class="ft22">metastatic breast cancer cell line MDA-MB-231 because&#160;</p>
<p style="position:absolute;top:1006px;left:87px;white-space:nowrap" class="ft22">IK inhibition studies demonstrated decreased proliferation,&#160;</p>
<p style="position:absolute;top:1024px;left:87px;white-space:nowrap" class="ft22">migration, and colony formation indicating IK has an&#160;</p>
<p style="position:absolute;top:1042px;left:87px;white-space:nowrap" class="ft22">important physiological&#160;role&#160;in aggressive behaviors in this&#160;</p>
<p style="position:absolute;top:1060px;left:87px;white-space:nowrap" class="ft22">cell line [18]. Surprisingly, we found that MDA-MB-231&#160;</p>
<p style="position:absolute;top:70px;left:487px;white-space:nowrap" class="ft23"><i>in&#160;vitro</i>&#160;proliferation,&#160;invasion,&#160;and&#160;migration&#160;were&#160;not&#160;</p>
<p style="position:absolute;top:88px;left:487px;white-space:nowrap" class="ft22">affected by IK over-expression or activation. Interestingly,&#160;</p>
<p style="position:absolute;top:106px;left:487px;white-space:nowrap" class="ft22">however, increased IK decreased proliferation and invasion&#160;</p>
<p style="position:absolute;top:124px;left:487px;white-space:nowrap" class="ft22">of the spontaneously immortalized breast epithelial non-</p>
<p style="position:absolute;top:142px;left:487px;white-space:nowrap" class="ft22">tumorigenic MCF-10A&#160;cell line but had no effect on&#160;</p>
<p style="position:absolute;top:160px;left:487px;white-space:nowrap" class="ft22">migration. In contrast to the&#160;<i>in vitro</i>&#160;results, we found that&#160;</p>
<p style="position:absolute;top:178px;left:487px;white-space:nowrap" class="ft22">over-expressing&#160;&#160;IK&#160;&#160;in&#160;&#160;MDA-MB-231&#160;&#160;was&#160;&#160;sufficient&#160;&#160;to&#160;</p>
<p style="position:absolute;top:196px;left:487px;white-space:nowrap" class="ft22">increase primary tumor growth and metastasis in mice.&#160;</p>
<p style="position:absolute;top:214px;left:487px;white-space:nowrap" class="ft22">This&#160;study&#160;is&#160;the&#160;first&#160;to&#160;demonstrate&#160;the&#160;sufficiency&#160;of&#160;IK&#160;to&#160;</p>
<p style="position:absolute;top:232px;left:487px;white-space:nowrap" class="ft22">increase cancer aggression&#160;<i>in vivo</i>&#160;and suggests the possibility&#160;</p>
<p style="position:absolute;top:250px;left:487px;white-space:nowrap" class="ft22">of key differences in behavioral response to IK activation&#160;</p>
<p style="position:absolute;top:268px;left:487px;white-space:nowrap" class="ft22">between tumorigenic and non-tumorigenic cells, although&#160;</p>
<p style="position:absolute;top:286px;left:487px;white-space:nowrap" class="ft22">more&#160;cell&#160;lines&#160;must&#160;be&#160;tested&#160;to&#160;determine&#160;a&#160;potential&#160;trend.&#160;</p>
<p style="position:absolute;top:304px;left:487px;white-space:nowrap" class="ft22">Our results indicate that IK plays an important instructive role&#160;</p>
<p style="position:absolute;top:322px;left:487px;white-space:nowrap" class="ft22">in cancer progression and suggest the possibility of unique&#160;</p>
<p style="position:absolute;top:340px;left:487px;white-space:nowrap" class="ft22">signaling mechanisms that could be used as specific targets.</p>
<p style="position:absolute;top:375px;left:487px;white-space:nowrap" class="ft24"><b>RESULTS</b></p>
<p style="position:absolute;top:414px;left:487px;white-space:nowrap" class="ft25"><b>IK over-expression increases potassium current&#160;</b></p>
<p style="position:absolute;top:434px;left:487px;white-space:nowrap" class="ft25"><b>and&#160;hyperpolarizes&#160;V</b></p>
<p style="position:absolute;top:447px;left:638px;white-space:nowrap" class="ft26"><b>mem</b></p>
<p style="position:absolute;top:468px;left:523px;white-space:nowrap" class="ft22">In&#160;&#160;order&#160;&#160;to&#160;&#160;test&#160;&#160;the&#160;&#160;sufficiency&#160;&#160;of&#160;&#160;increased&#160;&#160;IK&#160;&#160;to&#160;</p>
<p style="position:absolute;top:486px;left:487px;white-space:nowrap" class="ft22">induce increased aggression in the breast cancer cell line&#160;</p>
<p style="position:absolute;top:504px;left:487px;white-space:nowrap" class="ft22">MDA-MB-231,&#160;we&#160;first&#160;generated&#160;cells&#160;with&#160;increased&#160;IK&#160;</p>
<p style="position:absolute;top:522px;left:487px;white-space:nowrap" class="ft22">expression. Cells were infected by a retrovirus encoding&#160;</p>
<p style="position:absolute;top:540px;left:487px;white-space:nowrap" class="ft22">either&#160;IK&#160;and&#160;red&#160;fluorescent&#160;protein&#160;(RFP)&#160;or&#160;RFP&#160;alone&#160;</p>
<p style="position:absolute;top:558px;left:487px;white-space:nowrap" class="ft22">as&#160;vector&#160;control&#160;and&#160;selected&#160;for&#160;RFP&#160;using&#160;fluorescence&#160;</p>
<p style="position:absolute;top:576px;left:487px;white-space:nowrap" class="ft22">activated cell sorting (FACS) (Supplementary Figure&#160;</p>
<p style="position:absolute;top:594px;left:487px;white-space:nowrap" class="ft22">1). MDA&#160;MB 231 have previously been reported to&#160;</p>
<p style="position:absolute;top:612px;left:487px;white-space:nowrap" class="ft22">endogenously express IK [19](data accessible at NCBI Geo&#160;</p>
<p style="position:absolute;top:630px;left:487px;white-space:nowrap" class="ft22">database&#160;GSE41678).&#160;We&#160;confirmed&#160;that&#160;IK&#160;was&#160;expressed&#160;</p>
<p style="position:absolute;top:648px;left:487px;white-space:nowrap" class="ft22">in&#160;&#160;control&#160;&#160;cells&#160;&#160;(MDA-MB-231-RFP)&#160;&#160;by&#160;&#160;RT-PCR&#160;&#160;and&#160;</p>
<p style="position:absolute;top:666px;left:487px;white-space:nowrap" class="ft22">that cells infected with IK virus (MDA-MB-231-IK) had&#160;</p>
<p style="position:absolute;top:684px;left:487px;white-space:nowrap" class="ft22">significantly&#160;increased&#160;IK&#160;expression&#160;(p&#160;=&#160;0.0027,&#160;2-sample&#160;</p>
<p style="position:absolute;top:702px;left:487px;white-space:nowrap" class="ft22">t-test,&#160;Figure&#160;1A).&#160;Overexpression&#160;was&#160;further&#160;confirmed&#160;at&#160;</p>
<p style="position:absolute;top:720px;left:487px;white-space:nowrap" class="ft22">the protein level by immunofluorescence (Figure 1B).</p>
<p style="position:absolute;top:738px;left:523px;white-space:nowrap" class="ft22">To validate functional activity of the over-expressed&#160;</p>
<p style="position:absolute;top:756px;left:487px;white-space:nowrap" class="ft22">IK&#160;channel,&#160;the electric&#160;current&#160;density&#160;and&#160;V</p>
<p style="position:absolute;top:767px;left:794px;white-space:nowrap" class="ft27">mem&#160;of&#160;</p>
<p style="position:absolute;top:774px;left:487px;white-space:nowrap" class="ft22">individual cells were measured in the presence or absence&#160;</p>
<p style="position:absolute;top:792px;left:487px;white-space:nowrap" class="ft22">of&#160;200&#160;μM&#160;of&#160;the&#160;IK&#160;agonist&#160;1-&#160;Ethylbenzimidazolinone&#160;</p>
<p style="position:absolute;top:810px;left:487px;white-space:nowrap" class="ft22">(1-EBIO). It should be noted that 1-EBIO is also an&#160;</p>
<p style="position:absolute;top:828px;left:487px;white-space:nowrap" class="ft22">agonist of the closely related small conductance calcium&#160;</p>
<p style="position:absolute;top:846px;left:487px;white-space:nowrap" class="ft22">activated potassium channels (SK) [20]. However, SK&#160;</p>
<p style="position:absolute;top:864px;left:487px;white-space:nowrap" class="ft22">transcripts&#160;&#160;were&#160;&#160;below&#160;&#160;the&#160;&#160;limit&#160;&#160;of&#160;&#160;detection&#160;&#160;using&#160;&#160;RT-</p>
<p style="position:absolute;top:882px;left:487px;white-space:nowrap" class="ft22">PCR&#160;suggesting&#160;that&#160;IK&#160;is&#160;more&#160;prevalent.&#160;Furthermore,&#160;</p>
<p style="position:absolute;top:900px;left:487px;white-space:nowrap" class="ft22">treatment of MDA-MB-231 with the IK specific antagonist&#160;</p>
<p style="position:absolute;top:918px;left:487px;white-space:nowrap" class="ft22">TRAM-34&#160;&#160;inhibits&#160;&#160;most&#160;&#160;calcium-sensitive&#160;&#160;potassium&#160;</p>
<p style="position:absolute;top:936px;left:487px;white-space:nowrap" class="ft22">current indicating&#160;that SK has lower endogenous&#160;activity&#160;</p>
<p style="position:absolute;top:954px;left:487px;white-space:nowrap" class="ft22">[18]. Electrophysiological recordings were acquired in&#160;</p>
<p style="position:absolute;top:972px;left:487px;white-space:nowrap" class="ft22">the&#160;cell&#160;attached&#160;configuration&#160;using&#160;a&#160;perforated&#160;patch&#160;in&#160;</p>
<p style="position:absolute;top:990px;left:487px;white-space:nowrap" class="ft22">order to best maintain the endogenous cytosolic contents&#160;</p>
<p style="position:absolute;top:1008px;left:487px;white-space:nowrap" class="ft22">and&#160;preserve V</p>
<p style="position:absolute;top:1019px;left:583px;white-space:nowrap" class="ft27">mem. 1-EBIO treatment had no effect on&#160;</p>
<p style="position:absolute;top:1026px;left:487px;white-space:nowrap" class="ft22">current&#160;&#160;density&#160;&#160;of&#160;&#160;control&#160;&#160;MDA-MB-231-RFP&#160;&#160;cells&#160;</p>
<p style="position:absolute;top:1044px;left:487px;white-space:nowrap" class="ft22">(q&#160;&#160;=&#160;&#160;0.15;&#160;&#160;1-way&#160;&#160;ANOVA&#160;&#160;of&#160;&#160;0&#160;&#160;mV&#160;&#160;current&#160;&#160;density).&#160;</p>
<p style="position:absolute;top:1062px;left:487px;white-space:nowrap" class="ft22">Similarly, IK over-expression had no effect on current&#160;</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>66c92c4fd6c5899239528c7d73898d26-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft30{font-size:11px;font-family:Times;color:#c02f3b;}
	.ft31{font-size:11px;font-family:Times;color:#231f20;}
	.ft32{font-size:13px;font-family:Times;color:#231f20;}
	.ft33{font-size:13px;font-family:Times;color:#231f20;}
	.ft34{font-size:6px;font-family:Times;color:#231f20;}
	.ft35{font-size:11px;font-family:Times;color:#231f20;}
	.ft36{font-size:5px;font-family:Times;color:#231f20;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page3-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft30">Oncotarget</p>
<p style="position:absolute;top:1111px;left:438px;white-space:nowrap" class="ft31">42384</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft30">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:70px;left:87px;white-space:nowrap" class="ft32">density&#160;in&#160;the&#160;absence&#160;of&#160;1-EBIO&#160;(q&#160;=&#160;.31;&#160;1-way&#160;ANOVA&#160;</p>
<p style="position:absolute;top:88px;left:87px;white-space:nowrap" class="ft32">of 0 mV&#160;current density). However, in MDA-MB-231-IK&#160;</p>
<p style="position:absolute;top:106px;left:87px;white-space:nowrap" class="ft32">cells,&#160;1-EBIO&#160;treatment&#160;significantly&#160;increased&#160;the&#160;current&#160;</p>
<p style="position:absolute;top:124px;left:87px;white-space:nowrap" class="ft32">density from 0.98 ± 2.32 pA/pF to 32.33 ± 13.60 pA/pF (p&#160;&lt;&#160;</p>
<p style="position:absolute;top:142px;left:87px;white-space:nowrap" class="ft32">.001,&#160;q&#160;=&#160;12.30&#160;1-way&#160;ANOVA&#160;of&#160;0&#160;mV&#160;current&#160;density;&#160;</p>
<p style="position:absolute;top:160px;left:87px;white-space:nowrap" class="ft32">Figure 1C). Furthermore, the current density of MDA-</p>
<p style="position:absolute;top:70px;left:487px;white-space:nowrap" class="ft32">MB-231-IK&#160;treated&#160;with&#160;1-EBIO&#160;was&#160;significantly&#160;larger&#160;</p>
<p style="position:absolute;top:88px;left:487px;white-space:nowrap" class="ft32">than&#160;either&#160;untreated&#160;or&#160;1-EBIO&#160;treated&#160;control&#160;cells&#160;(q&#160;=&#160;</p>
<p style="position:absolute;top:106px;left:487px;white-space:nowrap" class="ft32">11.31&#160;and&#160;q&#160;=&#160;11.14&#160;respectively,&#160;1-way&#160;ANOVA&#160;of&#160;0&#160;mV&#160;</p>
<p style="position:absolute;top:124px;left:487px;white-space:nowrap" class="ft32">current&#160;density).&#160;The&#160;reversal&#160;potential&#160;for&#160;MDA-MB-231-</p>
<p style="position:absolute;top:142px;left:487px;white-space:nowrap" class="ft32">IK EBIO treated cells was -76.21 ± 2.58 mV, relatively near&#160;</p>
<p style="position:absolute;top:160px;left:487px;white-space:nowrap" class="ft32">the potassium reversal potential predicted by the Nernst&#160;</p>
<p style="position:absolute;top:861px;left:87px;white-space:nowrap" class="ft33"><b>Figure 1: Functional contribution of IK over-expression to current density and&#160;V</b></p>
<p style="position:absolute;top:873px;left:624px;white-space:nowrap" class="ft34"><b>mem.</b>&#160;&#160;<b>(A)</b>&#160;&#160;IK&#160;&#160;mRNA&#160;&#160;expression&#160;&#160;levels&#160;</p>
<p style="position:absolute;top:879px;left:87px;white-space:nowrap" class="ft31">relative&#160;to&#160;GAPDH&#160;in&#160;total&#160;RNA&#160;collected&#160;from&#160;MDA-MB-231&#160;infected&#160;with&#160;pMIG-RFP&#160;(Cont.)&#160;or&#160;pMIG-IK&#160;(IK)&#160;and&#160;selected&#160;for&#160;RFP&#160;</p>
<p style="position:absolute;top:895px;left:87px;white-space:nowrap" class="ft31">fluorescence&#160;by&#160;FACS.&#160;Data&#160;are&#160;presented&#160;as&#160;mean&#160;with&#160;standard&#160;error&#160;of&#160;the&#160;mean&#160;(SEM)&#160;of&#160;3&#160;independent&#160;replicates&#160;(**&#160;significant&#160;</p>
<p style="position:absolute;top:912px;left:87px;white-space:nowrap" class="ft31">difference&#160;p&#160;&lt;&#160;0.01,&#160;2&#160;sample&#160;t-test).&#160;<b>(B)</b>&#160;MDA-MB-231&#160;control&#160;or&#160;MDA-MB-231-IK&#160;were&#160;fixed&#160;on&#160;coverslips&#160;and&#160;immunofluorescence&#160;</p>
<p style="position:absolute;top:928px;left:87px;white-space:nowrap" class="ft31">microscopy&#160;was&#160;performed&#160;using&#160;antibodies&#160;to&#160;IK&#160;(green)&#160;with&#160;DAPI&#160;(blue)&#160;staining&#160;of&#160;the&#160;nuclei.&#160;Increased&#160;intensity&#160;of&#160;the&#160;green&#160;IK&#160;</p>
<p style="position:absolute;top:944px;left:87px;white-space:nowrap" class="ft31">staining&#160;is evident&#160;in&#160;the&#160;MDA-MB-231-IK sample.&#160;<b>(C)</b>&#160;Endogenous&#160;and&#160;1-EBIO induced&#160;current-voltage&#160;relationship&#160;in&#160;control&#160;and&#160;</p>
<p style="position:absolute;top:960px;left:87px;white-space:nowrap" class="ft31">IK-expressing&#160;cells&#160;recorded&#160;in&#160;the&#160;cell&#160;attached&#160;perforated&#160;patch&#160;configuration&#160;from&#160;MDA-MB-231&#160;cells.&#160;Data&#160;are&#160;presented&#160;as&#160;mean&#160;</p>
<p style="position:absolute;top:976px;left:87px;white-space:nowrap" class="ft31">±&#160;SEM&#160;from&#160;a&#160;minimum&#160;of&#160;7&#160;recordings.&#160;The&#160;current&#160;density&#160;was&#160;significantly&#160;increased&#160;in&#160;MDA-MB-231-IK&#160;1-EBIO&#160;treated&#160;cells&#160;as&#160;</p>
<p style="position:absolute;top:993px;left:87px;white-space:nowrap" class="ft31">compared&#160;to&#160;control&#160;vehicle&#160;treated,&#160;control&#160;1-EBIO&#160;treated,&#160;and&#160;MDA-MB-231-IK&#160;vehicle&#160;treated&#160;cells&#160;(***&#160;p&#160;&lt;&#160;0.001,&#160;1-way&#160;ANOVA&#160;</p>
<p style="position:absolute;top:1009px;left:87px;white-space:nowrap" class="ft31">of 0 mV&#160;current density)&#160;<b>(D)</b>&#160;V</p>
<p style="position:absolute;top:1019px;left:260px;white-space:nowrap" class="ft36">mem&#160;averaged&#160;over 20 seconds from recordings of same cells&#160;as C. Data points represent&#160;individual&#160;cells,&#160;</p>
<p style="position:absolute;top:1025px;left:87px;white-space:nowrap" class="ft31">bars&#160;show&#160;mean&#160;with&#160;SEM&#160;(***&#160;indicates&#160;significantly&#160;different&#160;than&#160;vehicle&#160;treated&#160;control&#160;p&#160;&lt;&#160;.001,&#160;1-way&#160;ANOVA).&#160;<b>(E)</b>&#160;V</p>
<p style="position:absolute;top:1035px;left:762px;white-space:nowrap" class="ft36">mem&#160;recording&#160;</p>
<p style="position:absolute;top:1041px;left:87px;white-space:nowrap" class="ft31">of representative&#160;MDA-MB-231&#160;control&#160;cell&#160;(top) and MDA-MB-231-IK&#160;cell&#160;(bottom)&#160;with bath solution exchanged&#160;to 1-EBIO solution&#160;</p>
<p style="position:absolute;top:1057px;left:87px;white-space:nowrap" class="ft31">beginning at 30&#160;seconds and continuing through duration of recording.&#160;There is a ~7 second delay between when the solutions are changed&#160;</p>
<p style="position:absolute;top:1074px;left:87px;white-space:nowrap" class="ft31">and when the new solution reaches the cells.</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>66c92c4fd6c5899239528c7d73898d26-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft40{font-size:11px;font-family:Times;color:#c02f3b;}
	.ft41{font-size:11px;font-family:Times;color:#231f20;}
	.ft42{font-size:13px;font-family:Times;color:#231f20;}
	.ft43{font-size:6px;font-family:Times;color:#231f20;}
	.ft44{font-size:14px;font-family:Times;color:#231f20;}
	.ft45{font-size:14px;font-family:Times;color:#231f20;}
	.ft46{font-size:13px;font-family:Times;color:#231f20;}
	.ft47{font-size:13px;font-family:Times;color:#231f20;}
	.ft48{font-size:11px;font-family:Times;color:#231f20;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page4-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft40">Oncotarget</p>
<p style="position:absolute;top:1111px;left:438px;white-space:nowrap" class="ft41">42385</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft40">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:70px;left:87px;white-space:nowrap" class="ft42">equation (-89.9 mV), indicating the current was comprised&#160;</p>
<p style="position:absolute;top:88px;left:87px;white-space:nowrap" class="ft42">primarily&#160;of&#160;potassium&#160;flux.&#160;These&#160;data&#160;suggest&#160;that&#160;MDA-</p>
<p style="position:absolute;top:106px;left:87px;white-space:nowrap" class="ft42">MB-231-IK&#160;cells&#160;express&#160;significantly&#160;more&#160;functional&#160;IK&#160;</p>
<p style="position:absolute;top:124px;left:87px;white-space:nowrap" class="ft42">channels than control MDA-MB-231-RFP&#160;cells.</p>
<p style="position:absolute;top:142px;left:123px;white-space:nowrap" class="ft42">IK over-expression without agonist treatment did&#160;</p>
<p style="position:absolute;top:160px;left:87px;white-space:nowrap" class="ft42">not&#160;&#160;significantly&#160;&#160;alter&#160;&#160;the&#160;&#160;V</p>
<p style="position:absolute;top:172px;left:263px;white-space:nowrap" class="ft43">mem&#160;of MDA-MB-231 cells&#160;</p>
<p style="position:absolute;top:178px;left:87px;white-space:nowrap" class="ft42">(control -26.3 ± 8.2 mV, MDA-MB-231-IK -33.5 ± 16.5&#160;</p>
<p style="position:absolute;top:196px;left:87px;white-space:nowrap" class="ft42">mV,&#160;&#160;q&#160;&#160;=&#160;&#160;1.34,&#160;&#160;1-way&#160;&#160;ANOVA).&#160;&#160;However,&#160;&#160;there&#160;&#160;was&#160;</p>
<p style="position:absolute;top:214px;left:87px;white-space:nowrap" class="ft42">a greater range of&#160;V</p>
<p style="position:absolute;top:226px;left:221px;white-space:nowrap" class="ft43">mem&#160;values in the MDA-MB-231-</p>
<p style="position:absolute;top:232px;left:87px;white-space:nowrap" class="ft42">IK population (range of -6.4 to -67.6 mV) compared to&#160;</p>
<p style="position:absolute;top:250px;left:87px;white-space:nowrap" class="ft42">control&#160;cells&#160;(range&#160;of&#160;-13.9&#160;to&#160;-40.6&#160;mV;&#160;p&#160;=&#160;0.045;&#160;F&#160;</p>
<p style="position:absolute;top:268px;left:87px;white-space:nowrap" class="ft42">test&#160;to compare variance)&#160;with&#160;the&#160;IK&#160;population&#160;being&#160;</p>
<p style="position:absolute;top:286px;left:87px;white-space:nowrap" class="ft42">skewed towards hyperpolarized (control -0.26, MDA-</p>
<p style="position:absolute;top:304px;left:87px;white-space:nowrap" class="ft42">MB-231-IK&#160;-0.62,&#160;adjusted&#160;Fisher-Pearson&#160;standardized&#160;</p>
<p style="position:absolute;top:322px;left:87px;white-space:nowrap" class="ft42">moment&#160;coefficient),&#160;suggesting&#160;IK&#160;over-expression&#160;leads&#160;</p>
<p style="position:absolute;top:340px;left:87px;white-space:nowrap" class="ft42">to increased basal levels of conductance in some cells or&#160;</p>
<p style="position:absolute;top:358px;left:87px;white-space:nowrap" class="ft42">is transiently active (Figure 1D).&#160;Application of 1-EBIO&#160;</p>
<p style="position:absolute;top:376px;left:87px;white-space:nowrap" class="ft42">significantly&#160;hyperpolarized&#160;the&#160;V</p>
<p style="position:absolute;top:388px;left:296px;white-space:nowrap" class="ft43">mem&#160;of MDA-MB-231-</p>
<p style="position:absolute;top:394px;left:87px;white-space:nowrap" class="ft42">IK cells to -73.9 ± -2.8 mV&#160;(p &lt; .001, paired 2-sample&#160;</p>
<p style="position:absolute;top:412px;left:87px;white-space:nowrap" class="ft42">t-test). 1-EBIO also hyperpolarized the&#160;V</p>
<p style="position:absolute;top:424px;left:349px;white-space:nowrap" class="ft43">mem&#160;in control&#160;</p>
<p style="position:absolute;top:430px;left:87px;white-space:nowrap" class="ft42">cells,&#160;although&#160;this&#160;was&#160;not&#160;statistically&#160;significant&#160;(-40.3&#160;</p>
<p style="position:absolute;top:448px;left:87px;white-space:nowrap" class="ft42">±&#160;17.7&#160;mV;&#160;p&#160;=&#160;0.06&#160;paired&#160;2-sample&#160;t-test).&#160;Additionally,&#160;</p>
<p style="position:absolute;top:466px;left:87px;white-space:nowrap" class="ft42">control&#160;cells&#160;exhibited&#160;a&#160;fluctuation&#160;in&#160;V</p>
<p style="position:absolute;top:478px;left:331px;white-space:nowrap" class="ft43">mem&#160;at the time of&#160;</p>
<p style="position:absolute;top:484px;left:87px;white-space:nowrap" class="ft42">1-EBIO&#160;application,&#160;suggesting&#160;the&#160;presence&#160;of&#160;active&#160;IK&#160;</p>
<p style="position:absolute;top:502px;left:87px;white-space:nowrap" class="ft42">or SK channels (Figure 1E).</p>
<p style="position:absolute;top:538px;left:87px;white-space:nowrap" class="ft44"><b>MDA-MB-231&#160;<i>in vitro</i></b><b>&#160;proliferation, invasion,&#160;</b></p>
<p style="position:absolute;top:558px;left:87px;white-space:nowrap" class="ft44"><b>and migration are unaffected by IK over-</b></p>
<p style="position:absolute;top:578px;left:87px;white-space:nowrap" class="ft44"><b>expression and activation</b></p>
<p style="position:absolute;top:611px;left:123px;white-space:nowrap" class="ft42">We next investigated the effect of IK expression&#160;</p>
<p style="position:absolute;top:629px;left:87px;white-space:nowrap" class="ft42">and&#160;activity&#160;on&#160;<i>in&#160;vitro</i>&#160;behaviors&#160;of&#160;MDA-MB-231&#160;cells.&#160;</p>
<p style="position:absolute;top:647px;left:87px;white-space:nowrap" class="ft42">IK is endogenously activated by calcium signaling and&#160;</p>
<p style="position:absolute;top:665px;left:87px;white-space:nowrap" class="ft42">its activation is highly temporally and spatially regulated&#160;</p>
<p style="position:absolute;top:683px;left:87px;white-space:nowrap" class="ft42">which&#160;may&#160;be&#160;important&#160;to&#160;its&#160;downstream&#160;function&#160;[13].&#160;</p>
<p style="position:absolute;top:70px;left:487px;white-space:nowrap" class="ft42">We wanted to compare the effect of increased IK current&#160;</p>
<p style="position:absolute;top:88px;left:487px;white-space:nowrap" class="ft42">responding to endogenous temporal&#160;and spatial&#160;activation&#160;</p>
<p style="position:absolute;top:106px;left:487px;white-space:nowrap" class="ft42">as&#160;well&#160;as&#160;to&#160;low&#160;and&#160;high&#160;levels&#160;of&#160;continuous&#160;pan-IK&#160;</p>
<p style="position:absolute;top:124px;left:487px;white-space:nowrap" class="ft42">activation. Cells over-expressing IK were expected to&#160;</p>
<p style="position:absolute;top:142px;left:487px;white-space:nowrap" class="ft42">maintain&#160;endogenous&#160;activation&#160;patterning&#160;but&#160;with&#160;larger&#160;</p>
<p style="position:absolute;top:160px;left:487px;white-space:nowrap" class="ft42">currents.&#160;We therefore compared the behavioral response&#160;</p>
<p style="position:absolute;top:178px;left:487px;white-space:nowrap" class="ft42">of control and IK over-expressing cells treated or untreated&#160;</p>
<p style="position:absolute;top:196px;left:487px;white-space:nowrap" class="ft42">with agonist.</p>
<p style="position:absolute;top:214px;left:523px;white-space:nowrap" class="ft42">It has been previously reported that IK over-</p>
<p style="position:absolute;top:232px;left:487px;white-space:nowrap" class="ft42">activation by agonist treatment increases proliferation&#160;</p>
<p style="position:absolute;top:250px;left:487px;white-space:nowrap" class="ft42">in prostate cancer cells [12]. Here, we monitored the&#160;</p>
<p style="position:absolute;top:268px;left:487px;white-space:nowrap" class="ft42">proliferation&#160;of&#160;both&#160;control&#160;and&#160;IK&#160;over-expressing&#160;</p>
<p style="position:absolute;top:286px;left:487px;white-space:nowrap" class="ft42">MDA-MB-231 cells over 4 days in the presence or&#160;</p>
<p style="position:absolute;top:304px;left:487px;white-space:nowrap" class="ft42">absence&#160;of&#160;1-EBIO.&#160;We&#160;found&#160;that&#160;there&#160;was&#160;no&#160;significant&#160;</p>
<p style="position:absolute;top:322px;left:487px;white-space:nowrap" class="ft42">difference in proliferation across any of the conditions&#160;</p>
<p style="position:absolute;top:340px;left:487px;white-space:nowrap" class="ft42">(Day&#160;4:&#160;p&#160;=&#160;0.33&#160;1-way&#160;ANOVA;&#160;Figure&#160;2A).&#160;We&#160;next&#160;</p>
<p style="position:absolute;top:358px;left:487px;white-space:nowrap" class="ft42">evaluated&#160;<i>in vitro</i>&#160;behaviors associated with metastasis.&#160;</p>
<p style="position:absolute;top:376px;left:487px;white-space:nowrap" class="ft42">The ability of cells to invade was assayed&#160;<i>in vitro</i>&#160;using&#160;</p>
<p style="position:absolute;top:394px;left:487px;white-space:nowrap" class="ft42">a&#160;transwell&#160;assay&#160;in&#160;which&#160;the&#160;number&#160;of&#160;cells&#160;invading&#160;</p>
<p style="position:absolute;top:412px;left:487px;white-space:nowrap" class="ft42">across a Matrigel-coated membrane in response to a&#160;</p>
<p style="position:absolute;top:430px;left:487px;white-space:nowrap" class="ft42">serum&#160;gradient&#160;was&#160;quantified.&#160;There&#160;was&#160;no&#160;significant&#160;</p>
<p style="position:absolute;top:448px;left:487px;white-space:nowrap" class="ft42">difference in the number of invading cells across any&#160;</p>
<p style="position:absolute;top:466px;left:487px;white-space:nowrap" class="ft42">of&#160;the&#160;conditions&#160;(p&#160;=&#160;0.32&#160;1-way&#160;ANOVA;&#160;Figure&#160;2B).&#160;</p>
<p style="position:absolute;top:484px;left:487px;white-space:nowrap" class="ft42">Similarly, migration in&#160;a&#160;scratch&#160;wound assay&#160;was&#160;not&#160;</p>
<p style="position:absolute;top:502px;left:487px;white-space:nowrap" class="ft42">altered,&#160;with&#160;no&#160;significant&#160;difference&#160;in&#160;the&#160;surface&#160;area&#160;</p>
<p style="position:absolute;top:520px;left:487px;white-space:nowrap" class="ft42">of&#160;wound&#160;recovery&#160;after&#160;10&#160;h&#160;(p&#160;=&#160;0.41&#160;1-way&#160;ANOVA;&#160;</p>
<p style="position:absolute;top:538px;left:487px;white-space:nowrap" class="ft42">Figure 2C).&#160;These results suggest that increased IK&#160;</p>
<p style="position:absolute;top:556px;left:487px;white-space:nowrap" class="ft42">activity&#160;is&#160;not&#160;sufficient&#160;to&#160;increase&#160;<i>in vitro</i>&#160;measures&#160;of&#160;</p>
<p style="position:absolute;top:574px;left:487px;white-space:nowrap" class="ft42">MDA-MB-231 cell aggression.</p>
<p style="position:absolute;top:610px;left:487px;white-space:nowrap" class="ft44"><b>IK over-expression and activation decreases&#160;</b></p>
<p style="position:absolute;top:630px;left:487px;white-space:nowrap" class="ft44"><b>colony formation of MDA-MB-231 Cells</b></p>
<p style="position:absolute;top:663px;left:523px;white-space:nowrap" class="ft42">The ability to form colonies in soft agar is used as&#160;</p>
<p style="position:absolute;top:681px;left:487px;white-space:nowrap" class="ft42">an&#160;<i>in vitro</i>&#160;measure of transformation and tumor forming&#160;</p>
<p style="position:absolute;top:958px;left:87px;white-space:nowrap" class="ft47"><b>Figure 2: IK over-expression and&#160;activation with 1-EBIO had no effect on MDA-MB-231 proliferation, invasion, or&#160;</b></p>
<p style="position:absolute;top:975px;left:87px;white-space:nowrap" class="ft47"><b>migration.</b>&#160;<b>(A)</b>&#160;Proliferation&#160;of&#160;control&#160;and&#160;IK&#160;over-expressing&#160;MDA-MB-231&#160;cells&#160;was&#160;quantified&#160;over&#160;4&#160;days&#160;for&#160;cells&#160;treated&#160;with&#160;</p>
<p style="position:absolute;top:993px;left:87px;white-space:nowrap" class="ft41">vehicle&#160;control&#160;or&#160;1-EBIO.&#160;There&#160;was&#160;no&#160;significant&#160;difference&#160;in&#160;cell&#160;number&#160;on&#160;any&#160;day&#160;(Day&#160;4:&#160;p&#160;=&#160;0.33,&#160;1-way&#160;ANOVA).&#160;<b>(B)</b>&#160;Invasion&#160;</p>
<p style="position:absolute;top:1009px;left:87px;white-space:nowrap" class="ft41">through&#160;Matrigel&#160;coated&#160;transwell&#160;after&#160;16&#160;h&#160;using&#160;FBS&#160;as&#160;a&#160;chemoattractant.&#160;Average&#160;number&#160;of&#160;cells&#160;per&#160;field&#160;of&#160;view&#160;with&#160;4&#160;fields&#160;of&#160;view&#160;</p>
<p style="position:absolute;top:1025px;left:87px;white-space:nowrap" class="ft41">per&#160;sample&#160;and&#160;4&#160;replicates&#160;in&#160;each&#160;of&#160;3&#160;independent&#160;experiments.&#160;There&#160;was&#160;no&#160;significant&#160;difference&#160;in&#160;the&#160;number&#160;of&#160;invading&#160;cells&#160;across&#160;</p>
<p style="position:absolute;top:1041px;left:87px;white-space:nowrap" class="ft41">any&#160;condition&#160;(p&#160;=&#160;0.32,&#160;1-way&#160;ANOVA)&#160;<b>(C)</b>&#160;A&#160;confluent&#160;layer&#160;of&#160;MDA-MB-231&#160;control&#160;or&#160;MDA-MB-231-IK&#160;was&#160;scratched&#160;and&#160;healing&#160;</p>
<p style="position:absolute;top:1057px;left:87px;white-space:nowrap" class="ft41">was&#160;assessed&#160;after&#160;10&#160;h&#160;with&#160;vehicle&#160;control&#160;or&#160;1-EBIO&#160;treatment.&#160;There&#160;was&#160;no&#160;significant&#160;difference&#160;in&#160;the&#160;normalized&#160;surface&#160;area&#160;of&#160;</p>
<p style="position:absolute;top:1074px;left:87px;white-space:nowrap" class="ft41">wound recovery (p = 0.41, 1-way&#160;ANOVA).&#160;All data presented as mean with SEM of three independent replicates.</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>66c92c4fd6c5899239528c7d73898d26-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft50{font-size:11px;font-family:Times;color:#c02f3b;}
	.ft51{font-size:11px;font-family:Times;color:#231f20;}
	.ft52{font-size:13px;font-family:Times;color:#231f20;}
	.ft53{font-size:14px;font-family:Times;color:#231f20;}
	.ft54{font-size:6px;font-family:Times;color:#231f20;}
	.ft55{font-size:13px;font-family:Times;color:#231f20;}
	.ft56{font-size:13px;font-family:Times;color:#231f20;}
	.ft57{font-size:11px;font-family:Times;color:#231f20;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page5-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft50">Oncotarget</p>
<p style="position:absolute;top:1111px;left:438px;white-space:nowrap" class="ft51">42386</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft50">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:70px;left:87px;white-space:nowrap" class="ft52">ability. Inducing expression of oncogenes such as c-MYC&#160;</p>
<p style="position:absolute;top:88px;left:87px;white-space:nowrap" class="ft52">or&#160;RAS&#160;in&#160;non-tumorigenic&#160;cell&#160;lines&#160;can&#160;confer&#160;colony&#160;</p>
<p style="position:absolute;top:106px;left:87px;white-space:nowrap" class="ft52">forming ability which correlates with tumor formation&#160;</p>
<p style="position:absolute;top:124px;left:87px;white-space:nowrap" class="ft52">in mouse xenografts demonstrating the capacity of this&#160;</p>
<p style="position:absolute;top:142px;left:87px;white-space:nowrap" class="ft52">assay&#160;to&#160;assess conversion&#160;to&#160;a&#160;malignant&#160;phenotype&#160;[21].&#160;</p>
<p style="position:absolute;top:160px;left:87px;white-space:nowrap" class="ft52">MDA-MB-231 cells are highly malignant and therefore&#160;</p>
<p style="position:absolute;top:178px;left:87px;white-space:nowrap" class="ft52">readily form colonies. Given that IK is over-expressed&#160;</p>
<p style="position:absolute;top:196px;left:87px;white-space:nowrap" class="ft52">in many metastatic cancers, we anticipated increased IK&#160;</p>
<p style="position:absolute;top:214px;left:87px;white-space:nowrap" class="ft52">activity would increase colony formation. Surprisingly,&#160;</p>
<p style="position:absolute;top:232px;left:87px;white-space:nowrap" class="ft52">colony formation in IK-expressing cells was decreased&#160;</p>
<p style="position:absolute;top:250px;left:87px;white-space:nowrap" class="ft52">to 64% as compared to untreated control and was&#160;</p>
<p style="position:absolute;top:268px;left:87px;white-space:nowrap" class="ft52">further&#160;decreased&#160;to&#160;30%&#160;by&#160;1-EBIO&#160;treatment&#160;(Figure&#160;</p>
<p style="position:absolute;top:286px;left:87px;white-space:nowrap" class="ft52">3A–3B;&#160;&#160;p&#160;&#160;&lt;&#160;&#160;0.001&#160;&#160;1-way&#160;ANOVA).&#160;&#160;1-EBIO&#160;&#160;similarly&#160;</p>
<p style="position:absolute;top:304px;left:87px;white-space:nowrap" class="ft52">reduced the colony formation of control MDA-MB-231&#160;</p>
<p style="position:absolute;top:322px;left:87px;white-space:nowrap" class="ft52">cells to 32% of untreated cells.&#160;These&#160;data suggest that&#160;</p>
<p style="position:absolute;top:340px;left:87px;white-space:nowrap" class="ft52">treatment with 1-EBIO, which induces constant IK&#160;</p>
<p style="position:absolute;top:358px;left:87px;white-space:nowrap" class="ft52">activation, more severely inhibits colony formation than&#160;</p>
<p style="position:absolute;top:376px;left:87px;white-space:nowrap" class="ft52">elevated transiently&#160;activated&#160;IK&#160;induced&#160;by&#160;increased&#160;IK&#160;</p>
<p style="position:absolute;top:394px;left:87px;white-space:nowrap" class="ft52">expression.</p>
<p style="position:absolute;top:430px;left:87px;white-space:nowrap" class="ft53"><b>IK activation decreases MCF-10A&#160;proliferation&#160;</b></p>
<p style="position:absolute;top:450px;left:87px;white-space:nowrap" class="ft53"><b>and invasion</b></p>
<p style="position:absolute;top:483px;left:123px;white-space:nowrap" class="ft52">MDA-MB-231 cells are highly aggressive and&#160;</p>
<p style="position:absolute;top:501px;left:87px;white-space:nowrap" class="ft52">so the lack of effect of IK expression/activity on cell&#160;</p>
<p style="position:absolute;top:519px;left:87px;white-space:nowrap" class="ft52">proliferation, migration,&#160;and invasion may be due&#160;to&#160;an&#160;</p>
<p style="position:absolute;top:537px;left:87px;white-space:nowrap" class="ft52">inability to&#160;further&#160;augment&#160;these already&#160;aggressive&#160;</p>
<p style="position:absolute;top:555px;left:87px;white-space:nowrap" class="ft52">behaviors.&#160;We therefore tested the effect&#160;of increased IK&#160;</p>
<p style="position:absolute;top:573px;left:87px;white-space:nowrap" class="ft52">expression and activation in the non-tumorigenic breast&#160;</p>
<p style="position:absolute;top:591px;left:87px;white-space:nowrap" class="ft52">epithelial MCF-10A&#160;cell line.&#160;We created an IK over-</p>
<p style="position:absolute;top:609px;left:87px;white-space:nowrap" class="ft52">expressing population of MCF-10A&#160;cells.&#160;As with MDA-</p>
<p style="position:absolute;top:627px;left:87px;white-space:nowrap" class="ft52">MB-231, MCF-10A-IK cells had dramatically increased&#160;</p>
<p style="position:absolute;top:70px;left:487px;white-space:nowrap" class="ft52">IK&#160;expression&#160;(p&#160;&lt;&#160;0.001,&#160;2-sample&#160;t-test;&#160;Supplementary&#160;</p>
<p style="position:absolute;top:88px;left:487px;white-space:nowrap" class="ft52">Figure 2A)&#160;and&#160;increased current density at 0&#160;mV&#160;with&#160;</p>
<p style="position:absolute;top:106px;left:487px;white-space:nowrap" class="ft52">1-EBIO treatment from 0.483 +/- 0.344 pA/pF in control&#160;</p>
<p style="position:absolute;top:124px;left:487px;white-space:nowrap" class="ft52">cells&#160;to 22.90 +/- 18.46 pA/pF in MCF-10A-IK (p &lt; .001,&#160;</p>
<p style="position:absolute;top:142px;left:487px;white-space:nowrap" class="ft52">q&#160;=&#160;7.30&#160;1-way&#160;ANOVA,&#160;Supplementary&#160;Figure&#160;2B).&#160;IK&#160;</p>
<p style="position:absolute;top:160px;left:487px;white-space:nowrap" class="ft52">over-expression&#160;without&#160;agonist&#160;treatment&#160;hyperpolarized&#160;</p>
<p style="position:absolute;top:178px;left:487px;white-space:nowrap" class="ft52">the V</p>
<p style="position:absolute;top:190px;left:520px;white-space:nowrap" class="ft54">mem&#160;of MCF-10A&#160;cells from -21 ± 6.3 mV&#160;in control&#160;</p>
<p style="position:absolute;top:196px;left:487px;white-space:nowrap" class="ft52">cells to -47 ± 14.7 mV&#160;in MCF-10A-IK cells (p &lt; 0.001,&#160;</p>
<p style="position:absolute;top:214px;left:487px;white-space:nowrap" class="ft52">1-way&#160;ANOVA;&#160;Supplementary&#160;Figure&#160;2C)&#160;indicating&#160;the&#160;</p>
<p style="position:absolute;top:232px;left:487px;white-space:nowrap" class="ft52">overexpressed channels were activated by endogenous&#160;</p>
<p style="position:absolute;top:250px;left:487px;white-space:nowrap" class="ft52">signaling.&#160;Application of 1-EBIO hyperpolarized MCF-</p>
<p style="position:absolute;top:268px;left:487px;white-space:nowrap" class="ft52">10A&#160;control cell&#160;V</p>
<p style="position:absolute;top:280px;left:600px;white-space:nowrap" class="ft54">mem&#160;to -31 ± 7.4 mV&#160;(p &lt; 0.01, paired t&#160;</p>
<p style="position:absolute;top:286px;left:487px;white-space:nowrap" class="ft52">test) indicating that the cells have endogenous IK or SK&#160;</p>
<p style="position:absolute;top:304px;left:487px;white-space:nowrap" class="ft52">channels. 1-EBIO treatment induced a larger effect on&#160;</p>
<p style="position:absolute;top:322px;left:487px;white-space:nowrap" class="ft52">MCF-10A-IK cells, hyperpolarizing the&#160;V</p>
<p style="position:absolute;top:334px;left:755px;white-space:nowrap" class="ft54">mem&#160;to -69 ±&#160;</p>
<p style="position:absolute;top:340px;left:487px;white-space:nowrap" class="ft52">6.9 mV&#160;(p &lt; 0.01, paired t-test).&#160;Although the effect of&#160;</p>
<p style="position:absolute;top:358px;left:487px;white-space:nowrap" class="ft52">1-EBIO treatment may have been partially mediated by&#160;</p>
<p style="position:absolute;top:376px;left:487px;white-space:nowrap" class="ft52">SK&#160;channel activation, we were not able to detect SK&#160;</p>
<p style="position:absolute;top:394px;left:487px;white-space:nowrap" class="ft52">transcripts&#160;by&#160;RT-PCR&#160;suggesting&#160;SK&#160;has&#160;either&#160;very&#160;low&#160;</p>
<p style="position:absolute;top:412px;left:487px;white-space:nowrap" class="ft52">or no expression in MCF-10A&#160;cells. In summary, these&#160;</p>
<p style="position:absolute;top:430px;left:487px;white-space:nowrap" class="ft52">data&#160;demonstrate&#160;that&#160;IK&#160;overexpression&#160;in&#160;MCF-10A&#160;</p>
<p style="position:absolute;top:448px;left:487px;white-space:nowrap" class="ft52">cells induces a similar change in electrical properties to&#160;</p>
<p style="position:absolute;top:466px;left:487px;white-space:nowrap" class="ft52">MDA-MB-231 cells.</p>
<p style="position:absolute;top:484px;left:523px;white-space:nowrap" class="ft52">We next studied the effect of IK expression and&#160;</p>
<p style="position:absolute;top:502px;left:487px;white-space:nowrap" class="ft52">activity on&#160;<i>in vitro</i>&#160;measures of aggression in MCF-10A&#160;</p>
<p style="position:absolute;top:520px;left:487px;white-space:nowrap" class="ft52">cells. IK over-expression alone had no effect on MCF-10A&#160;</p>
<p style="position:absolute;top:538px;left:487px;white-space:nowrap" class="ft52">cell proliferation, but activation of IK by 1-EBIO treatment&#160;</p>
<p style="position:absolute;top:556px;left:487px;white-space:nowrap" class="ft52">significantly&#160;decreased&#160;proliferation&#160;of&#160;control&#160;MCF-10A&#160;</p>
<p style="position:absolute;top:574px;left:487px;white-space:nowrap" class="ft52">cells by 33 ± 4 % and IK expressing cells by 43 ± 16 %&#160;</p>
<p style="position:absolute;top:592px;left:487px;white-space:nowrap" class="ft52">(p&#160;&lt;&#160;0.01,&#160;1-way&#160;ANOVA;&#160;Figure&#160;4A).&#160;MCF-10A&#160;invasion&#160;</p>
<p style="position:absolute;top:610px;left:487px;white-space:nowrap" class="ft52">was&#160;significantly&#160;decreased&#160;by&#160;both&#160;IK&#160;over-expression&#160;</p>
<p style="position:absolute;top:628px;left:487px;white-space:nowrap" class="ft52">and&#160;activation&#160;(p&#160;&lt;&#160;0.001,&#160;1-way&#160;ANOVA;&#160;Figure&#160;4B).&#160;</p>
<p style="position:absolute;top:1007px;left:87px;white-space:nowrap" class="ft56"><b>Figure 3: MDA-MB-231 soft agarose colony formation is decreased by both IK expression and IK activation.</b>&#160;<b>(A)</b>&#160;Bright&#160;</p>
<p style="position:absolute;top:1025px;left:87px;white-space:nowrap" class="ft51">field&#160;images&#160;of&#160;crystal&#160;violet&#160;stained&#160;MDA-MB-231&#160;control&#160;and&#160;MDA-MB-231-IK&#160;cells&#160;grown&#160;in&#160;soft&#160;agarose&#160;and&#160;treated&#160;with&#160;vehicle&#160;</p>
<p style="position:absolute;top:1041px;left:87px;white-space:nowrap" class="ft51">control&#160;or 1-EBIO for 28 days.&#160;<b>(B)</b>&#160;Quantification&#160;of&#160;colonies&#160;from&#160;A.&#160;Data&#160;presented&#160;as&#160;mean&#160;with&#160;standard&#160;deviation&#160;of&#160;three&#160;independent&#160;</p>
<p style="position:absolute;top:1057px;left:87px;white-space:nowrap" class="ft51">replicates,&#160;***&#160;indicates&#160;significantly&#160;different&#160;than&#160;vehicle&#160;treated&#160;control,&#160;+++&#160;significant&#160;difference&#160;between&#160;indicated&#160;samples&#160;(p&#160;&lt;&#160;0.001&#160;</p>
<p style="position:absolute;top:1074px;left:87px;white-space:nowrap" class="ft51">1-way ANOVA).</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>66c92c4fd6c5899239528c7d73898d26-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft60{font-size:11px;font-family:Times;color:#c02f3b;}
	.ft61{font-size:11px;font-family:Times;color:#231f20;}
	.ft62{font-size:13px;font-family:Times;color:#231f20;}
	.ft63{font-size:14px;font-family:Times;color:#231f20;}
	.ft64{font-size:13px;font-family:Times;color:#231f20;}
	.ft65{font-size:6px;font-family:Times;color:#231f20;}
	.ft66{font-size:13px;font-family:Times;color:#231f20;}
	.ft67{font-size:11px;font-family:Times;color:#231f20;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page6-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft60">Oncotarget</p>
<p style="position:absolute;top:1111px;left:438px;white-space:nowrap" class="ft61">42387</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft60">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:70px;left:87px;white-space:nowrap" class="ft62">It should be noted that in the control condition, less than&#160;</p>
<p style="position:absolute;top:88px;left:87px;white-space:nowrap" class="ft62">1% of the cells loaded in the upper chamber invaded to&#160;</p>
<p style="position:absolute;top:106px;left:87px;white-space:nowrap" class="ft62">the&#160;lower&#160;chamber&#160;reflecting&#160;similar&#160;basal&#160;invasion&#160;levels&#160;</p>
<p style="position:absolute;top:124px;left:87px;white-space:nowrap" class="ft62">as&#160;has&#160;been&#160;reported&#160;elsewhere&#160;and&#160;significantly&#160;reduced&#160;</p>
<p style="position:absolute;top:142px;left:87px;white-space:nowrap" class="ft62">as compared to MDA-MB-231 [22–24]. However, no&#160;</p>
<p style="position:absolute;top:160px;left:87px;white-space:nowrap" class="ft62">significant&#160;change&#160;in&#160;cell&#160;migration&#160;using&#160;a&#160;wound&#160;scratch&#160;</p>
<p style="position:absolute;top:178px;left:87px;white-space:nowrap" class="ft62">assay&#160;was&#160;observed&#160;across&#160;any&#160;condition&#160;(p&#160;=&#160;0.28,&#160;1-way&#160;</p>
<p style="position:absolute;top:196px;left:87px;white-space:nowrap" class="ft62">ANOVA;&#160;Figure&#160;4C).&#160;Finally,&#160;we&#160;tested&#160;the&#160;effect&#160;of&#160;IK&#160;</p>
<p style="position:absolute;top:214px;left:87px;white-space:nowrap" class="ft62">expression and activity on colony-forming ability. MCF-</p>
<p style="position:absolute;top:232px;left:87px;white-space:nowrap" class="ft62">10A&#160;is an immortal but not transformed cell line and is&#160;</p>
<p style="position:absolute;top:250px;left:87px;white-space:nowrap" class="ft62">unable to form colonies in soft agarose but can be induced&#160;</p>
<p style="position:absolute;top:268px;left:87px;white-space:nowrap" class="ft62">to form colonies by expression of strong oncogenes [25].&#160;</p>
<p style="position:absolute;top:286px;left:87px;white-space:nowrap" class="ft62">Neither MCF-10A&#160;control nor MCF-10A-IK cells were&#160;</p>
<p style="position:absolute;top:304px;left:87px;white-space:nowrap" class="ft62">able to form colonies with or without 1-EBIO treatment&#160;</p>
<p style="position:absolute;top:322px;left:87px;white-space:nowrap" class="ft62">(Supplementary Figure 3).</p>
<p style="position:absolute;top:358px;left:87px;white-space:nowrap" class="ft63"><b>IK over-activation by 1-EBIO causes MCF-10A&#160;</b></p>
<p style="position:absolute;top:378px;left:87px;white-space:nowrap" class="ft63"><b>but not MDA-MB-231 cells to accumulate in G2</b></p>
<p style="position:absolute;top:411px;left:123px;white-space:nowrap" class="ft62">We initially hypothesized that the differential&#160;</p>
<p style="position:absolute;top:429px;left:87px;white-space:nowrap" class="ft62">proliferative response between MCF-10A&#160;and MDA-</p>
<p style="position:absolute;top:447px;left:87px;white-space:nowrap" class="ft62">MB-231 cells was due to a difference in apoptosis&#160;</p>
<p style="position:absolute;top:465px;left:87px;white-space:nowrap" class="ft62">sensitivity. High potassium currents have been reported&#160;</p>
<p style="position:absolute;top:483px;left:87px;white-space:nowrap" class="ft62">to&#160;induce apoptosis and one possibility was that MCF-</p>
<p style="position:absolute;top:501px;left:87px;white-space:nowrap" class="ft62">10A&#160;cells are sensitive to large potassium currents while&#160;</p>
<p style="position:absolute;top:519px;left:87px;white-space:nowrap" class="ft62">MDA-MB-231 cells could be protected by anti-apoptotic&#160;</p>
<p style="position:absolute;top:537px;left:87px;white-space:nowrap" class="ft62">signaling that is often active in highly metastatic cells&#160;</p>
<p style="position:absolute;top:555px;left:87px;white-space:nowrap" class="ft62">[26].&#160;To test this, we measured the percentage of apoptotic&#160;</p>
<p style="position:absolute;top:573px;left:87px;white-space:nowrap" class="ft62">and dead cells to determine if the decrease in MCF-</p>
<p style="position:absolute;top:591px;left:87px;white-space:nowrap" class="ft62">10A&#160;cell number following IK activation was due to an&#160;</p>
<p style="position:absolute;top:609px;left:87px;white-space:nowrap" class="ft62">increase in cell death. Control and IK over-expressing&#160;</p>
<p style="position:absolute;top:627px;left:87px;white-space:nowrap" class="ft62">cells were cultured for 24 hours in 1-EBIO or vehicle&#160;</p>
<p style="position:absolute;top:645px;left:87px;white-space:nowrap" class="ft62">control and stained with&#160;Annexin-V-FITC, which binds&#160;</p>
<p style="position:absolute;top:663px;left:87px;white-space:nowrap" class="ft62">external&#160;phosphatidylserine&#160;an&#160;early&#160;marker&#160;of&#160;apoptosis,&#160;</p>
<p style="position:absolute;top:70px;left:487px;white-space:nowrap" class="ft62">and violet dead cell stain. FACS was used to quantify&#160;</p>
<p style="position:absolute;top:88px;left:487px;white-space:nowrap" class="ft62">the&#160;percentage&#160;of&#160;labeled&#160;cells.&#160;There&#160;was&#160;no&#160;significant&#160;</p>
<p style="position:absolute;top:106px;left:487px;white-space:nowrap" class="ft62">difference in the percentage of apoptotic or dead cells&#160;</p>
<p style="position:absolute;top:124px;left:487px;white-space:nowrap" class="ft62">across all cell conditions for both MCF-10A&#160;and MDA-</p>
<p style="position:absolute;top:142px;left:487px;white-space:nowrap" class="ft62">MB-231 cells (Figure 5A, 5C).&#160;We next investigated&#160;</p>
<p style="position:absolute;top:160px;left:487px;white-space:nowrap" class="ft62">changes&#160;in&#160;the&#160;cell&#160;cycle&#160;distribution&#160;in&#160;the&#160;same&#160;samples&#160;</p>
<p style="position:absolute;top:178px;left:487px;white-space:nowrap" class="ft62">using propidium iodide staining. 1-EBIO treatment&#160;</p>
<p style="position:absolute;top:196px;left:487px;white-space:nowrap" class="ft62">increased the percentage of control and IK-overexpressing&#160;</p>
<p style="position:absolute;top:214px;left:487px;white-space:nowrap" class="ft62">MCF-10A&#160;cells in the G2 phase (from 14.80 ± 3.71 %&#160;</p>
<p style="position:absolute;top:232px;left:487px;white-space:nowrap" class="ft62">to&#160;18.48&#160;±&#160;3.27&#160;% in control&#160;MCF-10A&#160;cells and&#160;from&#160;</p>
<p style="position:absolute;top:250px;left:487px;white-space:nowrap" class="ft62">16.08&#160;±&#160;2.18&#160;%&#160;to&#160;21.4&#160;±&#160;5.1&#160;%&#160;in&#160;MCF-10A-IK&#160;cells;&#160;p&#160;&lt;&#160;</p>
<p style="position:absolute;top:268px;left:487px;white-space:nowrap" class="ft62">0.01,&#160;1-way&#160;ANOVA;&#160;Figure&#160;5C).&#160;However,&#160;no&#160;significant&#160;</p>
<p style="position:absolute;top:286px;left:487px;white-space:nowrap" class="ft62">differences&#160;were&#160;found&#160;in&#160;any&#160;of&#160;the&#160;conditions&#160;for&#160;MDA-</p>
<p style="position:absolute;top:304px;left:487px;white-space:nowrap" class="ft62">MB-231&#160;cells&#160;(p&#160;=&#160;0.29,&#160;1-way&#160;ANOVA;&#160;Figure&#160;5D).&#160;The&#160;</p>
<p style="position:absolute;top:322px;left:487px;white-space:nowrap" class="ft62">increased&#160;G2&#160;accumulation&#160;was&#160;therefore&#160;observed&#160;in&#160;the&#160;</p>
<p style="position:absolute;top:340px;left:487px;white-space:nowrap" class="ft62">same populations that had decreased proliferation.&#160;These&#160;</p>
<p style="position:absolute;top:358px;left:487px;white-space:nowrap" class="ft62">data&#160;suggest&#160;that&#160;in&#160;MCF-10A&#160;cells&#160;the&#160;G2/M&#160;checkpoint&#160;</p>
<p style="position:absolute;top:376px;left:487px;white-space:nowrap" class="ft62">includes a requirement for decreased IK activity and/or&#160;</p>
<p style="position:absolute;top:394px;left:487px;white-space:nowrap" class="ft62">depolarization and that MDA-MB-231 cells are able to&#160;</p>
<p style="position:absolute;top:412px;left:487px;white-space:nowrap" class="ft62">evade&#160;this&#160;requirement,&#160;possibly&#160;due&#160;to&#160;strong&#160;pro-growth&#160;</p>
<p style="position:absolute;top:430px;left:487px;white-space:nowrap" class="ft62">signaling active in this cell line.</p>
<p style="position:absolute;top:466px;left:487px;white-space:nowrap" class="ft63"><b>IK expression increases MDA-MB-231 primary&#160;</b></p>
<p style="position:absolute;top:486px;left:487px;white-space:nowrap" class="ft63"><b>tumor&#160;growth and metastasis</b></p>
<p style="position:absolute;top:519px;left:523px;white-space:nowrap" class="ft62">Given the various effects of IK expression and&#160;</p>
<p style="position:absolute;top:537px;left:487px;white-space:nowrap" class="ft62">activity on cellular aggressiveness&#160;<i>in vitro</i>, we next&#160;</p>
<p style="position:absolute;top:555px;left:487px;white-space:nowrap" class="ft62">assessed the effect of IK over-expression on&#160;<i>in vivo</i>&#160;</p>
<p style="position:absolute;top:573px;left:487px;white-space:nowrap" class="ft62">tumor growth and metastasis. MDA-MB-231 control and&#160;</p>
<p style="position:absolute;top:591px;left:487px;white-space:nowrap" class="ft62">MDA-MB-231-IK cells were injected into the mammary&#160;</p>
<p style="position:absolute;top:609px;left:487px;white-space:nowrap" class="ft62">fat&#160;pad&#160;of&#160;6 wk&#160;old&#160;female&#160;<i>Rag2-/-&#160;Il2rg-/-</i>&#160;mice.&#160;Caliper&#160;</p>
<p style="position:absolute;top:627px;left:487px;white-space:nowrap" class="ft62">measurements were used to estimate the tumor volume&#160;</p>
<p style="position:absolute;top:645px;left:487px;white-space:nowrap" class="ft62">over&#160;&#160;4&#160;&#160;wks&#160;&#160;of&#160;&#160;tumor&#160;&#160;growth.&#160;&#160;Primary&#160;&#160;tumor&#160;&#160;growth&#160;</p>
<p style="position:absolute;top:663px;left:487px;white-space:nowrap" class="ft62">was&#160;significantly&#160;increased&#160;in&#160;MDA-MB-231-IK&#160;tumors&#160;</p>
<p style="position:absolute;top:958px;left:87px;white-space:nowrap" class="ft66"><b>Figure&#160;4: 1-EBIO&#160;treatment&#160;decreased MCF-10A&#160;proliferation&#160;and invasion but had no effect&#160;on migration.</b>&#160;<b>(A)</b>&#160;Control&#160;</p>
<p style="position:absolute;top:976px;left:87px;white-space:nowrap" class="ft61">and&#160;IK&#160;over-expressing&#160;MCF-10A&#160;proliferation&#160;was&#160;quantified&#160;over&#160;4&#160;days&#160;for&#160;cells&#160;treated&#160;with&#160;vehicle&#160;control&#160;or&#160;1-EBIO&#160;(**&#160;p&#160;&lt;&#160;0.01&#160;</p>
<p style="position:absolute;top:993px;left:87px;white-space:nowrap" class="ft61">indicates&#160;significantly&#160;different&#160;than&#160;vehicle&#160;control,&#160;1-way&#160;ANOVA).&#160;<b>(B)</b>&#160;Invasion&#160;through&#160;Matrigel-coated&#160;transwell&#160;after&#160;24 h using horse&#160;</p>
<p style="position:absolute;top:1009px;left:87px;white-space:nowrap" class="ft61">serum&#160;and&#160;EGF&#160;as&#160;a&#160;chemoattractant.&#160;Average&#160;number&#160;of&#160;cells&#160;per&#160;field&#160;of&#160;view&#160;with&#160;4&#160;fields&#160;of&#160;view&#160;per&#160;sample&#160;and&#160;4&#160;replicates&#160;in&#160;each&#160;of&#160;</p>
<p style="position:absolute;top:1025px;left:87px;white-space:nowrap" class="ft61">3&#160;independent&#160;experiments&#160;(***&#160;p&#160;&lt;&#160;0.001&#160;indicates&#160;significantly&#160;different&#160;than&#160;vehicle&#160;treated&#160;control,&#160;+++&#160;p&#160;&lt;&#160;0.001&#160;indicates&#160;significant&#160;</p>
<p style="position:absolute;top:1041px;left:87px;white-space:nowrap" class="ft61">difference&#160;between&#160;indicated&#160;samples,&#160;1-way&#160;ANOVA).&#160;<b>(C)</b>&#160;A&#160;confluent&#160;layer&#160;of&#160;MCF-10A&#160;control&#160;or&#160;MCF-10A-IK&#160;was&#160;scratched&#160;and&#160;</p>
<p style="position:absolute;top:1057px;left:87px;white-space:nowrap" class="ft61">treated&#160;with&#160;vehicle&#160;control&#160;or&#160;1-EBIO.&#160;Healing&#160;was&#160;assessed&#160;after&#160;12&#160;h&#160;by&#160;quantifying&#160;the&#160;surface&#160;area&#160;of&#160;wound&#160;recovery&#160;(no&#160;significant&#160;</p>
<p style="position:absolute;top:1074px;left:87px;white-space:nowrap" class="ft61">difference across all conditions; p = 0.28, 1-way&#160;ANOVA).&#160;All data presented as mean with SEM of three independent replicates.</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>66c92c4fd6c5899239528c7d73898d26-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft70{font-size:11px;font-family:Times;color:#c02f3b;}
	.ft71{font-size:11px;font-family:Times;color:#231f20;}
	.ft72{font-size:13px;font-family:Times;color:#231f20;}
	.ft73{font-size:13px;font-family:Times;color:#231f20;}
	.ft74{font-size:13px;font-family:Times;color:#231f20;}
	.ft75{font-size:11px;font-family:Times;color:#231f20;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page7-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft70">Oncotarget</p>
<p style="position:absolute;top:1111px;left:438px;white-space:nowrap" class="ft71">42388</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft70">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:70px;left:87px;white-space:nowrap" class="ft72">beginning 17 days post cell injection (p &lt; 0.05, 2-sample&#160;</p>
<p style="position:absolute;top:88px;left:87px;white-space:nowrap" class="ft72">t&#160;test;&#160;Figure&#160;6A).&#160;To&#160;demonstrate&#160;that&#160;the&#160;tumors&#160;were&#160;</p>
<p style="position:absolute;top:106px;left:87px;white-space:nowrap" class="ft72">derived from the injected cells, tumor sections were&#160;</p>
<p style="position:absolute;top:124px;left:87px;white-space:nowrap" class="ft72">stained for human nuclear antigen (HNA) and cells&#160;</p>
<p style="position:absolute;top:142px;left:87px;white-space:nowrap" class="ft72">stained positively throughout the bulk of the tumor&#160;</p>
<p style="position:absolute;top:160px;left:87px;white-space:nowrap" class="ft72">(Figure 6B). MDA-MB-231-IK tumors showed higher IK&#160;</p>
<p style="position:absolute;top:178px;left:87px;white-space:nowrap" class="ft72">immunoreactivity compared to control tumors, suggesting&#160;</p>
<p style="position:absolute;top:196px;left:87px;white-space:nowrap" class="ft72">that IK&#160;over-expression was retained&#160;<i>in vivo</i>&#160;(Figure 6B).&#160;</p>
<p style="position:absolute;top:214px;left:87px;white-space:nowrap" class="ft72">Despite&#160;the&#160;increase&#160;in&#160;tumor&#160;size,&#160;there&#160;was&#160;no&#160;significant&#160;</p>
<p style="position:absolute;top:232px;left:87px;white-space:nowrap" class="ft72">difference in the number of Ki67 positive proliferating&#160;</p>
<p style="position:absolute;top:250px;left:87px;white-space:nowrap" class="ft72">cells&#160;in&#160;28&#160;day&#160;tumor&#160;sections&#160;(p&#160;=&#160;0.27,&#160;2-sample&#160;t-test;&#160;</p>
<p style="position:absolute;top:268px;left:87px;white-space:nowrap" class="ft72">Figure&#160;&#160;6C).&#160;&#160;There&#160;&#160;was&#160;&#160;also&#160;&#160;no&#160;&#160;significant&#160;&#160;difference&#160;</p>
<p style="position:absolute;top:286px;left:87px;white-space:nowrap" class="ft72">in the number of cleaved caspase-3 positive apoptotic&#160;</p>
<p style="position:absolute;top:70px;left:487px;white-space:nowrap" class="ft72">cells&#160;&#160;in&#160;&#160;tumor&#160;&#160;sections&#160;&#160;at&#160;&#160;day&#160;&#160;28&#160;&#160;(p&#160;&#160;=&#160;&#160;0.15,&#160;&#160;2-sample&#160;</p>
<p style="position:absolute;top:88px;left:487px;white-space:nowrap" class="ft72">t-test;&#160;Figure&#160;6E).&#160;However,&#160;there&#160;was&#160;a&#160;trend&#160;towards&#160;</p>
<p style="position:absolute;top:106px;left:487px;white-space:nowrap" class="ft72">increased Ki67+ cells and reduced caspase-3+ cells in&#160;</p>
<p style="position:absolute;top:124px;left:487px;white-space:nowrap" class="ft72">the IK-overexpressing tumors, suggesting that increased&#160;</p>
<p style="position:absolute;top:142px;left:487px;white-space:nowrap" class="ft72">proliferation and/or reduced apoptosis may contribute to&#160;</p>
<p style="position:absolute;top:160px;left:487px;white-space:nowrap" class="ft72">the increased size of these tumors. In addition, as these&#160;</p>
<p style="position:absolute;top:178px;left:487px;white-space:nowrap" class="ft72">measurements were taken at the end of the experiment,&#160;</p>
<p style="position:absolute;top:196px;left:487px;white-space:nowrap" class="ft72">they may underestimate a larger difference in proliferation&#160;</p>
<p style="position:absolute;top:214px;left:487px;white-space:nowrap" class="ft72">or apoptosis that occurred earlier on in the growth of the&#160;</p>
<p style="position:absolute;top:232px;left:487px;white-space:nowrap" class="ft72">tumor.</p>
<p style="position:absolute;top:250px;left:523px;white-space:nowrap" class="ft72">We next investigated whether the primary tumors&#160;</p>
<p style="position:absolute;top:268px;left:487px;white-space:nowrap" class="ft72">also displayed differences in aggressive phenotypes.&#160;</p>
<p style="position:absolute;top:286px;left:487px;white-space:nowrap" class="ft72">Staining of primary tumor sections with H&amp;E revealed&#160;</p>
<p style="position:absolute;top:975px;left:87px;white-space:nowrap" class="ft74"><b>Figure 5: 1-EBIO treatment increased G2 phase&#160;accumulation in MCF-10A&#160;but&#160;had&#160;no&#160;effect on&#160;MDA-MB-231.</b>&#160;Control&#160;</p>
<p style="position:absolute;top:993px;left:87px;white-space:nowrap" class="ft71">and&#160;IK over-expressing&#160;MCF-10A&#160;<b>(A)</b>&#160;and&#160;MDA-MB-231&#160;<b>(C)</b>&#160;cells&#160;were&#160;treated&#160;with&#160;vehicle&#160;control&#160;or&#160;1-EBIO&#160;for&#160;24&#160;h,&#160;stained&#160;with&#160;</p>
<p style="position:absolute;top:1009px;left:87px;white-space:nowrap" class="ft71">annexin-FITC&#160;and&#160;violet&#160;dead&#160;stain,&#160;and&#160;analyzed&#160;by&#160;flow&#160;cytometry&#160;to&#160;quantify&#160;the&#160;percentage&#160;of&#160;positively&#160;stained&#160;cells&#160;(no&#160;significant&#160;</p>
<p style="position:absolute;top:1025px;left:87px;white-space:nowrap" class="ft71">difference in annexin-V&#160;or dead stained cells across any condition, 1-way&#160;ANOVA).&#160;<b>(B, D)</b>&#160;Plot&#160;of&#160;cell&#160;count&#160;versus&#160;propidium&#160;iodide&#160;</p>
<p style="position:absolute;top:1041px;left:87px;white-space:nowrap" class="ft71">(PI)&#160;fluorescence&#160;to&#160;analyze&#160;cell&#160;cycle.&#160;Arrow&#160;marks&#160;fluorescence&#160;intensity&#160;corresponding&#160;to&#160;G2&#160;phase.&#160;Plot&#160;is&#160;representative&#160;of&#160;three&#160;</p>
<p style="position:absolute;top:1057px;left:87px;white-space:nowrap" class="ft71">independent&#160;replicates&#160;(MCF-10A&#160;**p&#160;&lt;&#160;0.01,&#160;MDA-MB-231&#160;p&#160;=&#160;0.29,&#160;1-way&#160;ANOVA).&#160;All&#160;data&#160;presented&#160;as&#160;mean&#160;with&#160;SEM&#160;of&#160;three&#160;</p>
<p style="position:absolute;top:1074px;left:87px;white-space:nowrap" class="ft71">independent replicates.</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>66c92c4fd6c5899239528c7d73898d26-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft80{font-size:11px;font-family:Times;color:#c02f3b;}
	.ft81{font-size:11px;font-family:Times;color:#231f20;}
	.ft82{font-size:13px;font-family:Times;color:#231f20;}
	.ft83{font-size:6px;font-family:Times;color:#231f20;}
	.ft84{font-size:16px;font-family:Times;color:#ac2b30;}
	.ft85{font-size:13px;font-family:Times;color:#231f20;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page8-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft80">Oncotarget</p>
<p style="position:absolute;top:1111px;left:438px;white-space:nowrap" class="ft81">42389</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft80">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:70px;left:87px;white-space:nowrap" class="ft82">similar local invasion into surrounding muscle and&#160;</p>
<p style="position:absolute;top:88px;left:87px;white-space:nowrap" class="ft82">fibroadipose&#160;tissue&#160;from&#160;both&#160;MDA-MB-231&#160;control&#160;and&#160;</p>
<p style="position:absolute;top:106px;left:87px;white-space:nowrap" class="ft82">MDA-MB-231-IK&#160;primary tumors (Figure 7A).&#160;To assess&#160;</p>
<p style="position:absolute;top:124px;left:87px;white-space:nowrap" class="ft82">vascular density, primary tumor sections were stained&#160;</p>
<p style="position:absolute;top:142px;left:87px;white-space:nowrap" class="ft82">with the endothelial marker CD-31 and the number of&#160;</p>
<p style="position:absolute;top:160px;left:87px;white-space:nowrap" class="ft82">vessels&#160;per&#160;square&#160;millimeter&#160;was&#160;quantified.&#160;There&#160;was&#160;</p>
<p style="position:absolute;top:178px;left:87px;white-space:nowrap" class="ft82">no&#160;significant&#160;difference&#160;in&#160;the&#160;vascular&#160;density&#160;between&#160;</p>
<p style="position:absolute;top:196px;left:87px;white-space:nowrap" class="ft82">control and MDA-MB-231-IK tumors and surprisingly if&#160;</p>
<p style="position:absolute;top:214px;left:87px;white-space:nowrap" class="ft82">anything&#160;there&#160;was&#160;a&#160;trend&#160;towards&#160;denser&#160;vascularization&#160;</p>
<p style="position:absolute;top:232px;left:87px;white-space:nowrap" class="ft82">in control cells (p = 0.14, 2-sample t-test, Figure 7B).</p>
<p style="position:absolute;top:250px;left:123px;white-space:nowrap" class="ft82">We also assessed metastatic dissemination by&#160;</p>
<p style="position:absolute;top:269px;left:87px;white-space:nowrap" class="ft82">comparing&#160;the&#160;number&#160;of&#160;cells&#160;metastasizing&#160;to&#160;the&#160;</p>
<p style="position:absolute;top:287px;left:87px;white-space:nowrap" class="ft82">lung. Lungs were sectioned and stained with anti-</p>
<p style="position:absolute;top:305px;left:87px;white-space:nowrap" class="ft82">HNA&#160;antibody and the number of metastasizing cells&#160;</p>
<p style="position:absolute;top:323px;left:87px;white-space:nowrap" class="ft82">was&#160;&#160;quantified.&#160;There&#160;&#160;was&#160;&#160;a&#160;&#160;significant&#160;&#160;increase&#160;&#160;in&#160;&#160;the&#160;</p>
<p style="position:absolute;top:341px;left:87px;white-space:nowrap" class="ft82">number of metastasizing cells/mm2&#160;in MDA-MB-231-IK&#160;</p>
<p style="position:absolute;top:359px;left:87px;white-space:nowrap" class="ft82">injected mice as compared to control (p &lt; 0.01, 2-sample&#160;</p>
<p style="position:absolute;top:377px;left:87px;white-space:nowrap" class="ft82">t-test;&#160;Figure&#160;8A-8B).&#160;In&#160;summary,&#160;IK&#160;over-expression&#160;</p>
<p style="position:absolute;top:395px;left:87px;white-space:nowrap" class="ft82">significantly&#160;increased&#160;primary&#160;tumor&#160;growth&#160;as&#160;well&#160;as&#160;</p>
<p style="position:absolute;top:413px;left:87px;white-space:nowrap" class="ft82">dissemination of cells to lung tissue.</p>
<p style="position:absolute;top:449px;left:87px;white-space:nowrap" class="ft84"><b>DISCUSSION</b></p>
<p style="position:absolute;top:488px;left:123px;white-space:nowrap" class="ft82">Despite decades of research, metastatic cancer&#160;</p>
<p style="position:absolute;top:506px;left:87px;white-space:nowrap" class="ft82">continues to have high rates of recurrence and patient&#160;</p>
<p style="position:absolute;top:524px;left:87px;white-space:nowrap" class="ft82">mortality.&#160;A&#160;better understanding of the molecular&#160;</p>
<p style="position:absolute;top:542px;left:87px;white-space:nowrap" class="ft82">pathways that promote aggressive behaviors is needed in&#160;</p>
<p style="position:absolute;top:560px;left:87px;white-space:nowrap" class="ft82">order to develop treatments aimed at preventing metastasis.&#160;</p>
<p style="position:absolute;top:578px;left:87px;white-space:nowrap" class="ft82">IK channels play important functions in proliferation,&#160;</p>
<p style="position:absolute;top:596px;left:87px;white-space:nowrap" class="ft82">migration, and invasion as shown by a decrease in these&#160;</p>
<p style="position:absolute;top:614px;left:87px;white-space:nowrap" class="ft82">behaviors&#160;<i>in vitro</i>&#160;and&#160;<i>in vivo</i>&#160;with IK inhibition or knock-</p>
<p style="position:absolute;top:632px;left:87px;white-space:nowrap" class="ft82">down [11, 14, 27, 28]. In this study we investigated&#160;</p>
<p style="position:absolute;top:650px;left:87px;white-space:nowrap" class="ft82">whether&#160;IK&#160;was&#160;also&#160;sufficient&#160;to&#160;promote&#160;these&#160;behaviors,&#160;</p>
<p style="position:absolute;top:668px;left:87px;white-space:nowrap" class="ft82">as&#160;sufficiency&#160;would&#160;suggest&#160;IK&#160;plays&#160;important&#160;roles&#160;in&#160;</p>
<p style="position:absolute;top:686px;left:87px;white-space:nowrap" class="ft82">upstream signaling pathways driving disease progression.&#160;</p>
<p style="position:absolute;top:705px;left:87px;white-space:nowrap" class="ft82">We&#160;&#160;found&#160;&#160;that&#160;&#160;over-expression&#160;&#160;of&#160;&#160;IK&#160;&#160;was&#160;&#160;sufficient&#160;&#160;to&#160;</p>
<p style="position:absolute;top:723px;left:87px;white-space:nowrap" class="ft82">increase primary tumor growth and metastasis but that it&#160;</p>
<p style="position:absolute;top:741px;left:87px;white-space:nowrap" class="ft82">had cell line dependent differential effects on aggressive&#160;</p>
<p style="position:absolute;top:759px;left:87px;white-space:nowrap" class="ft82">behaviors&#160;<i>in&#160;vitro</i>.&#160;This&#160;study&#160;adds&#160;to&#160;data&#160;from&#160;inhibition&#160;</p>
<p style="position:absolute;top:777px;left:87px;white-space:nowrap" class="ft82">studies suggesting differences in behavioral response&#160;</p>
<p style="position:absolute;top:795px;left:87px;white-space:nowrap" class="ft82">to potassium channel activation between cell lines of&#160;</p>
<p style="position:absolute;top:813px;left:87px;white-space:nowrap" class="ft82">different tumor aggressiveness [15, 29]. Furthermore, there&#160;</p>
<p style="position:absolute;top:831px;left:87px;white-space:nowrap" class="ft82">was&#160;no&#160;significant&#160;change&#160;in&#160;MDA-MB-231&#160;proliferation&#160;</p>
<p style="position:absolute;top:849px;left:87px;white-space:nowrap" class="ft82">in response to IK activation, which is in contrast to the&#160;</p>
<p style="position:absolute;top:867px;left:87px;white-space:nowrap" class="ft82">previously reported increased proliferation of prostate&#160;</p>
<p style="position:absolute;top:885px;left:87px;white-space:nowrap" class="ft82">cancer cell lines [12, 17].&#160;These results suggest important&#160;</p>
<p style="position:absolute;top:903px;left:87px;white-space:nowrap" class="ft82">differences&#160;exist&#160;in&#160;the&#160;signaling&#160;networks&#160;downstream&#160;of&#160;</p>
<p style="position:absolute;top:921px;left:87px;white-space:nowrap" class="ft82">IK activation between different cell lines and support the&#160;</p>
<p style="position:absolute;top:939px;left:87px;white-space:nowrap" class="ft82">investigation&#160;of&#160;primary&#160;tissue&#160;and&#160;tumors&#160;to&#160;determine&#160;if&#160;</p>
<p style="position:absolute;top:957px;left:87px;white-space:nowrap" class="ft82">these differences correlate with disease state.</p>
<p style="position:absolute;top:975px;left:123px;white-space:nowrap" class="ft82">In support of the initial hypothesis that increased&#160;</p>
<p style="position:absolute;top:993px;left:87px;white-space:nowrap" class="ft82">IK activity promotes cancer progression,&#160;<i>in vivo</i>&#160;primary&#160;</p>
<p style="position:absolute;top:1011px;left:87px;white-space:nowrap" class="ft82">tumor growth and metastasis of MDA-MB-231 to the&#160;</p>
<p style="position:absolute;top:1029px;left:87px;white-space:nowrap" class="ft82">lung was increased by IK over-expression. MDA-</p>
<p style="position:absolute;top:1047px;left:87px;white-space:nowrap" class="ft82">MB-231 control and MDA-MB-231-IK cells developed&#160;</p>
<p style="position:absolute;top:1065px;left:87px;white-space:nowrap" class="ft82">similarly aggressive primary tumors with no observable&#160;</p>
<p style="position:absolute;top:70px;left:487px;white-space:nowrap" class="ft82">difference in local tissue invasion or vascularity.&#160;This may&#160;</p>
<p style="position:absolute;top:88px;left:487px;white-space:nowrap" class="ft82">be because MDA-MB-231 cells are endogenously highly&#160;</p>
<p style="position:absolute;top:106px;left:487px;white-space:nowrap" class="ft82">invasive&#160;and&#160;it&#160;may&#160;be&#160;difficult&#160;to&#160;observe&#160;potentiation&#160;</p>
<p style="position:absolute;top:125px;left:487px;white-space:nowrap" class="ft82">in primary tumors.&#160;The&#160;<i>in vivo</i>&#160;data are in contrast to&#160;</p>
<p style="position:absolute;top:143px;left:487px;white-space:nowrap" class="ft82">the effect of IK over-expression on&#160;<i>in vitro</i>&#160;proliferation&#160;</p>
<p style="position:absolute;top:161px;left:487px;white-space:nowrap" class="ft82">and aggressive behaviors of MDA-MB-231 cells.&#160;While&#160;</p>
<p style="position:absolute;top:179px;left:487px;white-space:nowrap" class="ft82">there&#160;&#160;was&#160;&#160;no&#160;&#160;significant&#160;&#160;effect&#160;&#160;of&#160;&#160;IK&#160;&#160;on&#160;&#160;proliferation,&#160;</p>
<p style="position:absolute;top:197px;left:487px;white-space:nowrap" class="ft82">migration, or invasion, it is interesting to note that there&#160;</p>
<p style="position:absolute;top:215px;left:487px;white-space:nowrap" class="ft82">was a trend of MDA-MB-231-IK having the highest&#160;</p>
<p style="position:absolute;top:233px;left:487px;white-space:nowrap" class="ft82">value&#160;in&#160;each&#160;assay.&#160;It&#160;is&#160;possible&#160;that&#160;IK&#160;over-expression&#160;</p>
<p style="position:absolute;top:251px;left:487px;white-space:nowrap" class="ft82">results in a small increase of each behavior that is&#160;</p>
<p style="position:absolute;top:269px;left:487px;white-space:nowrap" class="ft82">challenging to detect within the inherent variability of&#160;</p>
<p style="position:absolute;top:287px;left:487px;white-space:nowrap" class="ft82">the assays. But&#160;<i>in vivo</i>&#160;where the effect of all of these&#160;</p>
<p style="position:absolute;top:305px;left:487px;white-space:nowrap" class="ft82">behaviors&#160;is&#160;combined&#160;during&#160;tumor&#160;growth,&#160;the&#160;overall&#160;</p>
<p style="position:absolute;top:323px;left:487px;white-space:nowrap" class="ft82">effect&#160;is&#160;amplified&#160;and&#160;becomes&#160;statistically&#160;significant.&#160;</p>
<p style="position:absolute;top:342px;left:487px;white-space:nowrap" class="ft82">Alternatively, we speculate the opposing&#160;<i>in vitro</i>&#160;and&#160;</p>
<p style="position:absolute;top:359px;left:487px;white-space:nowrap" class="ft85"><i>in&#160;vivo</i>&#160;results&#160;could&#160;reflect&#160;a&#160;requirement&#160;for&#160;signaling&#160;</p>
<p style="position:absolute;top:378px;left:487px;white-space:nowrap" class="ft82">from the surrounding tumor microenvironment. It is well&#160;</p>
<p style="position:absolute;top:396px;left:487px;white-space:nowrap" class="ft82">known that many&#160;<i>in&#160;vivo</i>&#160;factors with important effects&#160;</p>
<p style="position:absolute;top:414px;left:487px;white-space:nowrap" class="ft82">on cancer cell behavior are not recapitulated&#160;<i>in vitro</i>&#160;and&#160;</p>
<p style="position:absolute;top:432px;left:487px;white-space:nowrap" class="ft82">often&#160;treatments&#160;that&#160;reduce&#160;aggressive&#160;<i>in&#160;vitro</i>&#160;behaviors&#160;</p>
<p style="position:absolute;top:450px;left:487px;white-space:nowrap" class="ft82">have no effect&#160;<i>in&#160;vivo</i>&#160;[30–32]<i>.</i>&#160;Microenvironmental&#160;</p>
<p style="position:absolute;top:468px;left:487px;white-space:nowrap" class="ft82">factors&#160;that&#160;influence&#160;IK&#160;activation&#160;and&#160;signaling&#160;have&#160;not&#160;</p>
<p style="position:absolute;top:486px;left:487px;white-space:nowrap" class="ft82">been studied extensively and may have&#160;important roles.&#160;</p>
<p style="position:absolute;top:504px;left:487px;white-space:nowrap" class="ft82">For example, growth-promoting effects of IK signaling&#160;</p>
<p style="position:absolute;top:522px;left:487px;white-space:nowrap" class="ft82">may require highly specialized&#160;spatio-temporal&#160;activation&#160;</p>
<p style="position:absolute;top:540px;left:487px;white-space:nowrap" class="ft82">that is not recapitulated&#160;<i>in vitro</i>. IK signaling may be&#160;</p>
<p style="position:absolute;top:559px;left:487px;white-space:nowrap" class="ft82">initiated&#160;by&#160;interactions&#160;with&#160;stromal&#160;cell&#160;types,&#160;activation&#160;</p>
<p style="position:absolute;top:577px;left:487px;white-space:nowrap" class="ft82">of&#160;&#160;specific&#160;&#160;adhesion&#160;&#160;molecules,&#160;&#160;or&#160;&#160;microenvironmental&#160;</p>
<p style="position:absolute;top:595px;left:487px;white-space:nowrap" class="ft82">factors&#160;&#160;such&#160;&#160;as&#160;&#160;hypoxia&#160;&#160;or&#160;&#160;inflammatory&#160;&#160;cytokines,&#160;&#160;as&#160;</p>
<p style="position:absolute;top:613px;left:487px;white-space:nowrap" class="ft82">potassium conductance has been shown to be sensitive&#160;</p>
<p style="position:absolute;top:631px;left:487px;white-space:nowrap" class="ft82">to&#160;&#160;all&#160;&#160;of&#160;&#160;these&#160;&#160;factors&#160;&#160;[33,&#160;&#160;34].&#160;As&#160;&#160;a&#160;&#160;specific&#160;&#160;example,&#160;</p>
<p style="position:absolute;top:649px;left:487px;white-space:nowrap" class="ft82">signaling from the human eag-related gene 1&#160;potassium&#160;</p>
<p style="position:absolute;top:667px;left:487px;white-space:nowrap" class="ft82">channel&#160;&#160;(hERG1)&#160;&#160;is&#160;&#160;dependent&#160;&#160;on&#160;&#160;interactions&#160;&#160;with&#160;</p>
<p style="position:absolute;top:685px;left:487px;white-space:nowrap" class="ft82">integrin receptors, demonstrating one mechanism by&#160;</p>
<p style="position:absolute;top:703px;left:487px;white-space:nowrap" class="ft82">which potassium channel activity is linked to a feature&#160;</p>
<p style="position:absolute;top:721px;left:487px;white-space:nowrap" class="ft82">of the surrounding microenvironment [35, 36]. Further&#160;</p>
<p style="position:absolute;top:739px;left:487px;white-space:nowrap" class="ft82">experiments are needed to determine how IK activity is&#160;</p>
<p style="position:absolute;top:757px;left:487px;white-space:nowrap" class="ft82">responsive to microenvironmental factors.</p>
<p style="position:absolute;top:776px;left:523px;white-space:nowrap" class="ft82">Migration of both MCF-10A&#160;and&#160;MDA-MB-231&#160;</p>
<p style="position:absolute;top:794px;left:487px;white-space:nowrap" class="ft82">cells&#160;was unaffected&#160;by&#160;IK&#160;over-expression&#160;and&#160;activation&#160;</p>
<p style="position:absolute;top:812px;left:487px;white-space:nowrap" class="ft82">suggesting&#160;IK&#160;activity&#160;is&#160;insufficient&#160;to&#160;drive&#160;migration.&#160;</p>
<p style="position:absolute;top:830px;left:487px;white-space:nowrap" class="ft82">Prior&#160;studies&#160;have&#160;reported&#160;that&#160;IK&#160;inhibition&#160;decreases&#160;</p>
<p style="position:absolute;top:848px;left:487px;white-space:nowrap" class="ft82">migration&#160;in&#160;MDA-MB-231&#160;and&#160;have&#160;supported&#160;a&#160;role&#160;for&#160;</p>
<p style="position:absolute;top:866px;left:487px;white-space:nowrap" class="ft82">activation&#160;of&#160;IK&#160;specifically&#160;on&#160;the&#160;lagging&#160;edge&#160;[13,&#160;18].&#160;</p>
<p style="position:absolute;top:884px;left:487px;white-space:nowrap" class="ft82">Activation&#160;lacking&#160;spatial&#160;regulation,&#160;such&#160;as&#160;occurs&#160;with&#160;</p>
<p style="position:absolute;top:902px;left:487px;white-space:nowrap" class="ft82">addition of agonist, may have counteracting effects.&#160;The&#160;</p>
<p style="position:absolute;top:920px;left:487px;white-space:nowrap" class="ft82">effect of increased IK expression on spatially restricted&#160;</p>
<p style="position:absolute;top:938px;left:487px;white-space:nowrap" class="ft82">activation is not known.&#160;Activation of IK has been&#160;</p>
<p style="position:absolute;top:956px;left:487px;white-space:nowrap" class="ft82">reported to increase intracellular calcium [17], allowing&#160;</p>
<p style="position:absolute;top:974px;left:487px;white-space:nowrap" class="ft82">for the possibility of a positive feed-back loop whereby&#160;</p>
<p style="position:absolute;top:993px;left:487px;white-space:nowrap" class="ft82">activation of some channels increases intracellular calcium&#160;</p>
<p style="position:absolute;top:1011px;left:487px;white-space:nowrap" class="ft82">which&#160;then&#160;activates&#160;additional&#160;channels.&#160;High&#160;expression&#160;</p>
<p style="position:absolute;top:1029px;left:487px;white-space:nowrap" class="ft82">of IK could increase positive feedback mechanisms and&#160;</p>
<p style="position:absolute;top:1047px;left:487px;white-space:nowrap" class="ft82">cause spatially restricted signals to be propagated to larger&#160;</p>
<p style="position:absolute;top:1065px;left:487px;white-space:nowrap" class="ft82">portions or the entire cell.</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>66c92c4fd6c5899239528c7d73898d26-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft90{font-size:11px;font-family:Times;color:#c02f3b;}
	.ft91{font-size:11px;font-family:Times;color:#231f20;}
	.ft92{font-size:13px;font-family:Times;color:#231f20;}
	.ft93{font-size:13px;font-family:Times;color:#231f20;}
	.ft94{font-size:11px;font-family:Times;color:#231f20;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page9-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft90">Oncotarget</p>
<p style="position:absolute;top:1111px;left:438px;white-space:nowrap" class="ft91">42390</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft90">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:927px;left:87px;white-space:nowrap" class="ft92"><b>Figure 6: IK over-expression increases&#160;<i>in vivo</i></b><b>&#160;tumor&#160;growth of MDA-MB-231.</b>&#160;<b>(A)</b>&#160;MDA-MB-231&#160;control&#160;(n&#160;=&#160;11)&#160;and&#160;</p>
<p style="position:absolute;top:945px;left:87px;white-space:nowrap" class="ft91">MDA-MB-231-IK&#160;(n = 9) cells were injected&#160;into the inguinal mammary fat pad of 6 wk old female&#160;mice and tumor size was plotted over&#160;</p>
<p style="position:absolute;top:961px;left:87px;white-space:nowrap" class="ft91">time.&#160;Data&#160;presented&#160;as&#160;mean&#160;with&#160;SEM&#160;(*&#160;p&#160;&lt;&#160;.05,&#160;**&#160;p&#160;&lt;&#160;.01,&#160;***p&#160;&lt;&#160;.001&#160;2&#160;sample&#160;t-test).&#160;<b>(B)</b>&#160;Fixed&#160;primary&#160;tumor&#160;sections&#160;stained&#160;</p>
<p style="position:absolute;top:977px;left:87px;white-space:nowrap" class="ft91">with&#160;antibody&#160;to&#160;human&#160;nuclear&#160;antigen&#160;(green)&#160;with&#160;DAPI&#160;(blue)&#160;staining&#160;of&#160;the&#160;nuclei&#160;(top)&#160;or&#160;with&#160;anti-IK&#160;antibody&#160;(green;&#160;bottom).&#160;</p>
<p style="position:absolute;top:993px;left:87px;white-space:nowrap" class="ft94"><b>(C)</b>&#160;Quantification&#160;of&#160;Ki67&#160;positive&#160;(left)&#160;and&#160;active&#160;Caspase-3&#160;positive&#160;(right)&#160;cells&#160;in&#160;primary&#160;tumor&#160;sections&#160;with&#160;representative&#160;images&#160;</p>
<p style="position:absolute;top:1009px;left:87px;white-space:nowrap" class="ft91">of&#160;Ki67&#160;and&#160;active&#160;caspase-3&#160;(green)&#160;staining&#160;with&#160;DAPI&#160;(blue)&#160;staining&#160;of&#160;the&#160;nuclei&#160;shown&#160;below.&#160;There&#160;was&#160;no&#160;significant&#160;difference&#160;in&#160;</p>
<p style="position:absolute;top:1026px;left:87px;white-space:nowrap" class="ft91">the percentage of either Ki67 or active caspase-3 positive cells (p = 0.27, 2-sample t-test and p = 0.15, 2-sample t-test).</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>66c92c4fd6c5899239528c7d73898d26-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft100{font-size:11px;font-family:Times;color:#c02f3b;}
	.ft101{font-size:11px;font-family:Times;color:#231f20;}
	.ft102{font-size:13px;font-family:Times;color:#231f20;}
	.ft103{font-size:13px;font-family:Times;color:#231f20;}
	.ft104{font-size:13px;font-family:Times;color:#231f20;}
	.ft105{font-size:11px;font-family:Times;color:#231f20;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page10-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft100">Oncotarget</p>
<p style="position:absolute;top:1111px;left:438px;white-space:nowrap" class="ft101">42391</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft100">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:70px;left:123px;white-space:nowrap" class="ft102">IK expression and activation decreased&#160;<i>in vitro</i>&#160;</p>
<p style="position:absolute;top:88px;left:87px;white-space:nowrap" class="ft102">invasion of MCF-10A&#160;but not MDA-MB-231 cells.&#160;This&#160;</p>
<p style="position:absolute;top:106px;left:87px;white-space:nowrap" class="ft102">effect was most pronounced in IK over-expressing cells&#160;</p>
<p style="position:absolute;top:124px;left:87px;white-space:nowrap" class="ft102">treated with agonist and thus the degree to which MCF-</p>
<p style="position:absolute;top:142px;left:87px;white-space:nowrap" class="ft102">10A&#160;invasion was inhibited correlated with the level of&#160;</p>
<p style="position:absolute;top:160px;left:87px;white-space:nowrap" class="ft102">IK&#160;activity. Given that there was no change in MCF-10A&#160;</p>
<p style="position:absolute;top:178px;left:87px;white-space:nowrap" class="ft102">migration, the decreased invasion is likely related to&#160;</p>
<p style="position:absolute;top:196px;left:87px;white-space:nowrap" class="ft102">either&#160;an&#160;inability&#160;to&#160;degrade&#160;the&#160;ECM&#160;or&#160;dysregulation&#160;of&#160;</p>
<p style="position:absolute;top:214px;left:87px;white-space:nowrap" class="ft102">volume control preventing volume reduction required to&#160;</p>
<p style="position:absolute;top:232px;left:87px;white-space:nowrap" class="ft102">pass through the pores in the membrane. Further studies&#160;</p>
<p style="position:absolute;top:250px;left:87px;white-space:nowrap" class="ft102">are needed to distinguish these two possibilities as well&#160;</p>
<p style="position:absolute;top:268px;left:87px;white-space:nowrap" class="ft102">as to understand why MCF-10A&#160;but not MDA-MB-231&#160;</p>
<p style="position:absolute;top:286px;left:87px;white-space:nowrap" class="ft102">invasion is sensitive to increased IK currents. Surprisingly,&#160;</p>
<p style="position:absolute;top:304px;left:87px;white-space:nowrap" class="ft102">IK expression and activation decreased MDA-MB-231&#160;</p>
<p style="position:absolute;top:322px;left:87px;white-space:nowrap" class="ft102">colony formation. Further studies are needed to delineate&#160;</p>
<p style="position:absolute;top:340px;left:87px;white-space:nowrap" class="ft102">a mechanism for this result.</p>
<p style="position:absolute;top:70px;left:523px;white-space:nowrap" class="ft102">In contrast to increased proliferation seen in&#160;</p>
<p style="position:absolute;top:88px;left:487px;white-space:nowrap" class="ft102">prostate cancer cells, neither IK over-expression nor&#160;</p>
<p style="position:absolute;top:106px;left:487px;white-space:nowrap" class="ft102">activation with 1-EBIO caused a change in MDA-MB-231&#160;</p>
<p style="position:absolute;top:124px;left:487px;white-space:nowrap" class="ft102">proliferation, suggesting the mechanism downstream of&#160;</p>
<p style="position:absolute;top:142px;left:487px;white-space:nowrap" class="ft102">IK activation may not be conserved across cancer types&#160;</p>
<p style="position:absolute;top:160px;left:487px;white-space:nowrap" class="ft102">[12].&#160;Additionally, proliferation of the non-tumorigenic&#160;</p>
<p style="position:absolute;top:178px;left:487px;white-space:nowrap" class="ft102">cell line MCF-10A&#160;was decreased by IK activation in&#160;</p>
<p style="position:absolute;top:196px;left:487px;white-space:nowrap" class="ft102">both control and IK over-expressing cells but not by IK&#160;</p>
<p style="position:absolute;top:214px;left:487px;white-space:nowrap" class="ft102">over-expression alone.&#160;There was no change in apoptosis&#160;</p>
<p style="position:absolute;top:232px;left:487px;white-space:nowrap" class="ft102">or cell death suggesting the diminished cell number&#160;</p>
<p style="position:absolute;top:250px;left:487px;white-space:nowrap" class="ft102">was due to a decrease in the rate of cell division. MCF-</p>
<p style="position:absolute;top:268px;left:487px;white-space:nowrap" class="ft102">10A&#160;control and IK over-expressing cells treated with&#160;</p>
<p style="position:absolute;top:286px;left:487px;white-space:nowrap" class="ft102">1-EBIO&#160;had&#160;a&#160;significant&#160;increase&#160;in&#160;the&#160;percentage&#160;of&#160;</p>
<p style="position:absolute;top:304px;left:487px;white-space:nowrap" class="ft102">cells in G2 while IK over-expression alone had no effect&#160;</p>
<p style="position:absolute;top:322px;left:487px;white-space:nowrap" class="ft102">on cell cycle distribution. MDA-MB-231, which had&#160;</p>
<p style="position:absolute;top:340px;left:487px;white-space:nowrap" class="ft102">no change in proliferation across any condition, also&#160;</p>
<p style="position:absolute;top:1039px;left:87px;white-space:nowrap" class="ft104"><b>Figure&#160;7:&#160;No evidence&#160;of increased&#160;aggression in&#160;primary&#160;tumor.</b>&#160;<b>(A)</b>&#160;Primary&#160;tumor&#160;sections&#160;stained&#160;with&#160;H&amp;E.&#160;<b>(B)</b>&#160;Quantification&#160;</p>
<p style="position:absolute;top:1057px;left:87px;white-space:nowrap" class="ft101">of&#160;vessel&#160;density&#160;in&#160;primary&#160;tumors&#160;(top)&#160;with&#160;representative&#160;CD31&#160;stained&#160;sections&#160;(bottom,&#160;green&#160;-&#160;CD31,&#160;blue&#160;-&#160;nuclei&#160;stained&#160;with&#160;DAPI;&#160;</p>
<p style="position:absolute;top:1074px;left:87px;white-space:nowrap" class="ft101">p =0.14, 2-sample t-test).</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>66c92c4fd6c5899239528c7d73898d26-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft110{font-size:11px;font-family:Times;color:#c02f3b;}
	.ft111{font-size:11px;font-family:Times;color:#231f20;}
	.ft112{font-size:13px;font-family:Times;color:#231f20;}
	.ft113{font-size:6px;font-family:Times;color:#231f20;}
	.ft114{font-size:13px;font-family:Times;color:#231f20;}
	.ft115{font-size:11px;font-family:Times;color:#231f20;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page11-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft110">Oncotarget</p>
<p style="position:absolute;top:1111px;left:438px;white-space:nowrap" class="ft111">42392</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft110">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:70px;left:87px;white-space:nowrap" class="ft112">had&#160;no&#160;significant&#160;difference&#160;in&#160;the&#160;percentage&#160;of&#160;cells&#160;</p>
<p style="position:absolute;top:88px;left:87px;white-space:nowrap" class="ft112">in G2.&#160;Thus, the accumulation of MCF-10A&#160;cells in G2&#160;</p>
<p style="position:absolute;top:106px;left:87px;white-space:nowrap" class="ft112">mirrored the decrease in proliferation, suggesting constant&#160;</p>
<p style="position:absolute;top:124px;left:87px;white-space:nowrap" class="ft112">IK activation decreases proliferation of MCF-10A&#160;by&#160;</p>
<p style="position:absolute;top:142px;left:87px;white-space:nowrap" class="ft112">inhibiting progression from G2 to mitosis. Changes in&#160;</p>
<p style="position:absolute;top:160px;left:87px;white-space:nowrap" class="ft112">potassium&#160;channel&#160;activity&#160;and&#160;V</p>
<p style="position:absolute;top:172px;left:293px;white-space:nowrap" class="ft113">mem&#160;are&#160;associated&#160;with&#160;</p>
<p style="position:absolute;top:178px;left:87px;white-space:nowrap" class="ft112">progression&#160;through&#160;check&#160;points&#160;of&#160;the&#160;cell&#160;cycle&#160;with&#160;</p>
<p style="position:absolute;top:196px;left:87px;white-space:nowrap" class="ft112">depolarization and a decrease in potassium channel&#160;</p>
<p style="position:absolute;top:214px;left:87px;white-space:nowrap" class="ft112">activity typically occuring during G2 [5].&#160;Activation of IK&#160;</p>
<p style="position:absolute;top:232px;left:87px;white-space:nowrap" class="ft112">may prevent depolarization during late G2 and progression&#160;</p>
<p style="position:absolute;top:250px;left:87px;white-space:nowrap" class="ft112">to&#160;mitosis.&#160;Further&#160;investigation&#160;is&#160;needed&#160;to&#160;determine&#160;if&#160;</p>
<p style="position:absolute;top:268px;left:87px;white-space:nowrap" class="ft112">G2&#160;accumulation&#160;is&#160;due&#160;to&#160;hyperpolarization&#160;specifically,&#160;</p>
<p style="position:absolute;top:286px;left:87px;white-space:nowrap" class="ft112">as&#160;this&#160;would&#160;for&#160;the&#160;first&#160;time&#160;indicate&#160;a&#160;requirement&#160;for&#160;</p>
<p style="position:absolute;top:304px;left:87px;white-space:nowrap" class="ft112">depolarization&#160;as&#160;part&#160;of&#160;the&#160;G2 checkpoint.&#160;The&#160;different&#160;</p>
<p style="position:absolute;top:322px;left:87px;white-space:nowrap" class="ft112">response seen between MDA-MB-231 and MCF-10A&#160;</p>
<p style="position:absolute;top:340px;left:87px;white-space:nowrap" class="ft112">cells&#160;suggests the cell lines may have distinct bioelectric&#160;</p>
<p style="position:absolute;top:358px;left:87px;white-space:nowrap" class="ft112">profiles&#160;&#160;with&#160;&#160;altered&#160;&#160;sensitivity&#160;&#160;to&#160;&#160;bioelectric&#160;&#160;events.&#160;</p>
<p style="position:absolute;top:376px;left:87px;white-space:nowrap" class="ft112">This may be a result of differences in expression of&#160;</p>
<p style="position:absolute;top:70px;left:487px;white-space:nowrap" class="ft112">bioelectric sensors including proteins related to calcium&#160;</p>
<p style="position:absolute;top:88px;left:487px;white-space:nowrap" class="ft112">signaling, or a difference in the ability to compensate&#160;</p>
<p style="position:absolute;top:106px;left:487px;white-space:nowrap" class="ft112">for the increased potassium current. Understanding the&#160;</p>
<p style="position:absolute;top:124px;left:487px;white-space:nowrap" class="ft112">bioelectric requirements of the G2 checkpoint may help&#160;</p>
<p style="position:absolute;top:142px;left:487px;white-space:nowrap" class="ft112">elucidate&#160;novel&#160;therapies&#160;designed&#160;to&#160;utilize&#160;differences&#160;in&#160;</p>
<p style="position:absolute;top:160px;left:487px;white-space:nowrap" class="ft112">sensitivity to target specific cell populations.</p>
<p style="position:absolute;top:178px;left:523px;white-space:nowrap" class="ft112">One possible mechanism to explain the contrasting&#160;</p>
<p style="position:absolute;top:196px;left:487px;white-space:nowrap" class="ft112">behavioral response between MCF-10A&#160;and MDA-</p>
<p style="position:absolute;top:214px;left:487px;white-space:nowrap" class="ft112">MB-231 is a difference in expression of IK binding&#160;</p>
<p style="position:absolute;top:232px;left:487px;white-space:nowrap" class="ft112">partners and other closely associated proteins&#160;that differ&#160;</p>
<p style="position:absolute;top:250px;left:487px;white-space:nowrap" class="ft112">between the two cell types. IK signaling is dependent&#160;</p>
<p style="position:absolute;top:268px;left:487px;white-space:nowrap" class="ft112">on&#160;&#160;interactions&#160;&#160;with&#160;&#160;beta-1-integrin&#160;&#160;and&#160;&#160;TRP&#160;&#160;member&#160;</p>
<p style="position:absolute;top:286px;left:487px;white-space:nowrap" class="ft112">calcium channels in other cell types [17, 37]. Little is&#160;</p>
<p style="position:absolute;top:304px;left:487px;white-space:nowrap" class="ft112">known about variability of associated proteins and how&#160;</p>
<p style="position:absolute;top:322px;left:487px;white-space:nowrap" class="ft112">it&#160;affects&#160;behavioral&#160;response.&#160;There&#160;are&#160;many&#160;members&#160;</p>
<p style="position:absolute;top:340px;left:487px;white-space:nowrap" class="ft112">within&#160;&#160;the&#160;&#160;TRP&#160;&#160;calcium&#160;&#160;channel&#160;&#160;family&#160;&#160;each&#160;&#160;with&#160;</p>
<p style="position:absolute;top:358px;left:487px;white-space:nowrap" class="ft112">unique activation properties and thus IK associated with&#160;</p>
<p style="position:absolute;top:376px;left:487px;white-space:nowrap" class="ft112">different&#160;members&#160;may&#160;have&#160;a&#160;different&#160;effect&#160;on&#160;calcium&#160;</p>
<p style="position:absolute;top:1023px;left:87px;white-space:nowrap" class="ft114"><b>Figure 8: IK over-expression increases metastasis to the lung.</b>&#160;<b>(A)</b>&#160;Quantification&#160;of&#160;HNA&#160;positive&#160;cells&#160;in&#160;lung&#160;tissue&#160;sections&#160;</p>
<p style="position:absolute;top:1041px;left:87px;white-space:nowrap" class="ft111">collected&#160;4 weeks after&#160;mice&#160;were injected&#160;in the mammary&#160;fat pad with MDA-MB-231&#160;cells.&#160;Data are mean&#160;with SEM of 3 sections per&#160;</p>
<p style="position:absolute;top:1057px;left:87px;white-space:nowrap" class="ft111">mouse&#160;control&#160;n&#160;=8,&#160;IK&#160;n&#160;=&#160;9&#160;p&#160;&lt;&#160;0.01,&#160;2-sample&#160;t-test).&#160;<b>(B)</b>&#160;Representative&#160;image&#160;of&#160;HNA&#160;staining&#160;(green)&#160;with&#160;DAPI&#160;(blue)&#160;counterstain&#160;</p>
<p style="position:absolute;top:1074px;left:87px;white-space:nowrap" class="ft111">in full lung section with arrows indicating positive cells.</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>66c92c4fd6c5899239528c7d73898d26-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft120{font-size:11px;font-family:Times;color:#c02f3b;}
	.ft121{font-size:11px;font-family:Times;color:#231f20;}
	.ft122{font-size:13px;font-family:Times;color:#231f20;}
	.ft123{font-size:13px;font-family:Times;color:#231f20;}
	.ft124{font-size:16px;font-family:Times;color:#ac2b30;}
	.ft125{font-size:14px;font-family:Times;color:#231f20;}
	.ft126{font-size:6px;font-family:Times;color:#231f20;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page12-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft120">Oncotarget</p>
<p style="position:absolute;top:1111px;left:438px;white-space:nowrap" class="ft121">42393</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft120">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:70px;left:87px;white-space:nowrap" class="ft122">dynamics&#160;and&#160;downstream&#160;signaling.&#160;While&#160;some&#160;studies&#160;</p>
<p style="position:absolute;top:88px;left:87px;white-space:nowrap" class="ft122">have investigated the requirement of associated proteins&#160;</p>
<p style="position:absolute;top:107px;left:87px;white-space:nowrap" class="ft122">to IK signaling, none have investigated the effect of&#160;</p>
<p style="position:absolute;top:125px;left:87px;white-space:nowrap" class="ft122">substituting related family members to gauge the response&#160;</p>
<p style="position:absolute;top:143px;left:87px;white-space:nowrap" class="ft122">to a more subtle perturbation of the system.&#160;Additionally,&#160;</p>
<p style="position:absolute;top:161px;left:87px;white-space:nowrap" class="ft122">a recent study found anomalous&#160;downstream responses to&#160;</p>
<p style="position:absolute;top:179px;left:87px;white-space:nowrap" class="ft122">different IK inhibitors likely caused by maintenance of&#160;</p>
<p style="position:absolute;top:198px;left:87px;white-space:nowrap" class="ft122">high intracellular&#160;calcium&#160;in response to one inhibitor&#160;but&#160;</p>
<p style="position:absolute;top:216px;left:87px;white-space:nowrap" class="ft122">not&#160;the&#160;other&#160;[38].&#160;Together&#160;with&#160;our&#160;work,&#160;these&#160;findings&#160;</p>
<p style="position:absolute;top:234px;left:87px;white-space:nowrap" class="ft122">suggest the downstream response to IK modulation is&#160;</p>
<p style="position:absolute;top:252px;left:87px;white-space:nowrap" class="ft122">complex and point to mechanisms that may make the&#160;</p>
<p style="position:absolute;top:270px;left:87px;white-space:nowrap" class="ft122">response&#160;cell-type&#160;specific.&#160;Analysis&#160;of&#160;additional&#160;cell&#160;lines&#160;</p>
<p style="position:absolute;top:289px;left:87px;white-space:nowrap" class="ft122">and primary cells is needed to determine if the divergent&#160;</p>
<p style="position:absolute;top:307px;left:87px;white-space:nowrap" class="ft122">behavioral responses to IK stimulation are characteristic&#160;</p>
<p style="position:absolute;top:325px;left:87px;white-space:nowrap" class="ft122">of&#160;specific&#160;cell&#160;types&#160;or&#160;disease&#160;states&#160;and&#160;to&#160;elucidate&#160;the&#160;</p>
<p style="position:absolute;top:343px;left:87px;white-space:nowrap" class="ft122">mechanism driving the different behaviors.</p>
<p style="position:absolute;top:361px;left:123px;white-space:nowrap" class="ft122">Prior&#160;studies&#160;have&#160;placed&#160;the&#160;cancer-associated&#160;ion&#160;</p>
<p style="position:absolute;top:380px;left:87px;white-space:nowrap" class="ft122">channel IK within a growing number of channels that&#160;</p>
<p style="position:absolute;top:398px;left:87px;white-space:nowrap" class="ft122">are required to support aggressive tumor behaviors.&#160;This&#160;</p>
<p style="position:absolute;top:416px;left:87px;white-space:nowrap" class="ft122">study&#160;is&#160;the&#160;first&#160;to&#160;demonstrate&#160;that&#160;IK&#160;is&#160;also&#160;sufficient&#160;to&#160;</p>
<p style="position:absolute;top:434px;left:87px;white-space:nowrap" class="ft122">promote&#160;<i>in vivo</i>&#160;cancer&#160;growth&#160;and&#160;metastasis.&#160;Our&#160;findings&#160;</p>
<p style="position:absolute;top:452px;left:87px;white-space:nowrap" class="ft122">suggest that IK has a greater impact on signaling pathways&#160;</p>
<p style="position:absolute;top:471px;left:87px;white-space:nowrap" class="ft122">driving&#160;cancer&#160;progression,&#160;likely&#160;calcium-sensitive&#160;</p>
<p style="position:absolute;top:489px;left:87px;white-space:nowrap" class="ft122">pathways, than previously thought. Ion channels are an&#160;</p>
<p style="position:absolute;top:507px;left:87px;white-space:nowrap" class="ft122">intriguing&#160;potential&#160;mechanism&#160;of&#160;metastasis&#160;initiation&#160;as&#160;</p>
<p style="position:absolute;top:525px;left:87px;white-space:nowrap" class="ft122">they are highly sensitive to microenvironmental factors&#160;</p>
<p style="position:absolute;top:543px;left:87px;white-space:nowrap" class="ft122">and therefore could explain why only a small percentage&#160;</p>
<p style="position:absolute;top:562px;left:87px;white-space:nowrap" class="ft122">of syngeneic cells go on to form metastases.&#160;The results of&#160;</p>
<p style="position:absolute;top:580px;left:87px;white-space:nowrap" class="ft122">this&#160;study&#160;support&#160;the&#160;ability&#160;of&#160;IK&#160;to&#160;increase&#160;aggression&#160;</p>
<p style="position:absolute;top:598px;left:87px;white-space:nowrap" class="ft122">of&#160;already&#160;transformed&#160;cancer&#160;cells.&#160;The&#160;ability&#160;of&#160;IK&#160;to&#160;</p>
<p style="position:absolute;top:616px;left:87px;white-space:nowrap" class="ft122">promote tumor growth and metastasis&#160;<i>in vivo</i>&#160;points to&#160;</p>
<p style="position:absolute;top:634px;left:87px;white-space:nowrap" class="ft122">the potential of IK-inhibiting drugs to decrease cancer&#160;</p>
<p style="position:absolute;top:653px;left:87px;white-space:nowrap" class="ft122">progression. Furthermore, the opposing behavioral&#160;</p>
<p style="position:absolute;top:671px;left:87px;white-space:nowrap" class="ft122">response&#160;between&#160;cancerous&#160;MDA-MB-231&#160;and&#160;non-</p>
<p style="position:absolute;top:689px;left:87px;white-space:nowrap" class="ft122">tumorigenic MCF-10A&#160;cell lines warrants further study&#160;</p>
<p style="position:absolute;top:707px;left:87px;white-space:nowrap" class="ft122">to determine if there are unique mechanisms conferring&#160;</p>
<p style="position:absolute;top:725px;left:87px;white-space:nowrap" class="ft122">different sensitivities that could be utilized to formulate&#160;</p>
<p style="position:absolute;top:744px;left:87px;white-space:nowrap" class="ft122">targeted therapies.</p>
<p style="position:absolute;top:780px;left:87px;white-space:nowrap" class="ft124"><b>MATERIALS AND&#160;METHODS</b></p>
<p style="position:absolute;top:820px;left:87px;white-space:nowrap" class="ft125"><b>Generation of pMIG expression plasmid</b></p>
<p style="position:absolute;top:853px;left:123px;white-space:nowrap" class="ft122">The&#160;retroviral&#160;expression&#160;plasmid&#160;pMIG&#160;and&#160;a&#160;</p>
<p style="position:absolute;top:871px;left:87px;white-space:nowrap" class="ft122">plasmid&#160;containing&#160;tagRFP&#160;(RFP-&#160;red&#160;fluorescent&#160;protein)&#160;</p>
<p style="position:absolute;top:890px;left:87px;white-space:nowrap" class="ft122">were purchased from&#160;Addgene (#12282 and #37537).&#160;</p>
<p style="position:absolute;top:908px;left:87px;white-space:nowrap" class="ft122">A&#160;plasmid&#160;containing&#160;the&#160;IK&#160;complete&#160;coding&#160;sequence&#160;</p>
<p style="position:absolute;top:926px;left:87px;white-space:nowrap" class="ft122">was purchased from Genecopoeia (GC-0G00902).&#160;The&#160;</p>
<p style="position:absolute;top:944px;left:87px;white-space:nowrap" class="ft122">IK&#160;&#160;coding&#160;&#160;sequence&#160;&#160;in&#160;&#160;tandem&#160;&#160;with&#160;&#160;P2A&#160;&#160;and&#160;&#160;tagRFP&#160;</p>
<p style="position:absolute;top:962px;left:87px;white-space:nowrap" class="ft122">was&#160;inserted&#160;into&#160;pMIG&#160;to&#160;replace&#160;the&#160;IRES&#160;and&#160;green&#160;</p>
<p style="position:absolute;top:981px;left:87px;white-space:nowrap" class="ft122">fluorescent&#160;&#160;protein&#160;&#160;(GFP)&#160;&#160;sequence&#160;&#160;using&#160;&#160;the&#160;&#160;Gibson&#160;</p>
<p style="position:absolute;top:999px;left:87px;white-space:nowrap" class="ft122">cloning method following manufacturer instructions&#160;</p>
<p style="position:absolute;top:1017px;left:87px;white-space:nowrap" class="ft122">(NEB).&#160;Briefly,&#160;primers&#160;were&#160;designed&#160;to&#160;amplify&#160;pMIG&#160;</p>
<p style="position:absolute;top:1035px;left:87px;white-space:nowrap" class="ft122">excluding&#160;&#160;the&#160;&#160;IRES-GFP&#160;&#160;sequence&#160;&#160;(forward&#160;&#160;primer&#160;&#160;5’&#160;</p>
<p style="position:absolute;top:1053px;left:87px;white-space:nowrap" class="ft122">GCCAAGCTTATCGATAAAATAAAAGA, reverse&#160;</p>
<p style="position:absolute;top:1071px;left:87px;white-space:nowrap" class="ft122">primer&#160;&#160;5’&#160;&#160;AATTCCGGCGCCTAGAGA).&#160;&#160;Primers&#160;&#160;for&#160;</p>
<p style="position:absolute;top:70px;left:487px;white-space:nowrap" class="ft122">the&#160;&#160;channels&#160;&#160;and&#160;&#160;tagRFP&#160;&#160;were&#160;&#160;designed&#160;&#160;with&#160;&#160;15-40&#160;</p>
<p style="position:absolute;top:88px;left:487px;white-space:nowrap" class="ft122">bp overhanging sequences to match the adjacent DNA&#160;</p>
<p style="position:absolute;top:106px;left:487px;white-space:nowrap" class="ft122">sequence&#160;&#160;of&#160;&#160;the&#160;&#160;final&#160;&#160;plasmid&#160;&#160;and&#160;&#160;to&#160;&#160;insert&#160;&#160;the&#160;&#160;P2A&#160;</p>
<p style="position:absolute;top:125px;left:487px;white-space:nowrap" class="ft122">sequence&#160;(IK&#160;forward&#160;primer&#160;5’&#160;CTAGGCGCCGGAATT</p>
<p style="position:absolute;top:143px;left:487px;white-space:nowrap" class="ft122">ACCATGGGCGGGGATCTGG,&#160;reverse&#160;primer&#160;5’&#160;TCTC</p>
<p style="position:absolute;top:161px;left:487px;white-space:nowrap" class="ft122">CTGCTTGCTTTAACAGAGAGAAGTTCGTGGCTCC</p>
<p style="position:absolute;top:179px;left:487px;white-space:nowrap" class="ft122">GGATCCCTTGGACTGCTGGCTGGG;&#160;tagRFP&#160;forward&#160;</p>
<p style="position:absolute;top:197px;left:487px;white-space:nowrap" class="ft122">primer&#160;5’&#160;TCTCTCTGTTAAAGCAAGCAGGAGACGT</p>
<p style="position:absolute;top:215px;left:487px;white-space:nowrap" class="ft122">GGAAGAAAACCCCGGTCCTGTGTCTAAGGGCGAA&#160;</p>
<p style="position:absolute;top:233px;left:487px;white-space:nowrap" class="ft122">GAGCTGA,&#160;reverse&#160;primer&#160;5’&#160;CCTACAGGTGGGGTC</p>
<p style="position:absolute;top:251px;left:487px;white-space:nowrap" class="ft122">TCACTTGTACAGCTCGTCCATGCC). All&#160;fragments&#160;</p>
<p style="position:absolute;top:269px;left:487px;white-space:nowrap" class="ft122">were&#160;&#160;amplified&#160;&#160;by&#160;&#160;PCR&#160;&#160;and&#160;&#160;gel&#160;&#160;purified.&#160;&#160;A&#160;&#160;Gibson&#160;</p>
<p style="position:absolute;top:287px;left:487px;white-space:nowrap" class="ft122">reaction was performed using three DNA&#160;fragments, the&#160;</p>
<p style="position:absolute;top:305px;left:487px;white-space:nowrap" class="ft122">pMIG&#160;backbone,&#160;channel,&#160;and&#160;tagRFP,&#160;to&#160;create&#160;the&#160;final&#160;</p>
<p style="position:absolute;top:323px;left:487px;white-space:nowrap" class="ft122">plasmid&#160;(pMIG-IK).&#160;A&#160;plasmid&#160;with&#160;only&#160;tagRFP&#160;inserted&#160;</p>
<p style="position:absolute;top:342px;left:487px;white-space:nowrap" class="ft122">was generated as a control (pMIG-RFP).</p>
<p style="position:absolute;top:378px;left:487px;white-space:nowrap" class="ft125"><b>Retrovirus production and transduction</b></p>
<p style="position:absolute;top:411px;left:523px;white-space:nowrap" class="ft122">Two days prior to transfection, 2 × 106&#160;&#160;293&#160;&#160;Plat&#160;</p>
<p style="position:absolute;top:429px;left:487px;white-space:nowrap" class="ft122">GP&#160;&#160;cells&#160;&#160;(Cell&#160;&#160;Biolabs)&#160;&#160;were&#160;&#160;plated&#160;&#160;on&#160;&#160;a&#160;&#160;10&#160;&#160;cm&#160;&#160;dish.&#160;</p>
<p style="position:absolute;top:447px;left:487px;white-space:nowrap" class="ft122">Transfection&#160;was&#160;performed&#160;with&#160;60&#160;μL&#160;of&#160;lipofectamine&#160;</p>
<p style="position:absolute;top:465px;left:487px;white-space:nowrap" class="ft122">2000,&#160;&#160;6&#160;&#160;μg&#160;&#160;of&#160;&#160;VSV&#160;&#160;packaging&#160;&#160;plasmid,&#160;&#160;and&#160;&#160;12&#160;&#160;μg&#160;&#160;of&#160;</p>
<p style="position:absolute;top:483px;left:487px;white-space:nowrap" class="ft122">pMIG-Channel-P2A-RFP&#160;&#160;plasmid&#160;&#160;per&#160;&#160;manufacturer&#160;</p>
<p style="position:absolute;top:501px;left:487px;white-space:nowrap" class="ft122">instructions. Cells were incubated in the DNA:liposome&#160;</p>
<p style="position:absolute;top:520px;left:487px;white-space:nowrap" class="ft122">complex&#160;overnight&#160;in&#160;a&#160;final&#160;volume&#160;of&#160;6&#160;mL.&#160;At&#160;72&#160;hours&#160;</p>
<p style="position:absolute;top:538px;left:487px;white-space:nowrap" class="ft122">post&#160;transfection,&#160;virus&#160;media&#160;was&#160;collected&#160;and&#160;filtered&#160;</p>
<p style="position:absolute;top:556px;left:487px;white-space:nowrap" class="ft122">through&#160;a&#160;45&#160;μm&#160;filter.&#160;Human&#160;breast&#160;epithelial&#160;cell&#160;lines&#160;</p>
<p style="position:absolute;top:574px;left:487px;white-space:nowrap" class="ft122">were&#160;transduced&#160;by&#160;incubating&#160;50%&#160;confluent&#160;cells&#160;with&#160;</p>
<p style="position:absolute;top:592px;left:487px;white-space:nowrap" class="ft122">virus&#160;in&#160;media&#160;supplemented&#160;with&#160;6&#160;μg/mL&#160;polybrene&#160;for&#160;</p>
<p style="position:absolute;top:610px;left:487px;white-space:nowrap" class="ft122">24&#160;hours.&#160;At&#160;72&#160;hours&#160;post-transduction,&#160;retrovirus&#160;treated&#160;</p>
<p style="position:absolute;top:628px;left:487px;white-space:nowrap" class="ft122">cells&#160;were&#160;placed&#160;in&#160;media&#160;containing&#160;50&#160;μg/mL&#160;G418&#160;for&#160;</p>
<p style="position:absolute;top:646px;left:487px;white-space:nowrap" class="ft122">selection.&#160;Retrovirus&#160;infected&#160;cells&#160;were&#160;expanded&#160;for&#160;later&#160;</p>
<p style="position:absolute;top:664px;left:487px;white-space:nowrap" class="ft122">FACS sorting.</p>
<p style="position:absolute;top:700px;left:487px;white-space:nowrap" class="ft125"><b>Cell cultivation</b></p>
<p style="position:absolute;top:734px;left:523px;white-space:nowrap" class="ft122">MCF-10A&#160;and&#160;MDA-MB-231&#160;cell&#160;line&#160;were&#160;</p>
<p style="position:absolute;top:752px;left:487px;white-space:nowrap" class="ft122">purchased&#160;directly&#160;from&#160;ATCC&#160;which&#160;certified&#160;the&#160;identity&#160;</p>
<p style="position:absolute;top:770px;left:487px;white-space:nowrap" class="ft122">of&#160;the&#160;cell&#160;lines&#160;by&#160;STR&#160;analysis&#160;and&#160;also&#160;certified&#160;the&#160;cell&#160;</p>
<p style="position:absolute;top:788px;left:487px;white-space:nowrap" class="ft122">lines as pathogen-free. Cells were maintained following&#160;</p>
<p style="position:absolute;top:806px;left:487px;white-space:nowrap" class="ft122">ATCC recommendations.</p>
<p style="position:absolute;top:842px;left:487px;white-space:nowrap" class="ft125"><b>IK activation</b></p>
<p style="position:absolute;top:875px;left:523px;white-space:nowrap" class="ft122">Cells were treated with 200 µM 1-EBIO diluted&#160;</p>
<p style="position:absolute;top:894px;left:487px;white-space:nowrap" class="ft122">from a 400 mM 1-EBIO stock solution in dimethyl&#160;</p>
<p style="position:absolute;top:912px;left:487px;white-space:nowrap" class="ft122">sulfoxide&#160;(DMSO)&#160;resulting&#160;in&#160;a&#160;final&#160;concentration&#160;of&#160;</p>
<p style="position:absolute;top:930px;left:487px;white-space:nowrap" class="ft122">0.05% DMSO in the cell medium. Control samples were&#160;</p>
<p style="position:absolute;top:948px;left:487px;white-space:nowrap" class="ft122">treated with an equivalent concentration of DMSO as&#160;</p>
<p style="position:absolute;top:966px;left:487px;white-space:nowrap" class="ft122">vehicle control.</p>
<p style="position:absolute;top:1002px;left:487px;white-space:nowrap" class="ft125"><b>Electrophysiology</b></p>
<p style="position:absolute;top:1035px;left:523px;white-space:nowrap" class="ft122">Patch&#160;clamp&#160;recordings&#160;were&#160;performed&#160;in&#160;the&#160;cell&#160;</p>
<p style="position:absolute;top:1053px;left:487px;white-space:nowrap" class="ft122">attached&#160;&#160;perforated&#160;&#160;patch&#160;&#160;configuration&#160;&#160;and&#160;&#160;data&#160;&#160;were&#160;</p>
<p style="position:absolute;top:1071px;left:487px;white-space:nowrap" class="ft122">recorded with an&#160;Axon DigiData 1550 (Axon Instruments)&#160;</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>66c92c4fd6c5899239528c7d73898d26-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft130{font-size:11px;font-family:Times;color:#c02f3b;}
	.ft131{font-size:11px;font-family:Times;color:#231f20;}
	.ft132{font-size:13px;font-family:Times;color:#231f20;}
	.ft133{font-size:6px;font-family:Times;color:#231f20;}
	.ft134{font-size:13px;font-family:Times;color:#231f20;}
	.ft135{font-size:14px;font-family:Times;color:#231f20;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page13-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft130">Oncotarget</p>
<p style="position:absolute;top:1111px;left:438px;white-space:nowrap" class="ft131">42394</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft130">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:70px;left:87px;white-space:nowrap" class="ft132">data acquisition system and an&#160;Axopatch 200B (Molecular&#160;</p>
<p style="position:absolute;top:89px;left:87px;white-space:nowrap" class="ft132">Devices)&#160;amplifier.&#160;Data&#160;were&#160;low&#160;pass&#160;filtered&#160;at&#160;5&#160;kHz,&#160;</p>
<p style="position:absolute;top:107px;left:87px;white-space:nowrap" class="ft132">sampled at 50 kHz, and analyzed using pClamp 10&#160;</p>
<p style="position:absolute;top:125px;left:87px;white-space:nowrap" class="ft132">software&#160;(Axon&#160;Instruments).&#160;Patch&#160;pipettes&#160;were&#160;pulled&#160;</p>
<p style="position:absolute;top:143px;left:87px;white-space:nowrap" class="ft132">from&#160;thin-wall&#160;borosilicate&#160;glass&#160;with&#160;a&#160;P-97&#160;micropipette&#160;</p>
<p style="position:absolute;top:161px;left:87px;white-space:nowrap" class="ft132">puller&#160;&#160;(Sutter&#160;&#160;Instruments)&#160;&#160;and&#160;&#160;fire&#160;&#160;polished&#160;&#160;resulting&#160;</p>
<p style="position:absolute;top:180px;left:87px;white-space:nowrap" class="ft132">in&#160;4-7&#160;MΩ&#160;resistance&#160;pipettes.&#160;Pipettes&#160;were&#160;filled&#160;with&#160;</p>
<p style="position:absolute;top:198px;left:87px;white-space:nowrap" class="ft132">intracellular&#160;electrode&#160;solution (5&#160;mM NaCl, 145&#160;mM&#160;</p>
<p style="position:absolute;top:216px;left:87px;white-space:nowrap" class="ft132">KCl, 2 mM MgCl</p>
<p style="position:absolute;top:227px;left:206px;white-space:nowrap" class="ft133">2, 1 mM CaCl2, 1.57 mM ethylene&#160;</p>
<p style="position:absolute;top:234px;left:87px;white-space:nowrap" class="ft132">glycol-bis(2-aminoethylether)-<i>N-N-N’-N’</i>-tetraacetic&#160;</p>
<p style="position:absolute;top:253px;left:87px;white-space:nowrap" class="ft132">acid (EGTA), 10 mM 4-(2-Hydroxyethyl)piperazine-1-</p>
<p style="position:absolute;top:271px;left:87px;white-space:nowrap" class="ft132">ethanesulfonic&#160;acid&#160;(HEPES),&#160;pH&#160;adjusted&#160;to&#160;7.4&#160;with&#160;1&#160;</p>
<p style="position:absolute;top:289px;left:87px;white-space:nowrap" class="ft132">M KOH) supplemented with 150 ng/ml Nystatin to induce&#160;</p>
<p style="position:absolute;top:307px;left:87px;white-space:nowrap" class="ft132">pore&#160;formation.&#160;Prior&#160;to&#160;recording,&#160;cells&#160;plated&#160;on&#160;glass&#160;</p>
<p style="position:absolute;top:325px;left:87px;white-space:nowrap" class="ft132">coverslips were perfused with external&#160;bath solution (144&#160;</p>
<p style="position:absolute;top:344px;left:87px;white-space:nowrap" class="ft132">mM NaCl, 5.4 mM KCl, 1 mM MgCl</p>
<p style="position:absolute;top:355px;left:326px;white-space:nowrap" class="ft133">2, 2.5 mM CaCl2,&#160;</p>
<p style="position:absolute;top:362px;left:87px;white-space:nowrap" class="ft132">5.6&#160;mM&#160;Glucose,&#160;5mM&#160;HEPES,&#160;adjusted&#160;to&#160;pH&#160;7.2&#160;with&#160;</p>
<p style="position:absolute;top:380px;left:87px;white-space:nowrap" class="ft132">1 M NaOH).&#160;After initial seal formation, with a minimal&#160;</p>
<p style="position:absolute;top:398px;left:87px;white-space:nowrap" class="ft132">seal&#160;resistance&#160;cut&#160;off&#160;of&#160;1.0&#160;GΩ,&#160;perforation&#160;was&#160;assayed&#160;</p>
<p style="position:absolute;top:417px;left:87px;white-space:nowrap" class="ft132">by monitoring the capacitive current transient to a 2.5&#160;</p>
<p style="position:absolute;top:435px;left:87px;white-space:nowrap" class="ft132">mV&#160;step&#160;with&#160;-30&#160;mV&#160;holding&#160;potential.&#160;Recordings&#160;were&#160;</p>
<p style="position:absolute;top:453px;left:87px;white-space:nowrap" class="ft132">acquired&#160;once&#160;the&#160;series&#160;resistance&#160;was&#160;below&#160;75&#160;MΩ.&#160;</p>
<p style="position:absolute;top:471px;left:87px;white-space:nowrap" class="ft132">V</p>
<p style="position:absolute;top:483px;left:98px;white-space:nowrap" class="ft133">mem&#160;recordings were taken for 30 seconds in control&#160;</p>
<p style="position:absolute;top:490px;left:87px;white-space:nowrap" class="ft132">extracellular solution supplemented with vehicle control&#160;</p>
<p style="position:absolute;top:508px;left:87px;white-space:nowrap" class="ft132">with&#160;no&#160;fluid-flow,&#160;during&#160;30&#160;seconds&#160;of&#160;bath&#160;exchange&#160;</p>
<p style="position:absolute;top:526px;left:87px;white-space:nowrap" class="ft132">with&#160;the&#160;same&#160;solution,&#160;during&#160;30&#160;seconds&#160;of&#160;bath&#160;</p>
<p style="position:absolute;top:544px;left:87px;white-space:nowrap" class="ft132">exchange with bath solution containing 200 uM 1-EBIO,&#160;</p>
<p style="position:absolute;top:562px;left:87px;white-space:nowrap" class="ft132">and&#160;for&#160;30&#160;seconds&#160;in&#160;200&#160;µM&#160;1-EBIO&#160;with&#160;no&#160;fluid&#160;flow.&#160;</p>
<p style="position:absolute;top:581px;left:87px;white-space:nowrap" class="ft132">The&#160;reported V</p>
<p style="position:absolute;top:592px;left:183px;white-space:nowrap" class="ft133">mem&#160;values are the average from the last&#160;</p>
<p style="position:absolute;top:599px;left:87px;white-space:nowrap" class="ft132">20&#160;seconds&#160;recorded&#160;in&#160;static&#160;fluid&#160;from&#160;each&#160;condition.&#160;</p>
<p style="position:absolute;top:617px;left:87px;white-space:nowrap" class="ft132">For the current-voltage protocol, cells were held at -30&#160;</p>
<p style="position:absolute;top:635px;left:87px;white-space:nowrap" class="ft132">mV&#160;followed by 50 ms test pulses between -120 mV&#160;and&#160;</p>
<p style="position:absolute;top:654px;left:87px;white-space:nowrap" class="ft132">80&#160;mV&#160;in&#160;40&#160;mV&#160;steps.&#160;Current&#160;density&#160;was&#160;calculated&#160;</p>
<p style="position:absolute;top:672px;left:87px;white-space:nowrap" class="ft132">by&#160;dividing the average&#160;current during&#160;the&#160;voltage&#160;step&#160;</p>
<p style="position:absolute;top:690px;left:87px;white-space:nowrap" class="ft132">without leak subtraction by the whole cell capacitance.</p>
<p style="position:absolute;top:726px;left:87px;white-space:nowrap" class="ft135"><b>RNA&#160;isolation, purification, and quantitative&#160;</b></p>
<p style="position:absolute;top:746px;left:87px;white-space:nowrap" class="ft135"><b>PCR</b></p>
<p style="position:absolute;top:780px;left:123px;white-space:nowrap" class="ft132">RNA&#160;was&#160;isolated&#160;from&#160;confluent&#160;cells&#160;in&#160;a&#160;6-well&#160;</p>
<p style="position:absolute;top:798px;left:87px;white-space:nowrap" class="ft132">plate.&#160;Cells&#160;were&#160;rinsed&#160;with&#160;PBS&#160;and&#160;200&#160;μL&#160;RNA-later&#160;</p>
<p style="position:absolute;top:816px;left:87px;white-space:nowrap" class="ft132">(Ambion) was added before scraping and transferring&#160;</p>
<p style="position:absolute;top:835px;left:87px;white-space:nowrap" class="ft132">cells&#160;to&#160;a&#160;1.5&#160;mL&#160;tube.&#160;RNA&#160;was&#160;purified&#160;using&#160;an&#160;RNeasy&#160;</p>
<p style="position:absolute;top:853px;left:87px;white-space:nowrap" class="ft132">mini kit (Qiagen) per manufacturer instructions.&#160;The&#160;</p>
<p style="position:absolute;top:871px;left:87px;white-space:nowrap" class="ft132">concentration&#160;of&#160;RNA&#160;was&#160;determined&#160;with&#160;a&#160;NanoDrop&#160;</p>
<p style="position:absolute;top:889px;left:87px;white-space:nowrap" class="ft132">2000&#160;(Thermo&#160;Scientific).&#160;Reverse&#160;transcription&#160;reactions&#160;</p>
<p style="position:absolute;top:907px;left:87px;white-space:nowrap" class="ft132">were&#160;performed&#160;with&#160;1&#160;μg&#160;of&#160;RNA&#160;in&#160;a&#160;20&#160;μl&#160;reaction&#160;</p>
<p style="position:absolute;top:926px;left:87px;white-space:nowrap" class="ft132">using&#160;iScript&#160;Reverse&#160;Transcription&#160;Supermix&#160;(Bio-Rad)&#160;</p>
<p style="position:absolute;top:944px;left:87px;white-space:nowrap" class="ft132">following manufacturer instructions.&#160;Transcript expression&#160;</p>
<p style="position:absolute;top:962px;left:87px;white-space:nowrap" class="ft132">levels&#160;were&#160;quantified&#160;with&#160;a&#160;Bio-Rad&#160;CFX96&#160;Real&#160;Time&#160;</p>
<p style="position:absolute;top:980px;left:87px;white-space:nowrap" class="ft132">System.&#160;&#160;Reactions&#160;&#160;were&#160;&#160;performed&#160;&#160;in&#160;&#160;20&#160;&#160;μL&#160;&#160;using&#160;&#160;iQ&#160;</p>
<p style="position:absolute;top:999px;left:87px;white-space:nowrap" class="ft132">SYBR&#160;Green&#160;Supermix&#160;(Bio-Rad)&#160;and&#160;40&#160;ng&#160;cDNA&#160;with&#160;</p>
<p style="position:absolute;top:1017px;left:87px;white-space:nowrap" class="ft132">the following reaction conditions: 95 ° C 10 min, 40 cycles&#160;</p>
<p style="position:absolute;top:1035px;left:87px;white-space:nowrap" class="ft132">of 95° C 30 sec, 58° C 1 minute, 72 C° 1 minute.&#160;The&#160;</p>
<p style="position:absolute;top:1053px;left:87px;white-space:nowrap" class="ft132">primers used to amplify an IK fragment were forward&#160;</p>
<p style="position:absolute;top:1071px;left:87px;white-space:nowrap" class="ft132">primer&#160;&#160;5’&#160;&#160;CTGCTGCGTCTCTACCTGG&#160;&#160;and&#160;&#160;reverse&#160;</p>
<p style="position:absolute;top:70px;left:487px;white-space:nowrap" class="ft132">primer&#160;5’&#160;AGGGTGCGTGTTCATGTAAAG&#160;and&#160;GAPDH&#160;</p>
<p style="position:absolute;top:88px;left:487px;white-space:nowrap" class="ft132">was used as the housekeeping gene with forward primer&#160;</p>
<p style="position:absolute;top:106px;left:487px;white-space:nowrap" class="ft132">5’&#160;&#160;TTCGACAGTCAGCCGCATCTTCTT&#160;&#160;and&#160;&#160;reverse&#160;</p>
<p style="position:absolute;top:124px;left:487px;white-space:nowrap" class="ft132">primer&#160;&#160;5’&#160;&#160;ACCAAATCCGTTGACTCCGACCTT.&#160;&#160;To&#160;</p>
<p style="position:absolute;top:142px;left:487px;white-space:nowrap" class="ft132">detect&#160;SK&#160;and&#160;compare&#160;to&#160;IK&#160;expression&#160;levels,&#160;QPCR&#160;</p>
<p style="position:absolute;top:160px;left:487px;white-space:nowrap" class="ft132">was&#160;performed&#160;using&#160;Taqman&#160;probes&#160;(Thermo&#160;Scientific)&#160;</p>
<p style="position:absolute;top:178px;left:487px;white-space:nowrap" class="ft132">for&#160;SK,&#160;IK,&#160;and&#160;GAPDH&#160;with&#160;Taqman&#160;universal&#160;master&#160;</p>
<p style="position:absolute;top:196px;left:487px;white-space:nowrap" class="ft132">mix&#160;&#160;II&#160;&#160;(Thermo&#160;&#160;Scientific)&#160;&#160;following&#160;&#160;manufacturer’s&#160;</p>
<p style="position:absolute;top:215px;left:487px;white-space:nowrap" class="ft132">instructions.</p>
<p style="position:absolute;top:251px;left:487px;white-space:nowrap" class="ft135"><b>Proliferation assay</b></p>
<p style="position:absolute;top:284px;left:523px;white-space:nowrap" class="ft132">MCF-10A&#160;cells were plated at 7.5 × 103&#160;cells/cm2&#160;</p>
<p style="position:absolute;top:302px;left:487px;white-space:nowrap" class="ft132">and MDA-MB-231 cells were plated at 1 × 104&#160;cells/</p>
<p style="position:absolute;top:320px;left:487px;white-space:nowrap" class="ft132">cm2&#160;in 6 well plates. Cells were allowed to attach in&#160;</p>
<p style="position:absolute;top:338px;left:487px;white-space:nowrap" class="ft132">normal medium for 3 h followed by exchange to media&#160;</p>
<p style="position:absolute;top:356px;left:487px;white-space:nowrap" class="ft132">supplemented&#160;with&#160;drug&#160;treatment.&#160;Cells&#160;were&#160;trypsinized&#160;</p>
<p style="position:absolute;top:374px;left:487px;white-space:nowrap" class="ft132">and&#160;counted&#160;with&#160;a&#160;TC&#160;10&#160;automated&#160;cell&#160;counter&#160;(BioRad)&#160;</p>
<p style="position:absolute;top:392px;left:487px;white-space:nowrap" class="ft132">daily for 4 days with a media change after 2 days.</p>
<p style="position:absolute;top:428px;left:487px;white-space:nowrap" class="ft135"><b>Apoptosis, cell death, and cell cycle analysis</b></p>
<p style="position:absolute;top:461px;left:523px;white-space:nowrap" class="ft132">Cells were plated at 5 × 104&#160;cells/cm2&#160;and allowed&#160;</p>
<p style="position:absolute;top:479px;left:487px;white-space:nowrap" class="ft132">to attach for 3 hours. Medium was exchanged to medium&#160;</p>
<p style="position:absolute;top:497px;left:487px;white-space:nowrap" class="ft132">supplemented with vehicle or 200 µM 1-EBIO and cells&#160;</p>
<p style="position:absolute;top:515px;left:487px;white-space:nowrap" class="ft132">were incubated for 24 h.&#160;To quantify the percentage of&#160;</p>
<p style="position:absolute;top:533px;left:487px;white-space:nowrap" class="ft132">apoptotic and dead cells, cells were trypsinized, washed&#160;</p>
<p style="position:absolute;top:551px;left:487px;white-space:nowrap" class="ft132">in&#160;PBS,&#160;and&#160;incubated&#160;in&#160;0.1%&#160;Live/Dead&#160;Fixable&#160;Violet&#160;</p>
<p style="position:absolute;top:570px;left:487px;white-space:nowrap" class="ft132">Dead Cell stain for 30 min. Cells were washed in&#160;Annexin&#160;</p>
<p style="position:absolute;top:588px;left:487px;white-space:nowrap" class="ft132">V&#160;Binding Buffer and incubated&#160;in&#160;Annexin&#160;V&#160;conjugated&#160;</p>
<p style="position:absolute;top:606px;left:487px;white-space:nowrap" class="ft132">to FITC diluted 1:125 in&#160;Annexin&#160;V&#160;Binding Buffer&#160;</p>
<p style="position:absolute;top:624px;left:487px;white-space:nowrap" class="ft132">(Invitrogen).&#160;For&#160;cell&#160;cycle&#160;analysis,&#160;cells&#160;were&#160;fixed&#160;in&#160;</p>
<p style="position:absolute;top:642px;left:487px;white-space:nowrap" class="ft132">70% ethanol and washed in phosphate-buffered saline&#160;</p>
<p style="position:absolute;top:660px;left:487px;white-space:nowrap" class="ft132">(PBS).&#160;&#160;Cells&#160;&#160;were&#160;&#160;incubated&#160;&#160;in&#160;&#160;50&#160;&#160;ng/mL&#160;&#160;propidium&#160;</p>
<p style="position:absolute;top:678px;left:487px;white-space:nowrap" class="ft132">iodide&#160;&#160;(Invitrogen),&#160;&#160;250&#160;&#160;ng/mL&#160;&#160;RNase&#160;&#160;diluted&#160;&#160;in&#160;&#160;PBS&#160;</p>
<p style="position:absolute;top:696px;left:487px;white-space:nowrap" class="ft132">for&#160;1hr.&#160;Cell&#160;fluorescence&#160;was&#160;detected&#160;using&#160;an&#160;LSR&#160;II&#160;</p>
<p style="position:absolute;top:714px;left:487px;white-space:nowrap" class="ft132">(Becton&#160;&#160;Dickenson)&#160;&#160;fluorescent&#160;&#160;cell&#160;&#160;analyzer&#160;&#160;and&#160;&#160;data&#160;</p>
<p style="position:absolute;top:732px;left:487px;white-space:nowrap" class="ft132">were analyzed with FlowJo software.</p>
<p style="position:absolute;top:768px;left:487px;white-space:nowrap" class="ft135"><b>Migration assay</b></p>
<p style="position:absolute;top:801px;left:523px;white-space:nowrap" class="ft132">MDA-MB-231 cells were plated at 2.5 × 105&#160;cells/</p>
<p style="position:absolute;top:819px;left:487px;white-space:nowrap" class="ft132">cm2&#160;in&#160;a&#160;24&#160;well&#160;plate&#160;and&#160;were&#160;serum&#160;starved&#160;in&#160;1%&#160;FBS&#160;</p>
<p style="position:absolute;top:837px;left:487px;white-space:nowrap" class="ft132">media overnight.&#160;A&#160;scratch was made with a yellow tip&#160;</p>
<p style="position:absolute;top:855px;left:487px;white-space:nowrap" class="ft132">and medium was exchanged with low serum medium&#160;</p>
<p style="position:absolute;top:873px;left:487px;white-space:nowrap" class="ft132">containing&#160;drug&#160;treatment.&#160;Phase&#160;contrast&#160;images&#160;were&#160;</p>
<p style="position:absolute;top:891px;left:487px;white-space:nowrap" class="ft132">acquired of the initial scratch. 10 h post scratch, cells&#160;</p>
<p style="position:absolute;top:909px;left:487px;white-space:nowrap" class="ft132">were incubated in 0.5 µg/mL&#160;calcein&#160;AM for 15 minutes&#160;</p>
<p style="position:absolute;top:927px;left:487px;white-space:nowrap" class="ft132">and&#160;fluorescent&#160;images&#160;were&#160;acquired.&#160;ImageJ&#160;was&#160;used&#160;</p>
<p style="position:absolute;top:945px;left:487px;white-space:nowrap" class="ft132">to&#160;calculate&#160;wound&#160;healing&#160;by&#160;first&#160;manually&#160;outlining&#160;the&#160;</p>
<p style="position:absolute;top:963px;left:487px;white-space:nowrap" class="ft132">wound&#160;at&#160;time&#160;0&#160;hr&#160;to&#160;create&#160;a&#160;region&#160;of&#160;interest&#160;(ROI).&#160;</p>
<p style="position:absolute;top:981px;left:487px;white-space:nowrap" class="ft132">The&#160;fluorescent&#160;10&#160;h&#160;image&#160;of&#160;calcein&#160;AM&#160;stained&#160;cells&#160;</p>
<p style="position:absolute;top:999px;left:487px;white-space:nowrap" class="ft132">was converted to a binary image such that white pixels&#160;</p>
<p style="position:absolute;top:1017px;left:487px;white-space:nowrap" class="ft132">corresponded to the surface area covered by cells.&#160;The&#160;</p>
<p style="position:absolute;top:1035px;left:487px;white-space:nowrap" class="ft132">percentage&#160;of&#160;white&#160;pixels&#160;within&#160;the&#160;initial&#160;wound&#160;ROI&#160;</p>
<p style="position:absolute;top:1053px;left:487px;white-space:nowrap" class="ft132">was&#160;quantified&#160;to&#160;measure&#160;wound&#160;healing.&#160;Scratch&#160;assays&#160;</p>
<p style="position:absolute;top:1071px;left:487px;white-space:nowrap" class="ft132">with MF-10A&#160;cells were performed similarly but 24-well&#160;</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>66c92c4fd6c5899239528c7d73898d26-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft140{font-size:11px;font-family:Times;color:#c02f3b;}
	.ft141{font-size:11px;font-family:Times;color:#231f20;}
	.ft142{font-size:13px;font-family:Times;color:#231f20;}
	.ft143{font-size:6px;font-family:Times;color:#231f20;}
	.ft144{font-size:14px;font-family:Times;color:#231f20;}
	.ft145{font-size:14px;font-family:Times;color:#ac2b30;}
	.ft146{font-size:13px;font-family:Times;color:#231f20;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page14-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft140">Oncotarget</p>
<p style="position:absolute;top:1111px;left:438px;white-space:nowrap" class="ft141">42395</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft140">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:70px;left:87px;white-space:nowrap" class="ft142">plates were seeded with 3.75 × 105&#160;cells/cm2&#160;cells, low&#160;</p>
<p style="position:absolute;top:88px;left:87px;white-space:nowrap" class="ft142">serum medium consisted of normal MCF-10A&#160;medium&#160;</p>
<p style="position:absolute;top:106px;left:87px;white-space:nowrap" class="ft142">with&#160;0.5%&#160;horse&#160;serum&#160;and&#160;2&#160;ng/mL&#160;EGF,&#160;and&#160;bright&#160;field&#160;</p>
<p style="position:absolute;top:124px;left:87px;white-space:nowrap" class="ft142">images were acquired 0 h and 12 h after scratching and&#160;</p>
<p style="position:absolute;top:142px;left:87px;white-space:nowrap" class="ft142">the&#160;area&#160;of&#160;the&#160;scratch&#160;wound&#160;was&#160;measured&#160;with&#160;image&#160;J.</p>
<p style="position:absolute;top:178px;left:87px;white-space:nowrap" class="ft144"><b>Invasion assay</b></p>
<p style="position:absolute;top:212px;left:123px;white-space:nowrap" class="ft142">The day prior to invasion assays, cells were placed&#160;</p>
<p style="position:absolute;top:230px;left:87px;white-space:nowrap" class="ft142">in low serum medium. Basement membrane coated&#160;</p>
<p style="position:absolute;top:248px;left:87px;white-space:nowrap" class="ft142">transwells&#160;with&#160;6.5&#160;mm&#160;diameter&#160;and&#160;8&#160;μm&#160;pore&#160;size&#160;(BD&#160;</p>
<p style="position:absolute;top:266px;left:87px;white-space:nowrap" class="ft142">Biosciences)&#160;were&#160;pre-incubated&#160;with&#160;500&#160;μL&#160;DMEM&#160;in&#160;</p>
<p style="position:absolute;top:284px;left:87px;white-space:nowrap" class="ft142">the&#160;upper&#160;chamber&#160;for&#160;2&#160;hours.&#160;MDA-MB-231&#160;cells&#160;were&#160;</p>
<p style="position:absolute;top:302px;left:87px;white-space:nowrap" class="ft142">diluted to 2.5 × 105&#160;cells/mL&#160;and MCF-10A&#160;cells were&#160;</p>
<p style="position:absolute;top:320px;left:87px;white-space:nowrap" class="ft142">diluted to 5 × 105&#160;cells/mL&#160;in low serum media and 200&#160;</p>
<p style="position:absolute;top:338px;left:87px;white-space:nowrap" class="ft142">μL&#160;of&#160;the&#160;cell&#160;suspension&#160;was&#160;placed&#160;in&#160;the&#160;upper&#160;chamber&#160;</p>
<p style="position:absolute;top:356px;left:87px;white-space:nowrap" class="ft142">giving 5 × 104&#160;and 1 × 105&#160;cells per well respectively.&#160;The&#160;</p>
<p style="position:absolute;top:374px;left:87px;white-space:nowrap" class="ft142">bottom&#160;chamber&#160;was&#160;filled&#160;with&#160;600&#160;μL&#160;of&#160;normal&#160;full&#160;</p>
<p style="position:absolute;top:392px;left:87px;white-space:nowrap" class="ft142">serum media as a chemoattractant.&#160;After 16 h for MDA-</p>
<p style="position:absolute;top:410px;left:87px;white-space:nowrap" class="ft142">MB-231&#160;cells&#160;or&#160;24&#160;h&#160;for&#160;MCF-10A&#160;cells,&#160;transwells&#160;were&#160;</p>
<p style="position:absolute;top:428px;left:87px;white-space:nowrap" class="ft142">rinsed&#160;&#160;in&#160;&#160;PBS&#160;&#160;and&#160;&#160;cells&#160;&#160;were&#160;&#160;scraped&#160;&#160;off&#160;&#160;of&#160;&#160;the&#160;&#160;upper&#160;</p>
<p style="position:absolute;top:446px;left:87px;white-space:nowrap" class="ft142">chamber.&#160;Remaining&#160;cells&#160;were&#160;fixed&#160;in&#160;4%&#160;PFA&#160;for&#160;10&#160;</p>
<p style="position:absolute;top:464px;left:87px;white-space:nowrap" class="ft142">minutes.&#160;Transwells&#160;were&#160;rinsed&#160;in&#160;PBS&#160;and&#160;stained&#160;with&#160;</p>
<p style="position:absolute;top:482px;left:87px;white-space:nowrap" class="ft142">1&#160;μg/mL&#160;4’,&#160;6-Diamidino-2-Phenylindole&#160;Dihydrochloride&#160;</p>
<p style="position:absolute;top:500px;left:87px;white-space:nowrap" class="ft142">(DAPI)&#160;for&#160;10&#160;minutes.&#160;The&#160;number&#160;of&#160;invading&#160;cells&#160;was&#160;</p>
<p style="position:absolute;top:518px;left:87px;white-space:nowrap" class="ft142">counted in 4 fields of view for each sample.</p>
<p style="position:absolute;top:554px;left:87px;white-space:nowrap" class="ft144"><b>Colony formation assay</b></p>
<p style="position:absolute;top:587px;left:123px;white-space:nowrap" class="ft142">MCF-10A&#160;cells were plated at 3 × 104&#160;cells per&#160;</p>
<p style="position:absolute;top:605px;left:87px;white-space:nowrap" class="ft142">well and MDA-MB-231 were plated at 5 × 103&#160;cells per&#160;</p>
<p style="position:absolute;top:623px;left:87px;white-space:nowrap" class="ft142">well&#160;of&#160;a&#160;six&#160;well&#160;plate.&#160;The&#160;wells&#160;were&#160;first&#160;coated&#160;in&#160;</p>
<p style="position:absolute;top:641px;left:87px;white-space:nowrap" class="ft142">1.5 mL&#160;of 0.8% agarose diluted in normal culture media.&#160;</p>
<p style="position:absolute;top:659px;left:87px;white-space:nowrap" class="ft142">Cells were plated in 1.5 mL&#160;of 0.4% agarose diluted in&#160;</p>
<p style="position:absolute;top:677px;left:87px;white-space:nowrap" class="ft142">normal culture media and the agarose was allowed to&#160;</p>
<p style="position:absolute;top:695px;left:87px;white-space:nowrap" class="ft142">set&#160;at&#160;room&#160;temperature&#160;for&#160;1&#160;hr.&#160;Samples&#160;were&#160;cultured&#160;</p>
<p style="position:absolute;top:713px;left:87px;white-space:nowrap" class="ft142">for 4 weeks with 0.5 mL&#160;culture media added on top of&#160;</p>
<p style="position:absolute;top:731px;left:87px;white-space:nowrap" class="ft142">the culture media with media exchanges every 2-3 days.&#160;</p>
<p style="position:absolute;top:749px;left:87px;white-space:nowrap" class="ft142">After&#160;4&#160;weeks,&#160;samples&#160;were&#160;fixed&#160;in&#160;10%&#160;formalin&#160;for&#160;</p>
<p style="position:absolute;top:767px;left:87px;white-space:nowrap" class="ft142">30&#160;minutes&#160;and&#160;incubated&#160;in&#160;.005%&#160;crystal&#160;violet&#160;for&#160;1&#160;hr.&#160;</p>
<p style="position:absolute;top:785px;left:87px;white-space:nowrap" class="ft142">Samples&#160;were&#160;rinsed&#160;in&#160;water&#160;until&#160;the&#160;washes&#160;were&#160;clear&#160;</p>
<p style="position:absolute;top:803px;left:87px;white-space:nowrap" class="ft142">of&#160;stain.&#160;Images&#160;were&#160;acquired&#160;using&#160;a&#160;ChemiDoc&#160;XRS+&#160;</p>
<p style="position:absolute;top:821px;left:87px;white-space:nowrap" class="ft142">gel&#160;imager&#160;(BioRad)&#160;and&#160;associated&#160;software.&#160;Colonies&#160;</p>
<p style="position:absolute;top:839px;left:87px;white-space:nowrap" class="ft142">were counted using ImageJ.</p>
<p style="position:absolute;top:875px;left:87px;white-space:nowrap" class="ft144"><b>Orthotopic breast tumor&#160;model</b></p>
<p style="position:absolute;top:908px;left:123px;white-space:nowrap" class="ft142">All&#160;procedures&#160;involving&#160;animals&#160;were&#160;approved&#160;by&#160;</p>
<p style="position:absolute;top:926px;left:87px;white-space:nowrap" class="ft142">the&#160;University&#160;of&#160;York&#160;Ethical&#160;Review&#160;Process&#160;and&#160;under&#160;</p>
<p style="position:absolute;top:944px;left:87px;white-space:nowrap" class="ft142">the&#160;authority&#160;of&#160;a&#160;UK&#160;Home&#160;Office&#160;project&#160;License.&#160;Six&#160;</p>
<p style="position:absolute;top:962px;left:87px;white-space:nowrap" class="ft142">week&#160;old&#160;female&#160;Rag2-/-, Il2rg-/-&#160;mice (Yorkshire Cancer&#160;</p>
<p style="position:absolute;top:980px;left:87px;white-space:nowrap" class="ft142">Research&#160;&#160;Unit,&#160;&#160;University&#160;&#160;of&#160;&#160;York)&#160;&#160;were&#160;&#160;selected&#160;&#160;at&#160;</p>
<p style="position:absolute;top:998px;left:87px;white-space:nowrap" class="ft142">random for MDA-MB-231 control or MDA-MB-231-IK&#160;</p>
<p style="position:absolute;top:1016px;left:87px;white-space:nowrap" class="ft142">injection.&#160;A&#160;5 × 105&#160;cell suspension was prepared in 20%&#160;</p>
<p style="position:absolute;top:1034px;left:87px;white-space:nowrap" class="ft142">v/v matrigel in saline and injected into the left inguinal&#160;</p>
<p style="position:absolute;top:1052px;left:87px;white-space:nowrap" class="ft142">mammary&#160;&#160;fat&#160;&#160;pad&#160;&#160;of&#160;&#160;isoflurane&#160;&#160;anaesthetized&#160;&#160;mice.&#160;&#160;A&#160;</p>
<p style="position:absolute;top:1070px;left:87px;white-space:nowrap" class="ft142">total&#160;of 14 and&#160;11 mice&#160;were&#160;injected&#160;with MDA-MB-231&#160;</p>
<p style="position:absolute;top:70px;left:487px;white-space:nowrap" class="ft142">control and MDA-MB-231-IK cells respectively across&#160;</p>
<p style="position:absolute;top:88px;left:487px;white-space:nowrap" class="ft142">4 independent experiments.&#160;Tumors did not take in 3 of&#160;</p>
<p style="position:absolute;top:106px;left:487px;white-space:nowrap" class="ft142">the control and 2 of the IK expressing mice and were not&#160;</p>
<p style="position:absolute;top:124px;left:487px;white-space:nowrap" class="ft142">included&#160;&#160;in&#160;&#160;analysis&#160;&#160;giving&#160;&#160;n&#160;&#160;=&#160;&#160;11&#160;&#160;for&#160;&#160;MDA-MB-231&#160;</p>
<p style="position:absolute;top:142px;left:487px;white-space:nowrap" class="ft142">control&#160;and&#160;n&#160;=&#160;9&#160;for&#160;MDA-MB-231-IK.&#160;The&#160;length&#160;and&#160;</p>
<p style="position:absolute;top:160px;left:487px;white-space:nowrap" class="ft142">width of primary tumors was measured daily with calipers&#160;</p>
<p style="position:absolute;top:178px;left:487px;white-space:nowrap" class="ft142">and the tumor volume was calculated as 0.5 × (length ×&#160;</p>
<p style="position:absolute;top:196px;left:487px;white-space:nowrap" class="ft142">width2). Mice were euthanized&#160;28 days after injection&#160;and&#160;</p>
<p style="position:absolute;top:214px;left:487px;white-space:nowrap" class="ft142">tumors&#160;and&#160;lungs&#160;were&#160;fixed&#160;in&#160;4%&#160;paraformaldehyde&#160;and&#160;</p>
<p style="position:absolute;top:232px;left:487px;white-space:nowrap" class="ft142">frozen.</p>
<p style="position:absolute;top:268px;left:487px;white-space:nowrap" class="ft144"><b>Immunohistochemistry</b></p>
<p style="position:absolute;top:302px;left:523px;white-space:nowrap" class="ft142">H&amp;E staining and immunohistochemistry were&#160;</p>
<p style="position:absolute;top:320px;left:487px;white-space:nowrap" class="ft142">performed as described [39].&#160;The following primary&#160;</p>
<p style="position:absolute;top:338px;left:487px;white-space:nowrap" class="ft142">antibodies&#160;were&#160;used:&#160;mouse&#160;anti-IK&#160;(1:20;&#160;Alomone);&#160;</p>
<p style="position:absolute;top:356px;left:487px;white-space:nowrap" class="ft142">rabbit&#160;anti-Ki67&#160;(1:5000;&#160;Abcam);&#160;rabbit&#160;anti-activated&#160;</p>
<p style="position:absolute;top:374px;left:487px;white-space:nowrap" class="ft142">caspase-3&#160;(1:200;&#160;R&amp;D&#160;Systems);&#160;rabbit&#160;anti-CD31&#160;(Santa&#160;</p>
<p style="position:absolute;top:392px;left:487px;white-space:nowrap" class="ft142">Cruz&#160;Biotechnology);&#160;mouse&#160;anti-HNA&#160;(1:100;&#160;Millipore).&#160;</p>
<p style="position:absolute;top:410px;left:487px;white-space:nowrap" class="ft142">Secondary antibodies were&#160;Alexa-488-conjugated goat&#160;</p>
<p style="position:absolute;top:428px;left:487px;white-space:nowrap" class="ft142">anti&#160;&#160;mouse/rabbit&#160;&#160;(1:500;&#160;&#160;Invitrogen).&#160;&#160;Samples&#160;&#160;were&#160;</p>
<p style="position:absolute;top:446px;left:487px;white-space:nowrap" class="ft142">mounted&#160;&#160;in&#160;&#160;Prolong&#160;&#160;Gold&#160;&#160;with&#160;&#160;DAPI&#160;&#160;(Invitrogen).&#160;</p>
<p style="position:absolute;top:464px;left:487px;white-space:nowrap" class="ft142">Sections&#160;were&#160;scanned&#160;at&#160;20X&#160;using&#160;a&#160;Zeiss&#160;AxioScan.</p>
<p style="position:absolute;top:482px;left:487px;white-space:nowrap" class="ft142">Z1&#160;slide&#160;scanner.&#160;Images&#160;were&#160;exported&#160;into&#160;ImageJ&#160;for&#160;</p>
<p style="position:absolute;top:500px;left:487px;white-space:nowrap" class="ft142">processing. Brightness/contrast was adjusted using the&#160;</p>
<p style="position:absolute;top:518px;left:487px;white-space:nowrap" class="ft142">ImageJ “Auto” function. Density of Ki67+&#160;or activated&#160;</p>
<p style="position:absolute;top:536px;left:487px;white-space:nowrap" class="ft142">caspase-3+&#160;cells, CD31+&#160;vessel structures, and metastasis&#160;</p>
<p style="position:absolute;top:554px;left:487px;white-space:nowrap" class="ft142">to lungs were measured across scanned images of whole&#160;</p>
<p style="position:absolute;top:572px;left:487px;white-space:nowrap" class="ft142">sections, blinded to treatment [39, 40].</p>
<p style="position:absolute;top:608px;left:487px;white-space:nowrap" class="ft144"><b>Statistics</b></p>
<p style="position:absolute;top:641px;left:523px;white-space:nowrap" class="ft142">Statistics&#160;&#160;were&#160;&#160;analyzed&#160;&#160;in&#160;&#160;Prism&#160;&#160;5&#160;&#160;and&#160;</p>
<p style="position:absolute;top:659px;left:487px;white-space:nowrap" class="ft142">significance&#160;was&#160;determined&#160;using&#160;a&#160;two&#160;sample&#160;t-test&#160;</p>
<p style="position:absolute;top:677px;left:487px;white-space:nowrap" class="ft142">or a one-way&#160;ANOVA&#160;followed by either a Dunett&#160;</p>
<p style="position:absolute;top:695px;left:487px;white-space:nowrap" class="ft142">post test (to compare multiple conditions to a single&#160;</p>
<p style="position:absolute;top:713px;left:487px;white-space:nowrap" class="ft142">control) or a&#160;Tukey post test (for a comparison of all&#160;</p>
<p style="position:absolute;top:731px;left:487px;white-space:nowrap" class="ft142">conditions),&#160;alpha&#160;=&#160;0.05.&#160;In&#160;cases&#160;where&#160;a&#160;comparison&#160;</p>
<p style="position:absolute;top:749px;left:487px;white-space:nowrap" class="ft142">is&#160;made&#160;between&#160;two&#160;specific&#160;conditions&#160;from&#160;within&#160;</p>
<p style="position:absolute;top:767px;left:487px;white-space:nowrap" class="ft142">an&#160;ANOVA&#160;the q value is given, otherwise only the&#160;</p>
<p style="position:absolute;top:785px;left:487px;white-space:nowrap" class="ft142">p-value is given.&#160;All results are presented as mean with&#160;</p>
<p style="position:absolute;top:803px;left:487px;white-space:nowrap" class="ft142">standard deviation from 3 independent experiments&#160;</p>
<p style="position:absolute;top:821px;left:487px;white-space:nowrap" class="ft142">unless otherwise noted.</p>
<p style="position:absolute;top:857px;left:487px;white-space:nowrap" class="ft145"><b>Abbreviations</b></p>
<p style="position:absolute;top:890px;left:523px;white-space:nowrap" class="ft142">1-EBIO,&#160;&#160;1-&#160;&#160;Ethylbenzimidazolinone;&#160;&#160;DAPI,&#160;</p>
<p style="position:absolute;top:908px;left:487px;white-space:nowrap" class="ft142">4’,&#160;&#160;6-Diamidino-2-Phenylindole&#160;&#160;Dihydrochloride;&#160;</p>
<p style="position:absolute;top:926px;left:487px;white-space:nowrap" class="ft142">DMSO,&#160;&#160;dimethyl&#160;&#160;sulfoxide;&#160;&#160;EGTA,&#160;&#160;ethylene&#160;&#160;glycol-</p>
<p style="position:absolute;top:944px;left:487px;white-space:nowrap" class="ft142">bis(2-aminoethylether)-<i>N-N-N’-N’</i>-tetraacetic&#160;</p>
<p style="position:absolute;top:944px;left:803px;white-space:nowrap" class="ft142">acid;&#160;</p>
<p style="position:absolute;top:962px;left:487px;white-space:nowrap" class="ft142">FACS,&#160;&#160;fluorescence&#160;&#160;activated&#160;&#160;cell&#160;&#160;sorting;&#160;&#160;FBS,&#160;&#160;fetal&#160;</p>
<p style="position:absolute;top:980px;left:487px;white-space:nowrap" class="ft142">bovine&#160;&#160;serum;&#160;&#160;HEPES,&#160;&#160;4-(2-Hydroxyethyl)piperazine-</p>
<p style="position:absolute;top:998px;left:487px;white-space:nowrap" class="ft142">1-ethanesulfonic&#160;&#160;acid;&#160;&#160;IK,&#160;&#160;intermediate&#160;&#160;conductance&#160;</p>
<p style="position:absolute;top:1016px;left:487px;white-space:nowrap" class="ft142">calcium-activated&#160;&#160;potassium&#160;&#160;channel;&#160;&#160;PBS,&#160;&#160;phosphate-</p>
<p style="position:absolute;top:1034px;left:487px;white-space:nowrap" class="ft142">buffered&#160;saline;&#160;RFP,&#160;red&#160;fluorescent&#160;protein;&#160;ROI,&#160;region&#160;</p>
<p style="position:absolute;top:1052px;left:487px;white-space:nowrap" class="ft142">of&#160;&#160;interest;&#160;&#160;SK,&#160;&#160;small&#160;&#160;conductance&#160;&#160;calcium-activated&#160;</p>
<p style="position:absolute;top:1070px;left:487px;white-space:nowrap" class="ft142">potassium channel;&#160;V</p>
<p style="position:absolute;top:1081px;left:616px;white-space:nowrap" class="ft143">mem, membrane potential</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>66c92c4fd6c5899239528c7d73898d26-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft150{font-size:11px;font-family:Times;color:#c02f3b;}
	.ft151{font-size:11px;font-family:Times;color:#231f20;}
	.ft152{font-size:14px;font-family:Times;color:#ac2b30;}
	.ft153{font-size:13px;font-family:Times;color:#231f20;}
	.ft154{font-size:16px;font-family:Times;color:#ac2b30;}
	.ft155{font-size:11px;line-height:18px;font-family:Times;color:#231f20;}
	.ft156{font-size:11px;line-height:21px;font-family:Times;color:#231f20;}
	.ft157{font-size:11px;line-height:17px;font-family:Times;color:#231f20;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page15-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft150">Oncotarget</p>
<p style="position:absolute;top:1111px;left:438px;white-space:nowrap" class="ft151">42396</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft150">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:69px;left:87px;white-space:nowrap" class="ft152"><b>Author&#160;contributions</b></p>
<p style="position:absolute;top:103px;left:123px;white-space:nowrap" class="ft153">The conception and the design of the studies were&#160;</p>
<p style="position:absolute;top:121px;left:87px;white-space:nowrap" class="ft153">performed by&#160;AET, DLK, and ML, acquisition of data&#160;</p>
<p style="position:absolute;top:139px;left:87px;white-space:nowrap" class="ft153">was performed by&#160;AET, MN, and CLF, and analysis and&#160;</p>
<p style="position:absolute;top:157px;left:87px;white-space:nowrap" class="ft153">interpretation&#160;of&#160;data&#160;was&#160;performed&#160;by&#160;AET&#160;and&#160;WB.&#160;</p>
<p style="position:absolute;top:175px;left:87px;white-space:nowrap" class="ft153">The original manuscript was drafted by&#160;AET&#160;and&#160;WB, and&#160;</p>
<p style="position:absolute;top:193px;left:87px;white-space:nowrap" class="ft153">manuscript revisions with important intellectual content&#160;</p>
<p style="position:absolute;top:211px;left:87px;white-space:nowrap" class="ft153">was performed by DLK and ML. No individuals who are&#160;</p>
<p style="position:absolute;top:229px;left:87px;white-space:nowrap" class="ft153">not already listed as authors made substantial contributions&#160;</p>
<p style="position:absolute;top:247px;left:87px;white-space:nowrap" class="ft153">to the manuscript.</p>
<p style="position:absolute;top:283px;left:87px;white-space:nowrap" class="ft154"><b>CONFLICTS OF&#160;INTEREST</b></p>
<p style="position:absolute;top:322px;left:123px;white-space:nowrap" class="ft153">The&#160;authors&#160;declare&#160;that&#160;they&#160;have&#160;no&#160;conflicts&#160;of&#160;</p>
<p style="position:absolute;top:340px;left:87px;white-space:nowrap" class="ft153">interest.</p>
<p style="position:absolute;top:379px;left:87px;white-space:nowrap" class="ft154"><b>FUNDING</b></p>
<p style="position:absolute;top:418px;left:123px;white-space:nowrap" class="ft153">Supported&#160;&#160;by&#160;&#160;Medical&#160;&#160;Research&#160;&#160;Council&#160;&#160;[UK]&#160;</p>
<p style="position:absolute;top:436px;left:87px;white-space:nowrap" class="ft153">Fellowship&#160;G1000508&#160;to&#160;WJB,&#160;the&#160;NIH&#160;(R01&#160;AR005593)&#160;</p>
<p style="position:absolute;top:454px;left:87px;white-space:nowrap" class="ft153">and the&#160;W.M. Keck Foundation to ML&#160;and DLK, and the&#160;</p>
<p style="position:absolute;top:472px;left:87px;white-space:nowrap" class="ft153">G.&#160;Harold and Leila&#160;Y. Mathers Charitable Foundation to&#160;</p>
<p style="position:absolute;top:490px;left:87px;white-space:nowrap" class="ft153">ML. M.L. gratefully acknowledges support of the&#160;Allen&#160;</p>
<p style="position:absolute;top:508px;left:87px;white-space:nowrap" class="ft153">Discovery&#160;&#160;Center&#160;&#160;program&#160;&#160;through&#160;&#160;The&#160;&#160;Paul&#160;&#160;G.&#160;Allen&#160;</p>
<p style="position:absolute;top:526px;left:87px;white-space:nowrap" class="ft153">Frontiers Group.</p>
<p style="position:absolute;top:564px;left:87px;white-space:nowrap" class="ft154"><b>REFERENCES</b></p>
<p style="position:absolute;top:605px;left:93px;white-space:nowrap" class="ft151">1.&#160;&#160;Institute&#160;NC.&#160;(2012).&#160;SEER&#160;Stat&#160;Fact&#160;Sheets:&#160;Female&#160;Breast&#160;</p>
<p style="position:absolute;top:623px;left:114px;white-space:nowrap" class="ft155">Cancer.&#160;&#160;Surveillance,&#160;&#160;Epidemiology,&#160;&#160;and&#160;&#160;End&#160;&#160;Results&#160;<br/>Program.&#160;(http://seer.cancer.gov/statfacts/html/breast.html:&#160;<br/>National Cancer Institute).</p>
<p style="position:absolute;top:680px;left:93px;white-space:nowrap" class="ft151">2.&#160;&#160;Mina&#160;&#160;LA,&#160;&#160;Sledge&#160;&#160;GW,&#160;&#160;Jr.&#160;&#160;Rethinking&#160;&#160;the&#160;&#160;metastatic&#160;</p>
<p style="position:absolute;top:698px;left:114px;white-space:nowrap" class="ft155">cascade&#160;as&#160;a&#160;therapeutic&#160;target.&#160;Nat&#160;Rev&#160;Clin&#160;Oncol.&#160;2011;&#160;<br/>8:325-332.</p>
<p style="position:absolute;top:737px;left:93px;white-space:nowrap" class="ft156">3.&#160;&#160;Huber&#160;SM.&#160;Oncochannels.&#160;Cell&#160;calcium.&#160;2013;&#160;53:241-255.<br/>4.&#160;&#160;Cardone&#160;RA,&#160;Casavola&#160;V,&#160;Reshkin&#160;SJ.&#160;The&#160;role&#160;of&#160;disturbed&#160;</p>
<p style="position:absolute;top:776px;left:114px;white-space:nowrap" class="ft157">pH&#160;dynamics&#160;and&#160;the&#160;Na+/H+&#160;exchanger&#160;in&#160;metastasis.&#160;<br/>Nature Reviews Cancer. 2005; 5:786-795.</p>
<p style="position:absolute;top:815px;left:93px;white-space:nowrap" class="ft151">5.&#160;&#160;Huang&#160;X,&#160;Jan&#160;LY.&#160;Targeting&#160;potassium&#160;channels&#160;in&#160;cancer.&#160;</p>
<p style="position:absolute;top:833px;left:114px;white-space:nowrap" class="ft151">Journal of Cell Biology. 2014; 206:151-162.</p>
<p style="position:absolute;top:854px;left:93px;white-space:nowrap" class="ft151">6.&#160;&#160;Nelson&#160;M,&#160;Yang&#160;M,&#160;Dowle&#160;AA,&#160;Thomas&#160;JR,&#160;Brackenbury&#160;</p>
<p style="position:absolute;top:872px;left:114px;white-space:nowrap" class="ft155">WJ.&#160;The sodium channel-blocking antiepileptic drug&#160;<br/>phenytoin inhibits breast tumour growth and metastasis.&#160;<br/>Mol Cancer. 2015; 14:13.</p>
<p style="position:absolute;top:929px;left:93px;white-space:nowrap" class="ft151">7.&#160;&#160;Okada&#160;Y. Ion channels and transporters involved in&#160;</p>
<p style="position:absolute;top:947px;left:114px;white-space:nowrap" class="ft155">cell volume regulation and sensor mechanisms. Cell&#160;<br/>Biochemistry and Biophysics. 2004; 41:233-258.</p>
<p style="position:absolute;top:986px;left:94px;white-space:nowrap" class="ft151">8.&#160;&#160;House CD,&#160;Vaske CJ, Schwartz&#160;AM, Obias&#160;V, Frank B, Luu&#160;</p>
<p style="position:absolute;top:1004px;left:114px;white-space:nowrap" class="ft155">T,&#160;&#160;Sarvazyan&#160;&#160;N,&#160;&#160;Irby&#160;&#160;R,&#160;&#160;Strausberg&#160;&#160;RL,&#160;&#160;Hales&#160;TG,&#160;&#160;Stuart&#160;<br/>JM, Lee NH.&#160;Voltage-Gated Na+ Channel SCN5A&#160;Is a Key&#160;<br/>Regulator&#160;of&#160;a&#160;Gene&#160;Transcriptional&#160;Network&#160;That&#160;Controls&#160;<br/>Colon&#160;Cancer&#160;Invasion.&#160;Cancer&#160;research.&#160;2010;&#160;70:6957-6967.</p>
<p style="position:absolute;top:71px;left:493px;white-space:nowrap" class="ft151">9.&#160;&#160;Pardo&#160;LA,&#160;del&#160;Camino&#160;D,&#160;Sanchez&#160;A,&#160;Alves&#160;F,&#160;Bruggemann&#160;</p>
<p style="position:absolute;top:89px;left:514px;white-space:nowrap" class="ft155">A, Beckh S, Stuhmer&#160;W. Oncogenic potential of EAG K+&#160;<br/>channels. Embo Journal. 1999; 18:5540-5547.</p>
<p style="position:absolute;top:128px;left:487px;white-space:nowrap" class="ft151">10.&#160;&#160;Kunzelmann K. Ion channels and&#160;cancer.&#160;Journal of&#160;</p>
<p style="position:absolute;top:146px;left:514px;white-space:nowrap" class="ft151">Membrane Biology. 2005; 205:159-173.</p>
<p style="position:absolute;top:167px;left:487px;white-space:nowrap" class="ft151">11.&#160;&#160;Ouadid-Ahidouch&#160;H,&#160;Roudbaraki&#160;M,&#160;Delcourt&#160;P,&#160;Ahidouch&#160;</p>
<p style="position:absolute;top:185px;left:514px;white-space:nowrap" class="ft155">A,&#160;&#160;Joury&#160;&#160;N,&#160;&#160;Prevarskaya&#160;&#160;N.&#160;&#160;Functional&#160;&#160;and&#160;&#160;molecular&#160;<br/>identification&#160;of&#160;intermediate-conductance&#160;Ca2+-activated&#160;<br/>K+ channels in breast cancer cells: association with cell&#160;<br/>cycle&#160;&#160;progression.&#160;American&#160;&#160;Journal&#160;&#160;of&#160;&#160;Physiology-Cell&#160;<br/>Physiology. 2004; 287:C125-C134.</p>
<p style="position:absolute;top:278px;left:487px;white-space:nowrap" class="ft151">12.&#160;&#160;Parihar&#160;AS,&#160;Coghlan&#160;MJ,&#160;Gopalakrishnan&#160;M,&#160;Shieh&#160;CC.&#160;</p>
<p style="position:absolute;top:296px;left:514px;white-space:nowrap" class="ft155">Effects of&#160;intermediate-conductance&#160;Ca2+ activated&#160;<br/>K+-channel modulators on human prostate cancer cell&#160;<br/>proliferation.&#160;&#160;European&#160;&#160;journal&#160;&#160;of&#160;&#160;pharmacology.&#160;&#160;2003;&#160;<br/>471:157-164.</p>
<p style="position:absolute;top:371px;left:487px;white-space:nowrap" class="ft151">13.&#160;&#160;Schwab&#160;&#160;A,&#160;&#160;Nechyporuk-Zloy&#160;&#160;V,&#160;&#160;Gassner&#160;&#160;B,&#160;&#160;Schulz&#160;&#160;C,&#160;</p>
<p style="position:absolute;top:389px;left:514px;white-space:nowrap" class="ft155">Kessler&#160;&#160;W,&#160;&#160;Mally&#160;&#160;S,&#160;&#160;Roemer&#160;&#160;M,&#160;&#160;Stock&#160;&#160;C.&#160;&#160;Dynamic&#160;<br/>redistribution of calcium sensitive potassium channels&#160;<br/>(hKCa3.1) in migrating cells. Journal of cellular physiology.&#160;<br/>2012; 227:686-696.</p>
<p style="position:absolute;top:464px;left:487px;white-space:nowrap" class="ft151">14.&#160;&#160;Liu&#160;Y,&#160;Zhao&#160;L,&#160;Ma&#160;WY,&#160;Cao&#160;XF,&#160;Chen&#160;HY,&#160;Feng&#160;D,&#160;Liang&#160;</p>
<p style="position:absolute;top:482px;left:514px;white-space:nowrap" class="ft155">J,&#160;&#160;Yin&#160;&#160;K,&#160;&#160;Jiang&#160;&#160;XF.&#160;&#160;The&#160;&#160;Blockage&#160;&#160;of&#160;&#160;KCa3.1&#160;&#160;Channel&#160;<br/>Inhibited&#160;Proliferation,&#160;Migration&#160;and&#160;Promoted&#160;Apoptosis&#160;<br/>of Human Hepatocellular Carcinoma Cells. Journal of&#160;<br/>Cancer. 2015; 6:643-651.</p>
<p style="position:absolute;top:557px;left:487px;white-space:nowrap" class="ft151">15.&#160;&#160;Turner&#160;&#160;KL,&#160;&#160;Honasoge&#160;&#160;A,&#160;&#160;Robert&#160;&#160;SM,&#160;&#160;McFerrin&#160;&#160;MM,&#160;</p>
<p style="position:absolute;top:575px;left:514px;white-space:nowrap" class="ft155">Sontheimer H.&#160;A&#160;proinvasive role for the Ca2+-activated K+&#160;<br/>channel&#160;KCa3.1&#160;in&#160;malignant&#160;glioma.&#160;Glia.&#160;2014;&#160;62:971-981.</p>
<p style="position:absolute;top:614px;left:487px;white-space:nowrap" class="ft151">16.&#160;&#160;Wang&#160;ZH,&#160;Shen&#160;B,&#160;Yao&#160;HL,&#160;Jia&#160;Y,&#160;Ren&#160;J,&#160;Feng&#160;Y,&#160;Wang&#160;YZ.&#160;</p>
<p style="position:absolute;top:632px;left:514px;white-space:nowrap" class="ft155">Blockage of intermediate-conductance-Ca2(+)-activated K+&#160;<br/>channels inhibits progression of human endometrial cancer.&#160;<br/>Oncogene. 2007; 26:5107-5114.</p>
<p style="position:absolute;top:689px;left:487px;white-space:nowrap" class="ft151">17.&#160;&#160;Lallet-Daher&#160;&#160;H,&#160;&#160;Roudbaraki&#160;&#160;M,&#160;&#160;Bavencoffe&#160;&#160;A,&#160;&#160;Mariot&#160;</p>
<p style="position:absolute;top:707px;left:514px;white-space:nowrap" class="ft155">P,&#160;Gackiere&#160;F,&#160;Bidaux&#160;G,&#160;Urbain&#160;R,&#160;Gosset&#160;P,&#160;Delcourt&#160;P,&#160;<br/>Fleurisse L, Slomianny C, Dewailly E, Mauroy B, Bonnal&#160;<br/>JL,&#160;Skryma&#160;R,&#160;Prevarskaya&#160;N.&#160;Intermediate-conductance&#160;<br/>Ca2+-activated K+ channels (IKCa1) regulate&#160;human&#160;<br/>prostate&#160;cancer&#160;cell&#160;proliferation&#160;through&#160;a&#160;close&#160;control&#160;of&#160;<br/>calcium entry. Oncogene. 2009; 28:1792-1806.</p>
<p style="position:absolute;top:818px;left:487px;white-space:nowrap" class="ft151">18.&#160;&#160;Zhang&#160;PS,&#160;Yang&#160;XW,&#160;Yin&#160;Q,&#160;Yi&#160;JL,&#160;Shen&#160;WZ,&#160;Zhao&#160;L,&#160;</p>
<p style="position:absolute;top:836px;left:514px;white-space:nowrap" class="ft155">Zhu&#160;&#160;Z,&#160;&#160;Liu&#160;&#160;JW.&#160;&#160;Inhibition&#160;&#160;of&#160;&#160;SK4&#160;&#160;Potassium&#160;&#160;Channels&#160;<br/>Suppresses&#160;Cell&#160;Proliferation,&#160;Migration&#160;and&#160;the&#160;Epithelial-<br/>Mesenchymal&#160;Transition in&#160;Triple-Negative Breast Cancer&#160;<br/>Cells. Plos One. 2016; 11:17.</p>
<p style="position:absolute;top:911px;left:487px;white-space:nowrap" class="ft151">19.&#160;&#160;Rajaram&#160;M,&#160;Li&#160;JY,&#160;Egeblad&#160;M,&#160;Powers&#160;RS.&#160;System-Wide&#160;</p>
<p style="position:absolute;top:929px;left:514px;white-space:nowrap" class="ft155">Analysis&#160;Reveals&#160;a&#160;Complex&#160;Network&#160;of&#160;Tumor-Fibroblast&#160;<br/>Interactions&#160;&#160;Involved&#160;&#160;in&#160;&#160;Tumorigenicity.&#160;&#160;Plos&#160;&#160;Genetics.&#160;<br/>2013; 9:16.</p>
<p style="position:absolute;top:986px;left:487px;white-space:nowrap" class="ft151">20.&#160;&#160;Pedarzani&#160;P,&#160;Mosbacher&#160;J,&#160;Rivard&#160;A,&#160;Cingolani&#160;LA,&#160;Oliver&#160;</p>
<p style="position:absolute;top:1004px;left:514px;white-space:nowrap" class="ft155">D,&#160;Stocker&#160;M,&#160;Adelman&#160;JP,&#160;Fakler&#160;B.&#160;Control&#160;of&#160;electrical&#160;<br/>activity in central neurons by modulating the gating of&#160;<br/>small conductance&#160;Ca2+-activated&#160;K+ channels. Journal of&#160;<br/>Biological Chemistry. 2001; 276:9762-9769.</p>
</div>
</body>
</html>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
<title>66c92c4fd6c5899239528c7d73898d26-html.html</title>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8"/>
 <br/>
<style type="text/css">
<!--
	p {margin: 0; padding: 0;}	.ft160{font-size:11px;font-family:Times;color:#c02f3b;}
	.ft161{font-size:11px;font-family:Times;color:#231f20;}
	.ft162{font-size:11px;font-family:Times;color:#231f20;}
	.ft163{font-size:11px;line-height:18px;font-family:Times;color:#231f20;}
	.ft164{font-size:11px;line-height:17px;font-family:Times;color:#231f20;}
-->
</style>
</head>
<body bgcolor="#A0A0A0" vlink="blue" link="blue">
<div id="page16-div" style="position:relative;width:918px;height:1188px;">
<p style="position:absolute;top:1111px;left:757px;white-space:nowrap" class="ft160">Oncotarget</p>
<p style="position:absolute;top:1111px;left:438px;white-space:nowrap" class="ft161">42397</p>
<p style="position:absolute;top:1109px;left:69px;white-space:nowrap" class="ft160">www.impactjournals.com/oncotarget</p>
<p style="position:absolute;top:71px;left:87px;white-space:nowrap" class="ft161">21.&#160;&#160;Ciardiello F, McGeady ML, Kim N, Basolo F, Hynes&#160;</p>
<p style="position:absolute;top:89px;left:114px;white-space:nowrap" class="ft163">N,&#160;Langton&#160;BC,&#160;Yokozaki&#160;H,&#160;Saeki&#160;T,&#160;Elliott&#160;JW,&#160;Masui&#160;<br/>H,&#160;&#160;Mendelsohn&#160;&#160;J,&#160;&#160;Soule&#160;&#160;H,&#160;&#160;Russo&#160;&#160;J,&#160;&#160;Salomon&#160;&#160;DS.&#160;<br/>Transforming&#160;growth&#160;factor-alpha&#160;expression&#160;is&#160;enhanced&#160;<br/>in human mammary epithelial-cells transformed by an&#160;<br/>activated&#160;C-HA-Ras&#160;protooncogene&#160;but&#160;not&#160;by&#160;the&#160;c-Neu&#160;<br/>Protooncogene,&#160;&#160;and&#160;&#160;overexpression&#160;&#160;of&#160;&#160;the&#160;Transforming&#160;<br/>growth factor-alpha complementary-DNA&#160;leads to&#160;<br/>transformation.&#160;&#160;Cell&#160;&#160;Growth&#160;&#160;&amp;&#160;&#160;Differentiation.&#160;&#160;1990;&#160;<br/>1:407-420.</p>
<p style="position:absolute;top:254px;left:87px;white-space:nowrap" class="ft161">22.&#160;&#160;Kim IY,&#160;Yong HY, Kang KW, Moon&#160;A. Overexpression of&#160;</p>
<p style="position:absolute;top:272px;left:114px;white-space:nowrap" class="ft163">ErbB2 induces invasion of MCF10A&#160;human breast epithelial&#160;<br/>cells via MMP-9. Cancer Letters. 2009; 275:227-233.</p>
<p style="position:absolute;top:311px;left:87px;white-space:nowrap" class="ft161">23.&#160;&#160;Zhang&#160;XJ,&#160;Zhao&#160;XA,&#160;Shao&#160;S,&#160;Zuo&#160;XX,&#160;Ning&#160;Q,&#160;Luo&#160;MN,&#160;</p>
<p style="position:absolute;top:329px;left:114px;white-space:nowrap" class="ft163">Gu&#160;SZ,&#160;Zhao&#160;XH.&#160;Notch1&#160;induces&#160;epithelial-mesenchymal&#160;<br/>transition and the cancer stem cell phenotype in breast&#160;<br/>cancer cells and STAT3 plays a key role. International&#160;<br/>Journal of Oncology. 2015; 46:1141-1148.</p>
<p style="position:absolute;top:404px;left:87px;white-space:nowrap" class="ft161">24.&#160;&#160;Buache E, Etique N,&#160;Alpy F, Stoll I, Muckensturm M,&#160;</p>
<p style="position:absolute;top:422px;left:114px;white-space:nowrap" class="ft163">Reina-San-Martin&#160;&#160;B,&#160;&#160;Chenard&#160;&#160;MP,&#160;&#160;Tomasetto&#160;&#160;C,&#160;&#160;Rio&#160;<br/>MC.&#160;&#160;Deficiency&#160;&#160;in&#160;&#160;trefoil&#160;&#160;factor&#160;&#160;1&#160;&#160;(TFF1)&#160;&#160;increases&#160;<br/>tumorigenicity&#160;of&#160;human&#160;breast&#160;cancer&#160;cells&#160;and&#160;mammary&#160;<br/>tumor development in&#160;TFF1-knockout mice. Oncogene.&#160;<br/>2011; 30:3261-3273.</p>
<p style="position:absolute;top:515px;left:87px;white-space:nowrap" class="ft161">25.&#160;&#160;Giunciuglio D, Culty M, Fassina G, Masiello L,&#160;</p>
<p style="position:absolute;top:533px;left:114px;white-space:nowrap" class="ft163">Melchiori&#160;&#160;A,&#160;&#160;Paglialunga&#160;&#160;G,&#160;&#160;Arand&#160;&#160;G,&#160;&#160;Ciardiello&#160;&#160;F,&#160;<br/>Basolo F,&#160;Thompson EW,&#160;Albini&#160;A. Invasive phenotype&#160;<br/>of&#160;MCF10A&#160;cells&#160;overexpressing&#160;c-Ha-ras&#160;and&#160;c-erbB-2&#160;<br/>oncogenes.&#160;&#160;International&#160;&#160;Journal&#160;&#160;of&#160;&#160;Cancer.&#160;&#160;1995;&#160;<br/>63:815-822.</p>
<p style="position:absolute;top:626px;left:87px;white-space:nowrap" class="ft161">26.&#160;&#160;Krick&#160;&#160;S,&#160;&#160;Platoshyn&#160;&#160;O,&#160;&#160;Sweeney&#160;&#160;M,&#160;&#160;Kim&#160;&#160;H,&#160;&#160;Yuan&#160;&#160;JX.&#160;</p>
<p style="position:absolute;top:644px;left:114px;white-space:nowrap" class="ft163">Activation of K+ channels induces apoptosis in vascular&#160;<br/>smooth&#160;muscle&#160;cells.&#160;American&#160;Journal&#160;of&#160;Physiology-Cell&#160;<br/>Physiology. 2001; 280:C970-C979.</p>
<p style="position:absolute;top:701px;left:87px;white-space:nowrap" class="ft161">27.&#160;&#160;Turner KL, Sontheimer H. KCa3.1 modulates neuroblast&#160;</p>
<p style="position:absolute;top:719px;left:114px;white-space:nowrap" class="ft163">migration&#160;along&#160;the&#160;rostral&#160;migratory&#160;stream&#160;(RMS)&#160;<i>in vivo</i>.&#160;<br/>Cereb Cortex. 2014; 24:2388-2400.</p>
<p style="position:absolute;top:758px;left:87px;white-space:nowrap" class="ft161">28.&#160;&#160;Wang&#160;&#160;ZH,&#160;&#160;Shen&#160;&#160;B,&#160;&#160;Yao&#160;&#160;HL,&#160;&#160;Jia&#160;&#160;YC,&#160;&#160;Ren&#160;&#160;J,&#160;&#160;Feng&#160;&#160;YJ,&#160;</p>
<p style="position:absolute;top:776px;left:114px;white-space:nowrap" class="ft163">Wang&#160;YZ.&#160;Blockage&#160;of&#160;intermediate-conductance-Ca(2+)&#160;<br/>-activated K(+) channels inhibits progression of human&#160;<br/>endometrial cancer. Oncogene. 2007; 26:5107-5114.</p>
<p style="position:absolute;top:833px;left:87px;white-space:nowrap" class="ft161">29.&#160;&#160;Jager H, Dreker&#160;T, Buck&#160;A, Giehl K, Gress&#160;T, Grissmer&#160;</p>
<p style="position:absolute;top:851px;left:114px;white-space:nowrap" class="ft164">S. Blockage of intermediate-conductance Ca2+-activated&#160;<br/>K+ channels inhibit human pancreatic cancer cell growth&#160;<br/><i>in vitro</i>. Molecular Pharmacology. 2004; 65:630-638.</p>
<p style="position:absolute;top:908px;left:87px;white-space:nowrap" class="ft161">30.&#160;&#160;Hickman&#160;&#160;JA,&#160;&#160;Graeser&#160;&#160;R,&#160;&#160;de&#160;&#160;Hoogt&#160;&#160;R,&#160;Vidic&#160;&#160;S,&#160;&#160;Brito&#160;&#160;C,&#160;</p>
<p style="position:absolute;top:926px;left:114px;white-space:nowrap" class="ft163">Gutekunst&#160;&#160;M,&#160;&#160;van&#160;&#160;der&#160;&#160;Kuip&#160;&#160;H,&#160;&#160;Consortium&#160;&#160;IP.&#160;&#160;Three-<br/>dimensional models of cancer for pharmacology and cancer&#160;</p>
<p style="position:absolute;top:71px;left:514px;white-space:nowrap" class="ft163">cell biology: Capturing tumor complexity&#160;<i>in vitro</i>/<i>ex vivo</i>.&#160;<br/>Biotechnol J. 2014; 9:1115-1128.</p>
<p style="position:absolute;top:110px;left:487px;white-space:nowrap" class="ft161">31.&#160;&#160;Cortazar&#160;&#160;P,&#160;&#160;Johnson&#160;&#160;BE.&#160;&#160;Review&#160;&#160;of&#160;&#160;the&#160;&#160;efficacy&#160;&#160;of&#160;</p>
<p style="position:absolute;top:128px;left:514px;white-space:nowrap" class="ft164">individualized&#160;chemotherapy&#160;selected&#160;by&#160;<i>in&#160;vitro</i>&#160;drug&#160;<br/>sensitivity testing for patients with cancer. J Clin Oncol.&#160;<br/>1999; 17:1625-1631.</p>
<p style="position:absolute;top:185px;left:487px;white-space:nowrap" class="ft161">32.&#160;&#160;Weigelt B, Ghajar CM, Bissell MJ.&#160;The need for complex&#160;</p>
<p style="position:absolute;top:203px;left:514px;white-space:nowrap" class="ft163">3D culture models to unravel novel pathways and identify&#160;<br/>accurate&#160;biomarkers&#160;in&#160;breast&#160;cancer.&#160;Advanced&#160;Drug&#160;<br/>Delivery Reviews. 2014; 69:42-51.</p>
<p style="position:absolute;top:260px;left:487px;white-space:nowrap" class="ft161">33.&#160;&#160;Marino&#160;M,&#160;Beny&#160;JL,&#160;Peyter&#160;AC,&#160;Bychkov&#160;R,&#160;Diaceri&#160;G,&#160;</p>
<p style="position:absolute;top:278px;left:514px;white-space:nowrap" class="ft163">Tolsa&#160;&#160;JF.&#160;&#160;Perinatal&#160;&#160;hypoxia&#160;&#160;triggers&#160;&#160;alterations&#160;&#160;in&#160;&#160;K+&#160;<br/>channels of adult pulmonary artery smooth muscle cells.&#160;<br/>American&#160;&#160;Journal&#160;&#160;of&#160;&#160;Physiology-Lung&#160;&#160;Cellular&#160;&#160;and&#160;<br/>Molecular Physiology. 2007; 293:L1171-L1182.</p>
<p style="position:absolute;top:353px;left:487px;white-space:nowrap" class="ft161">34.&#160;&#160;Eisenhut&#160;&#160;M,&#160;&#160;Wallace&#160;&#160;H.&#160;&#160;Ion&#160;&#160;channels&#160;&#160;in&#160;&#160;inflammation.&#160;</p>
<p style="position:absolute;top:371px;left:514px;white-space:nowrap" class="ft163">Pflugers&#160;&#160;Archiv-European&#160;&#160;Journal&#160;&#160;of&#160;&#160;Physiology.&#160;&#160;2011;&#160;<br/>461:401-421.</p>
<p style="position:absolute;top:410px;left:487px;white-space:nowrap" class="ft161">35.&#160;&#160;Arcangeli&#160;A, Becchetti&#160;A, Cherubini&#160;A, Crociani O,&#160;</p>
<p style="position:absolute;top:428px;left:514px;white-space:nowrap" class="ft163">Defilippi&#160;&#160;P,&#160;&#160;Guasti&#160;&#160;L,&#160;&#160;Hofmann&#160;&#160;G,&#160;&#160;Pillozzi&#160;&#160;S,&#160;&#160;Olivotto&#160;<br/>M,&#160;Wanke&#160;E.&#160;Physical&#160;and&#160;functional&#160;interaction&#160;between&#160;<br/>integrins&#160;&#160;and&#160;&#160;hERG&#160;&#160;potassium&#160;&#160;channels.&#160;&#160;Biochemical&#160;<br/>Society&#160;Transactions. 2004; 32:826-827.</p>
<p style="position:absolute;top:503px;left:487px;white-space:nowrap" class="ft161">36.&#160;&#160;Pillozzi&#160;S,&#160;Brizzi&#160;MF,&#160;Bernabei&#160;PA,&#160;Bartolozzi&#160;B,&#160;Caporale&#160;</p>
<p style="position:absolute;top:521px;left:514px;white-space:nowrap" class="ft163">R,&#160;Basile&#160;V,&#160;Boddi&#160;V,&#160;Pegoraro&#160;L,&#160;Becchetti&#160;A,&#160;Arcangeli&#160;A.&#160;<br/>VEGFR-1&#160;(FLT-1),&#160;beta(1)&#160;integrin,&#160;and&#160;hERG&#160;K+&#160;channel&#160;<br/>for a macromolecular signaling complex in acute myeloid&#160;<br/>leukemia:&#160;role&#160;in&#160;cell&#160;migration&#160;and&#160;clinical&#160;outcome.&#160;<br/>Blood. 2007; 110:1238-1250.</p>
<p style="position:absolute;top:614px;left:487px;white-space:nowrap" class="ft161">37.&#160;&#160;Girault&#160;&#160;A,&#160;&#160;Chebli&#160;&#160;J,&#160;&#160;Prive&#160;&#160;A,&#160;&#160;Trinh&#160;&#160;NT,&#160;&#160;Maille&#160;&#160;E,&#160;</p>
<p style="position:absolute;top:632px;left:514px;white-space:nowrap" class="ft163">Grygorczyk&#160;&#160;R,&#160;&#160;Brochiero&#160;&#160;E.&#160;&#160;Complementary&#160;&#160;roles&#160;&#160;of&#160;<br/>KCa3.1 channels and beta1-integrin&#160;during alveolar&#160;<br/>epithelial repair. Respir Res. 2015; 16:100.</p>
<p style="position:absolute;top:689px;left:487px;white-space:nowrap" class="ft161">38.&#160;&#160;Bonito&#160;B,&#160;Sauter&#160;DR,&#160;Schwab&#160;A,&#160;Djamgoz&#160;MB,&#160;Novak&#160;I.&#160;</p>
<p style="position:absolute;top:707px;left:514px;white-space:nowrap" class="ft163">K(Ca)3.1 (IK) modulates pancreatic cancer cell migration,&#160;<br/>invasion&#160;and&#160;proliferation:&#160;anomalous&#160;effects&#160;on&#160;TRAM-<br/>34.&#160;Pflugers&#160;Archiv-European&#160;Journal&#160;of&#160;Physiology.&#160;2016;&#160;<br/>468:1865-1875.</p>
<p style="position:absolute;top:782px;left:487px;white-space:nowrap" class="ft161">39.&#160;&#160;Nelson&#160;M,&#160;Millican-Slater&#160;R,&#160;Forrest&#160;LC,&#160;Brackenbury&#160;WJ.&#160;</p>
<p style="position:absolute;top:800px;left:514px;white-space:nowrap" class="ft163">The sodium channel beta1 subunit mediates outgrowth of&#160;<br/>neurite-like processes on breast cancer cells and promotes&#160;<br/>tumour&#160;&#160;growth&#160;&#160;and&#160;&#160;metastasis.&#160;&#160;Int&#160;&#160;J&#160;&#160;Cancer.&#160;&#160;2014;&#160;<br/>135:2338-2351.</p>
<p style="position:absolute;top:875px;left:487px;white-space:nowrap" class="ft161">40.&#160;&#160;Nelson&#160;M,&#160;Yang&#160;M,&#160;Millican-Slater&#160;R,&#160;Brackenbury&#160;WJ.&#160;</p>
<p style="position:absolute;top:893px;left:514px;white-space:nowrap" class="ft163">Nav1.5 regulates breast tumor growth and metastatic&#160;<br/>dissemination&#160;<i>in vivo</i>.&#160;Oncotarget.&#160;2015;&#160;6:32914-32929.&#160;<br/>doi: 10.18632/oncotarget.5441.</p>
</div>
</body>
</html>
